The Global COVID-19 Pandemic
Coronavirus disease (COVID-19) is an infectious disease caused by a novel member of the coronavirus family of viruses. Since Covid-19 was declared a global pandemic on March 11, 2020, millions of cases of have been documented in 192 countries and regions worldwide (Johns Hopkins University; World Health Organization)
About this Site: Coronavirus Research using the Laboratory Mouse
The laboratory mouse is an important preclinical model for studying coronavirus biology and treatment approaches. The information on this site summarizes information about mouse strains and genes relevant to the study of coronavirus infection and pathology. This information has been expertly curated from pre-prints and peer-reviewed publications dating back to the 1980s by biocuration scientists from the Mouse Genome Informatics (MGI) knowledgebase hosted at The Jackson Laboratory.
See all curated publications that report on mouse models and genes related to coronaviruses in MGI.
Mouse Strains Used in Coronavirus Research
Mouse strains used in coronavirus research with associated mouse phenotype categories and human disease terms and references citing the use of the mouse strains in coronavirus research. Under each reference is a list of keywords for the research areas and the viruses mentioned in the publication. A virus name appended with ‘MA’ indicates that the virus is a mouse adapted strain.
Mouse strain names are linked to strain detail pages at MGI. Human disease terms are linked to the Disease ontology resource at MGI. References are linked to the reference detail pages at MGI.
1-strain | 2-mgi | 3-attrs | 4-geno-mgi | 5-allele | 6-allele-mgi | 7-type | 8-subtypes | 9-do-term | 10-do-id | 11-mp-term | 12-mp-id | 13-cite | 14-jnum | 15-tags | Strain | Genotype Details | Human Disease and Mouse Phenotype Categories | References | Keywords |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
129-Ifngr1tm1Agt/J | MGI:2165098 | mutant strain|targeted mutation | MGI:6403197 | Ifngr1tm1Agt | MGI:1857286 | Targeted | Null/knockout | immune system | MP:0005387 | Frieman MB, PLoS Pathog 2010 Apr 8;6(4):e1000849 | J:286237 | Pathology|SARS-CoV-MA_virus | 129-Ifngr1tm1Agt/Jmutant strain|targeted mutation |
MGI:6403197 | immune system |
Frieman MB, PLoS Pathog 2010 Apr 8;6(4):e1000849 |
||
129S1/SvImJ | MGI:3037980 | inbred strain | MGI:3582226 | behavior/neurological immune system | MP:0005386 MP:0005387 | Gralinski LE, PLoS Genet 2015 Oct;11(10):e1005504 Josset L, RNA Biol 2014;11(7):875-90 Peng X, mBio 2010 Oct 26;1(5): Peng X, mBio 2011;2(6): Xiong H, G3 (Bethesda) 2014 Jun 5;4(8):1429-44 | J:268979 J:276026 J:276986 J:276989 J:276183 | Infection|SARS-CoV-MA_virus SARS-CoV-MA_virus | 129S1/SvImJinbred strain |
MGI:3582226 | behavior/neurological immune system |
Gralinski LE, PLoS Genet 2015 Oct;11(10):e1005504 Josset L, RNA Biol 2014;11(7):875-90 Peng X, mBio 2010 Oct 26;1(5): Peng X, mBio 2011;2(6): Xiong H, G3 (Bethesda) 2014 Jun 5;4(8):1429-44 |
||||||
129S2/SvPasCrl | MGI:3587894 | inbred strain | Walls AC, Cell Rep 2022 Aug 30;40(9):111299 Ying B, bioRxiv 2021 Aug;(): Ying B, bioRxiv 2022 Feb;(): | J:328107 J:309196 J:321873 | SARS-CoV-2_virus|Vaccine|Variant|VOC_B.1.351_Beta SARS-CoV-2-MA_virus|SARS-CoV-2_virus|Vaccine|VOC_B.1.1.7_Alpha|VOC_B.1.351_Beta|VOC_B.1.617.2_Delta Vaccine|VOC_B.1.1.529_Omicron | 129S2/SvPasCrlinbred strain |
Walls AC, Cell Rep 2022 Aug 30;40(9):111299 Ying B, bioRxiv 2021 Aug;(): Ying B, bioRxiv 2022 Feb;(): |
|||||||||||
129S6/SvEv-Stat1tm1Rds/Tac | MGI:3771555 | mutant strain|targeted mutation | MGI:3771372 | Stat1tm1Rds | MGI:1861949 | Targeted | Null/knockout | breast cancer severe acute respiratory syndrome | DOID:1612 DOID:2945 | cardiovascular system cellular digestive/alimentary system endocrine/exocrine glands hematopoietic system homeostasis/metabolism immune system integument liver/biliary system muscle nervous system respiratory system skeleton neoplasm mortality/aging | MP:0005385 MP:0005384 MP:0005381 MP:0005379 MP:0005397 MP:0005376 MP:0005387 MP:0010771 MP:0005370 MP:0005369 MP:0003631 MP:0005388 MP:0005390 MP:0002006 MP:0010768 | Frieman MB, PLoS Pathog 2010 Apr 8;6(4):e1000849 | J:286237 | Pathology|SARS-CoV-MA_virus | 129S6/SvEv-Stat1tm1Rds/Tacmutant strain|targeted mutation |
MGI:3771372 | cardiovascular system cellular digestive/alimentary system endocrine/exocrine glands hematopoietic system homeostasis/metabolism immune system integument liver/biliary system muscle nervous system respiratory system skeleton neoplasm mortality/aging breast cancer severe acute respiratory syndrome |
Frieman MB, PLoS Pathog 2010 Apr 8;6(4):e1000849 |
129S6/SvEvTac | MGI:3044417 | inbred strain | Roberts A, Virus Res 2008 Apr;133(1):20-32 Subbarao K, Trends Microbiol 2006 Jul;14(7):299-303 | J:286331 J:286332 | Infection|SARS-CoV_virus|Vaccine SARS-CoV_virus | 129S6/SvEvTacinbred strain |
Roberts A, Virus Res 2008 Apr;133(1):20-32 Subbarao K, Trends Microbiol 2006 Jul;14(7):299-303 |
|||||||||||
129X1/SvJ | MGI:3044210 | inbred strain | Okumura A, J Virol 1996 Jun;70(6):4146-9 | J:52540 | Mouse_Hepatitis_virus | 129X1/SvJinbred strain |
Okumura A, J Virol 1996 Jun;70(6):4146-9 |
|||||||||||
A/J | MGI:2159747 | inbred strain | MGI:3807714 | Coronavirus infectious disease | DOID:0080599 | hearing/vestibular/ear hematopoietic system immune system nervous system | MP:0005377 MP:0005397 MP:0005387 MP:0003631 | Dangi T, bioRxiv 2021 Jun;(): De Albuquerque N, J Virol 2006 Nov;80(21):10382-94 Gralinski LE, PLoS Genet 2015 Oct;11(10):e1005504 Josset L, RNA Biol 2014;11(7):875-90 Khanolkar A, J Immunol 2010 Jul 15;185(2):1132-41 Lee M, bioRxiv 2020 Dec;(): Lucchiari MA, J Gen Virol 1991 Jun;72(Pt 6):1317-22 Tian J, bioRxiv 2020;(): Tian J, bioRxiv 2021 Feb;(): Wang GZ, bioRxiv 2020;(): Wang Y, Invest Ophthalmol Vis Sci 1996 Jan;37(1):250-4 Xiong H, G3 (Bethesda) 2014 Jun 5;4(8):1429-44 | J:308670 J:288204 J:268979 J:276026 J:161935 J:299101 J:27269 J:295388 J:302152 J:296066 J:36900 J:276183 | SARS-CoV-2_virus|SARS-CoV_virus|Vaccine Mouse_Hepatitis_virus|Pathology Infection|SARS-CoV-MA_virus SARS-CoV-MA_virus Mouse_Hepatitis_virus|SARS-CoV-2_virus Mouse_Hepatitis_virus Mouse_Hepatitis_virus|Treatment Comorbidity|SARS-CoV-2_virus | A/Jinbred strain |
MGI:3807714 | Coronavirus infectious disease hearing/vestibular/ear hematopoietic system immune system nervous system |
Dangi T, bioRxiv 2021 Jun;(): De Albuquerque N, J Virol 2006 Nov;80(21):10382-94 Gralinski LE, PLoS Genet 2015 Oct;11(10):e1005504 Josset L, RNA Biol 2014;11(7):875-90 Khanolkar A, J Immunol 2010 Jul 15;185(2):1132-41 Lee M, bioRxiv 2020 Dec;(): Lucchiari MA, J Gen Virol 1991 Jun;72(Pt 6):1317-22 Tian J, bioRxiv 2020;(): Tian J, bioRxiv 2021 Feb;(): Wang GZ, bioRxiv 2020;(): Wang Y, Invest Ophthalmol Vis Sci 1996 Jan;37(1):250-4 Xiong H, G3 (Bethesda) 2014 Jun 5;4(8):1429-44 |
||||
A/JCr | MGI:6156905 | inbred strain | Khanolkar A, J Virol 2009 Sep;83(17):8946-56 | J:153918 | Mouse_Hepatitis_virus|Pathology | A/JCrinbred strain |
Khanolkar A, J Virol 2009 Sep;83(17):8946-56 |
|||||||||||
Arc:ARC(S) | MGI:5306408 | outbred stock | Eldi P, bioRxiv 2021 Sep;(): | J:310113 | SARS-CoV-2_virus|Vaccine | Arc:ARC(S)outbred stock |
Eldi P, bioRxiv 2021 Sep;(): |
|||||||||||
B10.BR-H2k2 H2-T18a/SgSnJ | MGI:2386242 | congenic|major histocompatibility congenic|mutant strain | Khanolkar A, J Virol 2009 Sep;83(17):8946-56 | J:153918 | Mouse_Hepatitis_virus|Pathology | B10.BR-H2k2 H2-T18a/SgSnJcongenic|major histocompatibility congenic|mutant strain |
Khanolkar A, J Virol 2009 Sep;83(17):8946-56 |
|||||||||||
B10.D2-Hc0 H2d H2-T18c/oSnJ | MGI:2160070 | congenic|major histocompatibility congenic|mutant strain | Khanolkar A, J Virol 2009 Sep;83(17):8946-56 | J:153918 | Mouse_Hepatitis_virus|Pathology | B10.D2-Hc0 H2d H2-T18c/oSnJcongenic|major histocompatibility congenic|mutant strain |
Khanolkar A, J Virol 2009 Sep;83(17):8946-56 |
|||||||||||
B6.129-Ido1tm1Alm/J | MGI:3603213 | congenic|mutant strain|targeted mutation | McDermott JE, BMC Syst Biol 2016 Sep 23;10(1):93 | J:288523 | Pathology|SARS-CoV-MA_virus | B6.129-Ido1tm1Alm/Jcongenic|mutant strain|targeted mutation |
McDermott JE, BMC Syst Biol 2016 Sep 23;10(1):93 |
|||||||||||
B6.129P2-Ace2tm1Pngr/J | MGI:5912242 | congenic|mutant strain|targeted mutation | MGI:5912243 MGI:6402915 | Ace2tm1Pngr | MGI:2661723 | Targeted | Null/knockout | cardiovascular system immune system | MP:0005385 MP:0005387 | Kuba K, Nat Med 2005 Aug;11(8):875-9 | J:286299 | Infection|SARS-CoV_virus | B6.129P2-Ace2tm1Pngr/Jcongenic|mutant strain|targeted mutation |
MGI:5912243 MGI:6402915 | cardiovascular system immune system |
Kuba K, Nat Med 2005 Aug;11(8):875-9 |
||
B6.129P2-Ccr2tm1Mae | MGI:3841132 | congenic|targeted mutation | MGI:3841005 | Ccr2tm1Mae | MGI:2158345 | Targeted | Null/knockout | age related macular degeneration Coronavirus infectious disease | DOID:10871 DOID:0080599 | behavior/neurological cardiovascular system hematopoietic system immune system nervous system pigmentation respiratory system vision/eye | MP:0005386 MP:0005385 MP:0005397 MP:0005387 MP:0003631 MP:0001186 MP:0005388 MP:0005391 | Sheahan T, PLoS Pathog 2008 Dec;4(12):e1000240 | J:162707 | Pathology|SARS-CoV-MA_virus | B6.129P2-Ccr2tm1Maecongenic|targeted mutation |
MGI:3841005 | behavior/neurological cardiovascular system hematopoietic system immune system nervous system pigmentation respiratory system vision/eye age related macular degeneration Coronavirus infectious disease |
Sheahan T, PLoS Pathog 2008 Dec;4(12):e1000240 |
B6.129P2-Ccr5tm1Kuz | MGI:4418878 | congenic|mutant strain|targeted mutation | MGI:4418655 | Ccr5tm1Kuz | MGI:1861911 | Targeted | Null/knockout | Coronavirus infectious disease | DOID:0080599 | behavior/neurological cardiovascular system immune system nervous system respiratory system vision/eye mortality/aging | MP:0005386 MP:0005385 MP:0005387 MP:0003631 MP:0005388 MP:0005391 MP:0010768 | Sheahan T, PLoS Pathog 2008 Dec;4(12):e1000240 | J:162707 | Pathology|SARS-CoV-MA_virus | B6.129P2-Ccr5tm1Kuzcongenic|mutant strain|targeted mutation |
MGI:4418655 | behavior/neurological cardiovascular system immune system nervous system respiratory system vision/eye mortality/aging Coronavirus infectious disease |
Sheahan T, PLoS Pathog 2008 Dec;4(12):e1000240 |
B6.129P2-Cxcr3tm1Dgen/J | MGI:3604638 | congenic|mutant strain|targeted mutation | McDermott JE, BMC Syst Biol 2016 Sep 23;10(1):93 | J:288523 | Pathology|SARS-CoV-MA_virus | B6.129P2-Cxcr3tm1Dgen/Jcongenic|mutant strain|targeted mutation |
McDermott JE, BMC Syst Biol 2016 Sep 23;10(1):93 |
|||||||||||
B6.129P2-Ighem1Rcas/J | MGI:6725129 | congenic|endonuclease-mediated mutation|mutant strain | Xu J, Nature 2021 Jun 7;(): | J:307753 | SARS-CoV-2_virus|Treatment|VOC_B.1.1.7_Alpha|VOC_B.1.351_Beta|VOC_P.1_Gamma | B6.129P2-Ighem1Rcas/Jcongenic|endonuclease-mediated mutation|mutant strain |
Xu J, Nature 2021 Jun 7;(): |
|||||||||||
B6.129P2-Lyz2tm1(cre)Ifo/J | MGI:2680712 | congenic|mutant strain|targeted mutation | Musiu C, bioRxiv 2021 May;(): Musiu C, Cell Death Differ 2021 Sep 13;(): | J:308717 J:313338 | SARS-CoV-2_virus Pathology|SARS-CoV-2_virus | B6.129P2-Lyz2tm1(cre)Ifo/Jcongenic|mutant strain|targeted mutation |
Musiu C, bioRxiv 2021 May;(): Musiu C, Cell Death Differ 2021 Sep 13;(): |
|||||||||||
B6.129P2-Myd88tm1Aki | MGI:3697090 | congenic|mutant strain|targeted mutation | MGI:3577712 | Myd88tm1Aki | MGI:2385681 | Targeted | Null/knockout | Coronavirus infectious disease | DOID:0080599 | cardiovascular system cellular digestive/alimentary system hearing/vestibular/ear hematopoietic system homeostasis/metabolism immune system nervous system renal/urinary system respiratory system mortality/aging | MP:0005385 MP:0005384 MP:0005381 MP:0005377 MP:0005397 MP:0005376 MP:0005387 MP:0003631 MP:0005367 MP:0005388 MP:0010768 | Sheahan T, PLoS Pathog 2008 Dec;4(12):e1000240 | J:162707 | Pathology|SARS-CoV-MA_virus | B6.129P2-Myd88tm1Akicongenic|mutant strain|targeted mutation |
MGI:3577712 | cardiovascular system cellular digestive/alimentary system hearing/vestibular/ear hematopoietic system homeostasis/metabolism immune system nervous system renal/urinary system respiratory system mortality/aging Coronavirus infectious disease |
Sheahan T, PLoS Pathog 2008 Dec;4(12):e1000240 |
B6.129P2-Nos2tm1Lau/J | MGI:2163101 | congenic|mutant strain|targeted mutation | Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 | J:296686 | Pathology|SARS-CoV-2_virus|Treatment | B6.129P2-Nos2tm1Lau/Jcongenic|mutant strain|targeted mutation |
Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 |
|||||||||||
B6.129P2(SJL)-Myd88tm1.1Defr | MGI:6272303 | congenic|mutant strain|targeted mutation | MGI:6272304 | Myd88tm1.1Defr | MGI:4421295 | Targeted | Null/knockout | behavior/neurological hematopoietic system immune system nervous system mortality/aging | MP:0005386 MP:0005397 MP:0005387 MP:0003631 MP:0010768 | Butchi N, J Virol 2015 Sep 15;89(18):9299-312 | J:224849 | Infection|Mouse_Hepatitis_virus|Pathology | B6.129P2(SJL)-Myd88tm1.1Defrcongenic|mutant strain|targeted mutation |
MGI:6272304 | behavior/neurological hematopoietic system immune system nervous system mortality/aging |
Butchi N, J Virol 2015 Sep 15;89(18):9299-312 |
||
B6.129S2(Cg)-Ace2tm1(ACE2)Dwnt/J | MGI:6469882 | congenic|mutant strain|targeted mutation | Winkler ES, J Virol 2022 Jan 12;96(1):e0151121 Zhou B, Nature 2021 Apr;592(7852):122-127 | J:331773 J:305777 | Infection|SARS-CoV-2_virus|VOC_B.1.1.7_Alpha|VOC_B.1.351_Beta Infection|SARS-CoV-2_virus | B6.129S2(Cg)-Ace2tm1(ACE2)Dwnt/Jcongenic|mutant strain|targeted mutation |
Winkler ES, J Virol 2022 Jan 12;96(1):e0151121 Zhou B, Nature 2021 Apr;592(7852):122-127 |
|||||||||||
B6.129S2-Ciitatm1Ccum/J | MGI:2164648 | congenic|mutant strain|targeted mutation | Chen JS, bioRxiv 2021 Jun;(): | J:308655 | SARS-CoV-2_virus|VOC_B.1.351_Beta | B6.129S2-Ciitatm1Ccum/Jcongenic|mutant strain|targeted mutation |
Chen JS, bioRxiv 2021 Jun;(): |
|||||||||||
B6.129S2-Ifnar1tm1Agt/Mmjax | MGI:4836218 | congenic|mutant strain|targeted mutation | Hassert M, PLoS Pathog 2020 Dec;16(12):e1009163 | J:319459 | Infection|SARS-CoV-2_virus | B6.129S2-Ifnar1tm1Agt/Mmjaxcongenic|mutant strain|targeted mutation |
Hassert M, PLoS Pathog 2020 Dec;16(12):e1009163 |
|||||||||||
B6.129S2-Ighmtm1Cgn/J | MGI:2163831 | congenic|mutant strain|targeted mutation | Israelow B, bioRxiv 2021 May;(): | J:308733 | Infection|SARS-CoV-2_virus | B6.129S2-Ighmtm1Cgn/Jcongenic|mutant strain|targeted mutation |
Israelow B, bioRxiv 2021 May;(): |
|||||||||||
B6.129S2-Plattm1Mlg/J | MGI:2162973 | congenic|mutant strain|targeted mutation | MGI:6433845 | Plattm1Mlg | MGI:1857288 | Targeted | Null/knockout | immune system mortality/aging | MP:0005387 MP:0010768 | Gralinski LE, mBio 2013 Aug 6;4(4): | J:288556 | Infection|Pathology|SARS-CoV-MA_virus | B6.129S2-Plattm1Mlg/Jcongenic|mutant strain|targeted mutation |
MGI:6433845 | immune system mortality/aging |
Gralinski LE, mBio 2013 Aug 6;4(4): |
||
B6.129S2-Serpine1tm1Mlg/J | MGI:2162090 | congenic|mutant strain|targeted mutation | MGI:3690223 | Serpine1tm1Mlg | MGI:1857287 | Targeted | Null/knockout | Coronavirus infectious disease | DOID:0080599 | cardiovascular system homeostasis/metabolism immune system liver/biliary system respiratory system mortality/aging | MP:0005385 MP:0005376 MP:0005387 MP:0005370 MP:0005388 MP:0010768 | Gralinski LE, mBio 2013 Aug 6;4(4): | J:288556 | Infection|Pathology|SARS-CoV-MA_virus | B6.129S2-Serpine1tm1Mlg/Jcongenic|mutant strain|targeted mutation |
MGI:3690223 | cardiovascular system homeostasis/metabolism immune system liver/biliary system respiratory system mortality/aging Coronavirus infectious disease |
Gralinski LE, mBio 2013 Aug 6;4(4): |
B6.129S2-Tnfrsf1btm1Mwm/J | MGI:2164652 | congenic|mutant strain|targeted mutation | MGI:3580520 | Tnfrsf1btm1Mwm | MGI:1857262 | Targeted | Null/knockout | cellular hematopoietic system immune system | MP:0005384 MP:0005397 MP:0005387 | McDermott JE, BMC Syst Biol 2016 Sep 23;10(1):93 | J:288523 | Pathology|SARS-CoV-MA_virus | B6.129S2-Tnfrsf1btm1Mwm/Jcongenic|mutant strain|targeted mutation |
MGI:3580520 | cellular hematopoietic system immune system |
McDermott JE, BMC Syst Biol 2016 Sep 23;10(1):93 |
||
B6;129S4-C3tm1Crr/J | MGI:2165043 | mutant stock|targeted mutation | MGI:3799624 | C3tm1Crr | MGI:1861799 | Targeted | Null/knockout | homeostasis/metabolism immune system nervous system vision/eye | MP:0005376 MP:0005387 MP:0003631 MP:0005391 | Gralinski LE, mBio 2018 Oct 9;9(5): | J:286325 | Pathology|SARS-CoV-MA_virus | B6;129S4-C3tm1Crr/Jmutant stock|targeted mutation |
MGI:3799624 | homeostasis/metabolism immune system nervous system vision/eye |
Gralinski LE, mBio 2018 Oct 9;9(5): |
||
B6.129S4-Ccr1tm1Gao | MGI:3614571 | congenic|mutant strain|targeted mutation | MGI:3614443 | Ccr1tm1Gao | MGI:1931850 | Targeted | Null/knockout | Coronavirus infectious disease | DOID:0080599 | cardiovascular system cellular hematopoietic system homeostasis/metabolism immune system respiratory system mortality/aging | MP:0005385 MP:0005384 MP:0005397 MP:0005376 MP:0005387 MP:0005388 MP:0010768 | Sheahan T, PLoS Pathog 2008 Dec;4(12):e1000240 | J:162707 | Pathology|SARS-CoV-MA_virus | B6.129S4-Ccr1tm1Gaocongenic|mutant strain|targeted mutation |
MGI:3614443 | cardiovascular system cellular hematopoietic system homeostasis/metabolism immune system respiratory system mortality/aging Coronavirus infectious disease |
Sheahan T, PLoS Pathog 2008 Dec;4(12):e1000240 |
B6.129S4-Ccr2tm1Ifc/J | MGI:3038272 | congenic|mutant strain|targeted mutation | MGI:3580323 | Ccr2tm1Ifc | MGI:2158213 | Targeted | Null/knockout | cellular hematopoietic system immune system nervous system skeleton mortality/aging neoplasm | MP:0005384 MP:0005397 MP:0005387 MP:0003631 MP:0005390 MP:0010768 MP:0002006 | Chen BP, J Immunol 2001 Oct 15;167(8):4585-92 | J:106738 | Mouse_Hepatitis_virus|Pathology | B6.129S4-Ccr2tm1Ifc/Jcongenic|mutant strain|targeted mutation |
MGI:3580323 | cellular hematopoietic system immune system nervous system skeleton mortality/aging neoplasm |
Chen BP, J Immunol 2001 Oct 15;167(8):4585-92 |
||
B6(129S4)-Ly6etm1c(EUCOMM)Hmgu/JwschJ | MGI:6507729 | mutant strain|targeted mutation | Pfaender S, Nat Microbiol 2020 Jul 23;(): | J:291868 | Gene|HCoV-229E_virus|HCoV-OC43_virus|MERS-CoV_virus|Mouse_Hepatitis_virus|SARS-CoV-2_virus|SARS-CoV_virus | B6(129S4)-Ly6etm1c(EUCOMM)Hmgu/JwschJmutant strain|targeted mutation |
Pfaender S, Nat Microbiol 2020 Jul 23;(): |
|||||||||||
B6;129S6-Apaf1tm1Her/J | MGI:2178674 | mutant stock|targeted mutation | Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 | J:296686 | Pathology|SARS-CoV-2_virus|Treatment | B6;129S6-Apaf1tm1Her/Jmutant stock|targeted mutation |
Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 |
|||||||||||
B6.129S6-Nlrp3tm1Bhk/J | MGI:5465029 | congenic|mutant strain|targeted mutation | Duhalde Vega M, Sci Adv 2022 Sep 23;8(38):eabn6545 Wu J, Immunity 2021 Nov 9;54(11):2632-2649.e6 | J:331762 J:323769 | Mouse_Hepatitis_virus Gene|Pathology | B6.129S6-Nlrp3tm1Bhk/Jcongenic|mutant strain|targeted mutation |
Duhalde Vega M, Sci Adv 2022 Sep 23;8(38):eabn6545 Wu J, Immunity 2021 Nov 9;54(11):2632-2649.e6 |
|||||||||||
B6;129S6-Ppp1r14ctm1Uhl/J | MGI:4839337 | mutant stock|targeted mutation | MGI:6433773 | Ppp1r14ctm1Uhl | MGI:4450989 | Targeted | Null/knockout | Coronavirus infectious disease | DOID:0080599 | immune system | MP:0005387 | McDermott JE, BMC Syst Biol 2016 Sep 23;10(1):93 | J:288523 | Pathology|SARS-CoV-MA_virus | B6;129S6-Ppp1r14ctm1Uhl/Jmutant stock|targeted mutation |
MGI:6433773 | immune system Coronavirus infectious disease |
McDermott JE, BMC Syst Biol 2016 Sep 23;10(1):93 |
B6.129S6-Ptges2tm1Bhk/J | MGI:3833371 | congenic|targeted mutation | McDermott JE, BMC Syst Biol 2016 Sep 23;10(1):93 | J:288523 | Pathology|SARS-CoV-MA_virus | B6.129S6-Ptges2tm1Bhk/Jcongenic|targeted mutation |
McDermott JE, BMC Syst Biol 2016 Sep 23;10(1):93 |
|||||||||||
B6.129S6-Shhtm2(cre/ERT2)Cjt/J | MGI:3612945 | congenic|mutant strain|targeted mutation | Anand G, bioRxiv 2020 Dec;(): | J:298270 | Pathology|SARS-CoV-2_virus | B6.129S6-Shhtm2(cre/ERT2)Cjt/Jcongenic|mutant strain|targeted mutation |
Anand G, bioRxiv 2020 Dec;(): |
|||||||||||
B6.129S7-Cd47tm1Fpl/J | MGI:2165071 | congenic|mutant strain|targeted mutation | Wenzek C, iScience 2022 Dec 22;25(12):105540 | J:331693 | SARS-CoV-2_virus | B6.129S7-Cd47tm1Fpl/Jcongenic|mutant strain|targeted mutation |
Wenzek C, iScience 2022 Dec 22;25(12):105540 |
|||||||||||
B6.129S7-Ifngtm1Ts | MGI:3713227 | congenic|mutant strain|targeted mutation | MGI:4365971 | Ifngtm1Ts | MGI:1857184 | Targeted | Null/knockout | endocrine/exocrine glands hematopoietic system immune system mortality/aging neoplasm | MP:0005379 MP:0005397 MP:0005387 MP:0010768 MP:0002006 | Parra B, J Immunol 1999 Feb 1;162(3):1641-7 | J:112048 | Infection|Mouse_Hepatitis_virus | B6.129S7-Ifngtm1Tscongenic|mutant strain|targeted mutation |
MGI:4365971 | endocrine/exocrine glands hematopoietic system immune system mortality/aging neoplasm |
Parra B, J Immunol 1999 Feb 1;162(3):1641-7 |
||
B6.129S7-Rag1tm1Mom/J | MGI:2163461 | congenic|mutant strain|targeted mutation | Dandekar AA, Am J Pathol 2004 Feb;164(2):363-9 Glass WG, J Immunol 2004 Sep 15;173(6):4030-9 Hassan AO, Cell 2020 Jun 10;(): Israelow B, bioRxiv 2021 May;(): Mao T, bioRxiv 2021 Jun;(): | J:88552 J:92752 J:290258 J:308733 J:308656 | Mouse_Hepatitis_virus Infection|SARS-CoV_virus Infection|SARS-CoV-2_virus|Treatment Infection|SARS-CoV-2_virus Treatment|VOC_B.1.1.7_Alpha|VOC_B.1.351_Beta|VOC_P.1_Gamma | B6.129S7-Rag1tm1Mom/Jcongenic|mutant strain|targeted mutation |
Dandekar AA, Am J Pathol 2004 Feb;164(2):363-9 Glass WG, J Immunol 2004 Sep 15;173(6):4030-9 Hassan AO, Cell 2020 Jun 10;(): Israelow B, bioRxiv 2021 May;(): Mao T, bioRxiv 2021 Jun;(): |
|||||||||||
B6.129S(Cg)-Stat1tm1Dlv/J | MGI:4452071 | congenic|mutant strain|targeted mutation | Hassan AO, Cell 2020 Jun 10;(): | J:290258 | Infection|SARS-CoV-2_virus|Treatment | B6.129S(Cg)-Stat1tm1Dlv/Jcongenic|mutant strain|targeted mutation |
Hassan AO, Cell 2020 Jun 10;(): |
|||||||||||
B6.129S(FVB)-Bcl6tm1.1Dent/J | MGI:5518537 | congenic|mutant strain|targeted mutation | Chen JS, bioRxiv 2021 Jun;(): | J:308655 | SARS-CoV-2_virus|VOC_B.1.351_Beta | B6.129S(FVB)-Bcl6tm1.1Dent/Jcongenic|mutant strain|targeted mutation |
Chen JS, bioRxiv 2021 Jun;(): |
|||||||||||
B6.129S-Sftpctm1(cre/ERT2)Blh/J | MGI:5661884 | congenic|mutant strain|targeted mutation | Tang AT, bioRxiv 2021 Dec;(): Tang AT, PLoS Biol 2023 Feb;21(2):e3001989 | J:315719 J:337814 | Pathology|SARS-CoV-2_virus Pathology|SARS-CoV-2_virus|VOC_B.1.1.529_Omicron | B6.129S-Sftpctm1(cre/ERT2)Blh/Jcongenic|mutant strain|targeted mutation |
Tang AT, bioRxiv 2021 Dec;(): Tang AT, PLoS Biol 2023 Feb;21(2):e3001989 |
|||||||||||
B6.129S-Tnfrsf1btm1Imx Tnfrsf1atm1Imx/J | MGI:2164568 | congenic|mutant strain|targeted mutation | MGI:6433775 | Tnfrsf1atm1Imx Tnfrsf1btm1Imx | MGI:1857468 MGI:1860087 | Targeted | Null/knockout | immune system | MP:0005387 | McDermott JE, BMC Syst Biol 2016 Sep 23;10(1):93 | J:288523 | Pathology|SARS-CoV-MA_virus | B6.129S-Tnfrsf1btm1Imx Tnfrsf1atm1Imx/Jcongenic|mutant strain|targeted mutation |
MGI:6433775 | immune system |
McDermott JE, BMC Syst Biol 2016 Sep 23;10(1):93 |
||
B6.129-Tnfrsf1atm1Mak/J | MGI:2164398 | congenic|mutant strain|targeted mutation | McDermott JE, BMC Syst Biol 2016 Sep 23;10(1):93 | J:288523 | Pathology|SARS-CoV-MA_virus | B6.129-Tnfrsf1atm1Mak/Jcongenic|mutant strain|targeted mutation |
McDermott JE, BMC Syst Biol 2016 Sep 23;10(1):93 |
|||||||||||
B6.129X1-Fgl2tm1Pam | MGI:3583761 | congenic|mutant strain|targeted mutation | MGI:3583697 | Fgl2tm1Pam | MGI:3582343 | Targeted | Null/knockout|Reporter | cardiovascular system cellular growth/size/body hematopoietic system homeostasis/metabolism immune system renal/urinary system mortality/aging | MP:0005385 MP:0005384 MP:0005378 MP:0005397 MP:0005376 MP:0005387 MP:0005367 MP:0010768 | Marsden PA, J Clin Invest 2003 Jul;112(1):58-66 | J:99453 | Mouse_Hepatitis_virus | B6.129X1-Fgl2tm1Pamcongenic|mutant strain|targeted mutation |
MGI:3583697 | cardiovascular system cellular growth/size/body hematopoietic system homeostasis/metabolism immune system renal/urinary system mortality/aging |
Marsden PA, J Clin Invest 2003 Jul;112(1):58-66 |
||
B6.129X1-Ifngtm1Yiw | MGI:6430477 | congenic|mutant strain|targeted mutation | MGI:6430478 | Ifngtm1Yiw | MGI:3036127 | Targeted | Null/knockout | behavior/neurological cellular digestive/alimentary system growth/size/body homeostasis/metabolism immune system liver/biliary system mortality/aging | MP:0005386 MP:0005384 MP:0005381 MP:0005378 MP:0005376 MP:0005387 MP:0005370 MP:0010768 | Kyuwa S, J Virol 1998 Nov;72(11):9286-90 Kyuwa S, Virus Res 2002 Feb 26;83(1-2):169-77 | J:50405 J:91691 | Mouse_Hepatitis_virus|Pathology Infection|Mouse_Hepatitis_virus|Pathology | B6.129X1-Ifngtm1Yiwcongenic|mutant strain|targeted mutation |
MGI:6430478 | behavior/neurological cellular digestive/alimentary system growth/size/body homeostasis/metabolism immune system liver/biliary system mortality/aging |
Kyuwa S, J Virol 1998 Nov;72(11):9286-90 Kyuwa S, Virus Res 2002 Feb 26;83(1-2):169-77 |
||
B6.Cg-B2mtm1Unc Cd4tm1Litt H2-Ab1b-tm1Doi Tg(Cd4-CD4)2362Litt Tg(H2-Aa-HLA-DPA1)1Lone Tg(H2-Ab1-HLA-DPB1)1Lone Tg(HLA-A/H2-D/B2M)1Bpe/Orl | MGI:5494679 | congenic|mutant strain|targeted mutation|transgenic | Brentville VA, bioRxiv 2021 Jun;(): | J:308658 | SARS-CoV-2_virus|Vaccine | B6.Cg-B2mtm1Unc Cd4tm1Litt H2-Ab1b-tm1Doi Tg(Cd4-CD4)2362Litt Tg(H2-Aa-HLA-DPA1)1Lone Tg(H2-Ab1-HLA-DPB1)1Lone Tg(HLA-A/H2-D/B2M)1Bpe/Orlcongenic|mutant strain|targeted mutation|transgenic |
Brentville VA, bioRxiv 2021 Jun;(): |
|||||||||||
B6.Cg-Ces1ctm1.1Loc/J | MGI:4939039 | congenic|mutant strain|targeted mutation | Martinez DR, bioRxiv 2021 Jan;(): Pruijssers AJ, Cell Rep 2020 Jul 21;32(3):107940 | J:302135 J:298752 | SARS-CoV-2-MA_virus|SARS-CoV-2_virus|Treatment | B6.Cg-Ces1ctm1.1Loc/Jcongenic|mutant strain|targeted mutation |
Martinez DR, bioRxiv 2021 Jan;(): Pruijssers AJ, Cell Rep 2020 Jul 21;32(3):107940 |
|||||||||||
B6.Cg-Edil3Tg(Sox2-cre)1Amc/J | MGI:3800753 | congenic|transgenic | Tang AT, bioRxiv 2021 Dec;(): Tang AT, PLoS Biol 2023 Feb;21(2):e3001989 | J:315719 J:337814 | Pathology|SARS-CoV-2_virus Pathology|SARS-CoV-2_virus|VOC_B.1.1.529_Omicron | B6.Cg-Edil3Tg(Sox2-cre)1Amc/Jcongenic|transgenic |
Tang AT, bioRxiv 2021 Dec;(): Tang AT, PLoS Biol 2023 Feb;21(2):e3001989 |
|||||||||||
B6.Cg-Fcgrttm1Dcr Prkdcscid Tg(FCGRT)32Dcr/DcrJ | MGI:5424138 | congenic|mutant strain|spontaneous mutation|targeted mutation|transgenic | Halwe S, bioRxiv 2021 Jun;(): | J:308648 | SARS-CoV-2_virus|Treatment|VOC_B.1.1.7_Alpha|VOC_B.1.351_Beta | B6.Cg-Fcgrttm1Dcr Prkdcscid Tg(FCGRT)32Dcr/DcrJcongenic|mutant strain|spontaneous mutation|targeted mutation|transgenic |
Halwe S, bioRxiv 2021 Jun;(): |
|||||||||||
B6.Cg-Foxn1nu/J | MGI:2163103 | congenic|mutant strain|spontaneous mutation | Houtman JJ, J Neurovirol 1996 APR;2(2):101-110 | J:33974 | Mouse_Hepatitis_virus | B6.Cg-Foxn1nu/Jcongenic|mutant strain|spontaneous mutation |
Houtman JJ, J Neurovirol 1996 APR;2(2):101-110 |
|||||||||||
B6.Cg-Gt(ROSA)26Sortm14(CAG-tdTomato)Hze/J | MGI:3813512 | congenic|targeted mutation | Tang AT, bioRxiv 2021 Dec;(): Tang AT, PLoS Biol 2023 Feb;21(2):e3001989 | J:315719 J:337814 | Pathology|SARS-CoV-2_virus Pathology|SARS-CoV-2_virus|VOC_B.1.1.529_Omicron | B6.Cg-Gt(ROSA)26Sortm14(CAG-tdTomato)Hze/Jcongenic|targeted mutation |
Tang AT, bioRxiv 2021 Dec;(): Tang AT, PLoS Biol 2023 Feb;21(2):e3001989 |
|||||||||||
B6.Cg-Gt(ROSA)26Sortm1(rtTA,EGFP)Nagy/J | MGI:3584524 | congenic|mutant strain|targeted mutation | Wu J, Immunity 2021 Nov 9;54(11):2632-2649.e6 | J:323769 | Gene|Pathology | B6.Cg-Gt(ROSA)26Sortm1(rtTA,EGFP)Nagy/Jcongenic|mutant strain|targeted mutation |
Wu J, Immunity 2021 Nov 9;54(11):2632-2649.e6 |
|||||||||||
B6(Cg)-Ifnar1tm1.1Ees/J | MGI:5692164 | congenic|mutant strain|targeted mutation | Anand G, bioRxiv 2020 Dec;(): | J:298270 | Pathology|SARS-CoV-2_virus | B6(Cg)-Ifnar1tm1.1Ees/Jcongenic|mutant strain|targeted mutation |
Anand G, bioRxiv 2020 Dec;(): |
|||||||||||
B6(Cg)-Ifnar1tm1.2Ees/J | MGI:5692173 | congenic|mutant strain|targeted mutation | Mao T, bioRxiv 2021 Jun;(): | J:308656 | Treatment|VOC_B.1.1.7_Alpha|VOC_B.1.351_Beta|VOC_P.1_Gamma | B6(Cg)-Ifnar1tm1.2Ees/Jcongenic|mutant strain|targeted mutation |
Mao T, bioRxiv 2021 Jun;(): |
|||||||||||
B6.Cg-Ly6etm1c(EUCOMM)Hmgu Commd10Tg(Vav1-icre)A2Kio | MGI:6449003 | congenic|mutant strain|targeted mutation|transgenic | MGI:6449004 | Commd10Tg(Vav1-icre)A2Kio Ly6etm1c(EUCOMM)Hmgu | MGI:2449949 MGI:6448980 | Transgenic Targeted | Null/knockout|Recombinase Conditional ready | cellular hematopoietic system homeostasis/metabolism immune system liver/biliary system mortality/aging | MP:0005384 MP:0005397 MP:0005376 MP:0005387 MP:0005370 MP:0010768 | Pfaender S, Nat Microbiol 2020 Jul 23;(): | J:291868 | Gene|HCoV-229E_virus|HCoV-OC43_virus|MERS-CoV_virus|Mouse_Hepatitis_virus|SARS-CoV-2_virus|SARS-CoV_virus | B6.Cg-Ly6etm1c(EUCOMM)Hmgu Commd10Tg(Vav1-icre)A2Kiocongenic|mutant strain|targeted mutation|transgenic |
MGI:6449004 | cellular hematopoietic system homeostasis/metabolism immune system liver/biliary system mortality/aging |
Pfaender S, Nat Microbiol 2020 Jul 23;(): |
||
B6.Cg-Mx1tm1.1Agsa/J | MGI:6280430 | congenic|mutant strain|targeted mutation | Anand G, bioRxiv 2020 Dec;(): | J:298270 | Pathology|SARS-CoV-2_virus | B6.Cg-Mx1tm1.1Agsa/Jcongenic|mutant strain|targeted mutation |
Anand G, bioRxiv 2020 Dec;(): |
|||||||||||
B6.Cg-Prkdcscid/SzJ | MGI:2163184 | congenic|mutant strain|spontaneous mutation | Houtman JJ, J Neurovirol 1996 APR;2(2):101-110 | J:33974 | Mouse_Hepatitis_virus | B6.Cg-Prkdcscid/SzJcongenic|mutant strain|spontaneous mutation |
Houtman JJ, J Neurovirol 1996 APR;2(2):101-110 |
|||||||||||
B6.Cg-Shhtm1(EGFP/cre)Cjt/J | MGI:3619470 | congenic|mutant strain|targeted mutation | Tang AT, bioRxiv 2021 Dec;(): Tang AT, PLoS Biol 2023 Feb;21(2):e3001989 | J:315719 J:337814 | Pathology|SARS-CoV-2_virus Pathology|SARS-CoV-2_virus|VOC_B.1.1.529_Omicron | B6.Cg-Shhtm1(EGFP/cre)Cjt/Jcongenic|mutant strain|targeted mutation |
Tang AT, bioRxiv 2021 Dec;(): Tang AT, PLoS Biol 2023 Feb;21(2):e3001989 |
|||||||||||
B6.Cg-Speer6-ps1Tg(Alb-cre)21Mgn/J | MGI:2164673 | congenic|mutant strain|transgenic | Wu J, Immunity 2021 Nov 9;54(11):2632-2649.e6 | J:323769 | Gene|Pathology | B6.Cg-Speer6-ps1Tg(Alb-cre)21Mgn/Jcongenic|mutant strain|transgenic |
Wu J, Immunity 2021 Nov 9;54(11):2632-2649.e6 |
|||||||||||
B6(Cg)-Sting1tm1.2Camb/J | MGI:5639268 | congenic|mutant strain|targeted mutation | Wu J, Immunity 2021 Nov 9;54(11):2632-2649.e6 | J:323769 | Gene|Pathology | B6(Cg)-Sting1tm1.2Camb/Jcongenic|mutant strain|targeted mutation |
Wu J, Immunity 2021 Nov 9;54(11):2632-2649.e6 |
|||||||||||
B6.Cg-Terctm1Rdp/J | MGI:2174164 | congenic|mutant strain|targeted mutation | Sepe S, bioRxiv 2021 Jun;(): Sepe S, EMBO Rep 2022 Feb 3;23(2):e53658 | J:309195 J:326929 | Comorbidity|Gene Gene | B6.Cg-Terctm1Rdp/Jcongenic|mutant strain|targeted mutation |
Sepe S, bioRxiv 2021 Jun;(): |
|||||||||||
B6.Cg-Tg(Cd4-cre)1Cwi/BfluJ | MGI:5566534 | congenic|mutant strain|transgenic | Chen JS, bioRxiv 2021 Jun;(): | J:308655 | SARS-CoV-2_virus|VOC_B.1.351_Beta | B6.Cg-Tg(Cd4-cre)1Cwi/BfluJcongenic|mutant strain|transgenic |
Chen JS, bioRxiv 2021 Jun;(): |
|||||||||||
B6.Cg-Tg(DPP4)2Nnag | MGI:6403117 | congenic|mutant strain|transgenic | MGI:6403118 | Tg(DPP4)2Nnag | MGI:6403115 | Transgenic | Humanized sequence|Inserted expressed sequence | Middle East respiratory syndrome | DOID:0080642 | homeostasis/metabolism immune system respiratory system | MP:0005376 MP:0005387 MP:0005388 | Iwata-Yoshikawa N, J Virol 2019 Mar 15;93(6): | J:286321 | Infection|MERS-CoV_virus | B6.Cg-Tg(DPP4)2Nnagcongenic|mutant strain|transgenic |
MGI:6403118 | homeostasis/metabolism immune system respiratory system Middle East respiratory syndrome |
Iwata-Yoshikawa N, J Virol 2019 Mar 15;93(6): |
B6.Cg-Tg(FOXJ1-ACE2)1Rba/Mmnc | MGI:6415225 | congenic|mutant strain|transgenic | Menachery VD, Proc Natl Acad Sci U S A 2016 Mar 15;113(11):3048-53 | J:287092 | Infection | B6.Cg-Tg(FOXJ1-ACE2)1Rba/Mmnccongenic|mutant strain|transgenic |
Menachery VD, Proc Natl Acad Sci U S A 2016 Mar 15;113(11):3048-53 |
|||||||||||
B6.Cg-Tg(Itgax-cre)1-1Reiz/J | MGI:3763375 | congenic|mutant strain|transgenic | Anand G, bioRxiv 2020 Dec;(): | J:298270 | Pathology|SARS-CoV-2_virus | B6.Cg-Tg(Itgax-cre)1-1Reiz/Jcongenic|mutant strain|transgenic |
Anand G, bioRxiv 2020 Dec;(): |
|||||||||||
B6.Cg-Tg(K18-ACE2)2Prlmn/J | MGI:6389236 | congenic|mutant strain|transgenic | MGI:6455041 | Tg(K18-ACE2)2Prlmn | MGI:6389235 | Transgenic | Humanized sequence|Inserted expressed sequence | COVID-19 | DOID:0080600 | behavior/neurological cardiovascular system cellular growth/size/body hematopoietic system homeostasis/metabolism immune system liver/biliary system nervous system respiratory system vision/eye mortality/aging | MP:0005386 MP:0005385 MP:0005384 MP:0005378 MP:0005397 MP:0005376 MP:0005387 MP:0005370 MP:0003631 MP:0005388 MP:0005391 MP:0010768 | Afkhami S, bioRxiv 2021 Jul;(): Amruta N, bioRxiv 2021 May;(): Awosanya OD, Bone 2022 Jan;154():116227 Barreiro A, bioRxiv 2021 Dec;(): Beaudoin-Bussieres G, bioRxiv 2021 Sep;(): Belouzard S, bioRxiv 2021 Jun;(): Biswas R, bioRxiv 2021 Feb;(): Carossino M, bioRxiv 2021 Jan;(): Ceon E, bioRxiv 2022 Jan;(): Chan CEZ, PLoS One 2021;16(6):e0253487 Chaparian RR, bioRxiv 2021 Apr;(): Chen IP, Cell Rep 2022 Jul 19;40(3):111088 Chen JS, bioRxiv 2020 Sep 25;(): Chen JS, bioRxiv 2021 Jun;(): Chen JS, J Virol 2021 Jan 13;(): Chong Z, bioRxiv 2022;(): Clark JJ, bioRxiv 2020;(): Colunga Biancatelli R, Am J Physiol Lung Cell Mol Physiol 2021 Jun;(): Conforti A, bioRxiv 2021 Jun;(): de Almeida L, Sci Adv 2022 Sep 16;8(37):eabo5400 Elia U, bioRxiv 2021 Mar;(): Fumagalli V, bioRxiv 2021 Aug;(): Gawish R, Elife 2022 Jan 13;11():e74623 Golden JW, JCI Insight 2020 Aug 25;(): Grandi A, bioRxiv 2021 Jul;(): Greer CD, bioRxiv 2021 Aug;(): Gretebeck LM, Curr Opin Virol 2015 Aug;13():123-9 Hassan AO, Cell Rep 2021 Jul 27;36(4):109452 Hassert M, PLoS Pathog 2020 Dec;16(12):e1009163 Hilligan KL, bioRxiv 2021 Aug;(): Ho JSY , bioRxiv 2020 Dec;(): Hong J, bioRxiv 2021 Oct;(): Humphries F, Sci Immunol 2021 May 18;6(59): Hunt AC, bioRxiv 2021 Jul;(): Israelow B, bioRxiv 2021 May;(): Israelow B, Sci Immunol 2021 Oct 15;6(64):eabl4509 Jeong GU, bioRxiv 2022;(): Joag V, J Immunol 2021 Mar 1;206(5):931-935 Johnson BA, Nature 2021 Mar;591(7849):293-299 Kaiser R, JCI Insight 2021 Sep 22;6(18):e150862 Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Khaddaj-Mallat R, Neurobiol Dis 2021 Dec;161():105561 Kim GN, PLoS Pathog 2021 Dec;17(12):e1010092 Ku MW, bioRxiv 2021 Feb;(): Ku MW, EMBO Mol Med 2021 Dec 7;13(12):e14459 Lee KS, bioRxiv 2022;(): Li K, mBio 2021 Aug 31;12(4):e0097021 Lin X, bioRxiv 2021 Dec;(): Liu R, bioRxiv 2021 Jan;(): Liu R, Proc Natl Acad Sci U S A 2021 Mar 23;118(12):e2026785118 Manangeeswaran M, Front Immunol 2022;13():919815 Mao T, bioRxiv 2021 Jun;(): Mao T, bioRxiv 2022;(): Marx S, bioRxiv 2021 Aug;(): McCray PB Jr, J Virol 2007 Jan;81(2):813-21 Mejia OR, bioRxiv 2021 Nov;(): Natekar JP, bioRxiv 2022 Apr;(): Noy-Porat T, bioRxiv 2021 Feb;(): Noy-Porat T, iScience 2021 May 21;24(5):102479 Oladunni FS, Nat Commun 2020 Nov 30;11(1):6122 Olivarria GM, bioRxiv 2021 Nov;(): Puhl AC, bioRxiv 2021;(): Puhl AC, bioRxiv 2021 Dec;(): Qin Z, Theranostics 2021;11(16):8076-8091 Radvak P, bioRxiv 2021 Jun;(): Robertson SJ, bioRxiv 2021 Sep;(): Rosenfeld R, Nat Commun 2021 Feb 11;12(1):944 Salzer R, bioRxiv 2021 May;(): Scaglione A, bioRxiv 2021 Jun;(): Seehusen F, bioRxiv 2021 Apr;(): Shapira T, bioRxiv 2021 May;(): Silvas J, bioRxiv 2021 Mar;(): Sims JJ, bioRxiv 2021 Apr;(): Smeyne RJ, bioRxiv 2022 Feb;(): Sohn SY, mBio 2021 Nov 2;():e0275621 Song E, J Exp Med 2021 Mar 1;218(3): Soni DK, bioRxiv 2020 Dec;(): Subramaniam S, bioRxiv 2021 Aug;(): Sun CP, PLoS Pathog 2021 Aug;17(8):e1009758 Su P, Mol Brain 2022 Aug 9;15(1):71 Tada T, Cell Rep 2020 Dec 22;33(12):108528 Tarres-Frexas F, bioRxiv 2021 Aug;(): Tatham L, bioRxiv 2022;(): Turan RD, Sci Rep 2021 Aug 4;11(1):15799 Ullah i, bioRxiv 2021 Mar;(): Van Dyke MC, bioRxiv 2021 May;(): Venzon M, bioRxiv 2021 Jul;(): Walls AC, Cell Rep 2022 Aug 30;40(9):111299 Wenzel J, Nat Neurosci 2021 Nov;24(11):1522-1533 White KM, Science 2021 Feb 26;371(6532):926-931 Winkler ES, bioRxiv 2020 Dec;(): Winkler ES, J Virol 2022 Jan 12;96(1):e0151121 Ying B, bioRxiv 2021 Aug;(): Ying B, bioRxiv 2022 Feb;(): Zhang L, bioRxiv 2022 Mar;(): Zhang L, EMBO Mol Med 2022 Sep 12;():e16109 Zhang X, Cell 2021 Apr 15;184(8):2229-2238.e13 Zheng J, bioRxiv 2020 Aug 10;(): Zheng J, Nature 2021 Jan;589(7843):603-607 Zheng M, Nat Immunol 2021 Jul;22(7):829-838 Zhu C, bioRxiv 2021 May;(): Zumla A, Nat Rev Drug Discov 2016 May;15(5):327-47 | J:308640 J:308724 J:319441 J:315723 J:310110 J:308621 J:302158 J:300428 J:321756 J:309634 J:308713 J:331767 J:298866 J:308655 J:300110 J:321761 J:296067 J:309512 J:308652 J:331763 J:303462 J:308584 J:318828 J:294084 J:308639 J:308745 J:284000 J:309629 J:319459 J:309197 J:298250 J:313447 J:333769 J:308637 J:308733 J:331753 J:321757 J:303898 J:307033 J:313337 J:296686 J:319440 J:319447 J:302144 J:319366 J:321763 J:313329 J:315744 J:299104 J:303465 J:331765 J:308656 J:321770 J:308571 J:283648 J:315717 J:324941 J:302148 J:308896 J:300960 J:315722 J:311915 J:316769 J:319458 J:308643 J:310124 J:303472 J:308749 J:308666 J:304647 J:308716 J:302912 J:304613 J:322638 J:312952 J:302314 J:299096 J:309192 J:322631 J:331766 J:313439 J:308579 J:321766 J:309630 J:303209 J:308721 J:308642 J:328107 J:323957 J:303457 J:299082 J:331773 J:309196 J:321873 J:324936 J:330045 J:305460 J:293212 J:303220 J:308903 J:308890 J:283999 | SARS-CoV-2_virus|Vaccine|VOC_B.1.1.7_Alpha|VOC_B.1.351_Beta SARS-CoV-2_virus|Treatment Pathology|SARS-CoV-2_virus SARS-CoV-2_virus|Vaccine SARS-CoV-2_virus Gene|SARS-CoV-2_virus SARS-CoV-2_virus|VOC_B.1.351_Beta SARS-CoV-2_virus|Treatment|VOC_B.1.1.529_Omicron|VOC_B.1.351_Beta Comorbidity|Pathology|SARS-CoV-2_virus Infection|SARS-CoV-2_virus Pathology|SARS-CoV-2-MA_virus Infection|Pathology|SARS-CoV-2_virus|Sex_bias MERS-CoV_virus|SARS-CoV_virus SARS-CoV-2_virus|Treatment|VOC_B.1.1.7_Alpha SARS-CoV-2_virus|Treatment|VOC_B.1.1.7_Alpha|VOC_B.1.351_Beta|VOC_B.1.617.2_Delta|VOC_P.1_Gamma SARS-CoV-2_virus|Treatment|VOC_B.1.1.7_Alpha|VOC_B.1.351_Beta|VOC_P.1_Gamma Pathology|SARS-CoV-2_virus|Treatment SARS-CoV-2_virus|Vaccine|VOC_P.1_Gamma Pathology|VOC_B.1.617.2_Delta MERS-CoV_virus|SARS-CoV-2_virus|Treatment Gene|Pathology|SARS-CoV-2_virus Treatment|VOC_B.1.1.7_Alpha|VOC_B.1.351_Beta|VOC_P.1_Gamma Infection|SARS-CoV_virus Comorbidity|SARS-CoV-2-MA_virus|SARS-CoV-2_virus Infection|SARS-CoV-2-MA_virus|SARS-CoV-2_virus|VOC_B.1.1.529_Omicron|VOC_B.1.1.7_Alpha|VOC_B.1.351_Beta|VOC_B.1.617.2_Delta Mouse_Hepatitis_virus|SARS-CoV-2_virus|Treatment Pathology|SARS-CoV-2_virus|VOC_B.1.1.7_Alpha|VOC_B.1.351_Beta SARS-CoV-2_virus|Treatment|VOC_B.1.1.7_Alpha|VOC_B.1.351_Beta PASC|SARS-CoV-2_virus Infection|SARS-CoV-2_virus|VOC_B.1.351_Beta Treatment|VOC_B.1.1.529_Omicron|VOC_B.1.617.2_Delta SARS-CoV-2_virus|Vaccine|Variant|VOC_B.1.351_Beta Pathology|SARS-CoV-2_virus|VOC_B.1.351_Beta Infection|SARS-CoV-2_virus|VOC_B.1.1.7_Alpha|VOC_B.1.351_Beta SARS-CoV-2-MA_virus|SARS-CoV-2_virus|Vaccine|VOC_B.1.1.7_Alpha|VOC_B.1.351_Beta|VOC_B.1.617.2_Delta Vaccine|VOC_B.1.1.529_Omicron SARS-CoV-2_virus|Treatment|Variant|VOC_B.1.1.529_Omicron|VOC_P.1_Gamma SARS-CoV-2_virus|Treatment|VOC_B.1.1.529_Omicron | B6.Cg-Tg(K18-ACE2)2Prlmn/Jcongenic|mutant strain|transgenic |
MGI:6455041 | behavior/neurological cardiovascular system cellular growth/size/body hematopoietic system homeostasis/metabolism immune system liver/biliary system nervous system respiratory system vision/eye mortality/aging COVID-19 |
Afkhami S, bioRxiv 2021 Jul;(): Amruta N, bioRxiv 2021 May;(): Awosanya OD, Bone 2022 Jan;154():116227 Barreiro A, bioRxiv 2021 Dec;(): Beaudoin-Bussieres G, bioRxiv 2021 Sep;(): Belouzard S, bioRxiv 2021 Jun;(): Biswas R, bioRxiv 2021 Feb;(): Carossino M, bioRxiv 2021 Jan;(): Ceon E, bioRxiv 2022 Jan;(): Chan CEZ, PLoS One 2021;16(6):e0253487 Chaparian RR, bioRxiv 2021 Apr;(): Chen IP, Cell Rep 2022 Jul 19;40(3):111088 Chen JS, bioRxiv 2020 Sep 25;(): Chen JS, bioRxiv 2021 Jun;(): Chen JS, J Virol 2021 Jan 13;(): Chong Z, bioRxiv 2022;(): Clark JJ, bioRxiv 2020;(): Colunga Biancatelli R, Am J Physiol Lung Cell Mol Physiol 2021 Jun;(): Conforti A, bioRxiv 2021 Jun;(): de Almeida L, Sci Adv 2022 Sep 16;8(37):eabo5400 Elia U, bioRxiv 2021 Mar;(): Fumagalli V, bioRxiv 2021 Aug;(): Gawish R, Elife 2022 Jan 13;11():e74623 Golden JW, JCI Insight 2020 Aug 25;(): Grandi A, bioRxiv 2021 Jul;(): Greer CD, bioRxiv 2021 Aug;(): Gretebeck LM, Curr Opin Virol 2015 Aug;13():123-9 Hassan AO, Cell Rep 2021 Jul 27;36(4):109452 Hassert M, PLoS Pathog 2020 Dec;16(12):e1009163 Hilligan KL, bioRxiv 2021 Aug;(): Ho JSY , bioRxiv 2020 Dec;(): Hong J, bioRxiv 2021 Oct;(): Humphries F, Sci Immunol 2021 May 18;6(59): Hunt AC, bioRxiv 2021 Jul;(): Israelow B, bioRxiv 2021 May;(): Israelow B, Sci Immunol 2021 Oct 15;6(64):eabl4509 Jeong GU, bioRxiv 2022;(): Joag V, J Immunol 2021 Mar 1;206(5):931-935 Johnson BA, Nature 2021 Mar;591(7849):293-299 Kaiser R, JCI Insight 2021 Sep 22;6(18):e150862 Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Khaddaj-Mallat R, Neurobiol Dis 2021 Dec;161():105561 Kim GN, PLoS Pathog 2021 Dec;17(12):e1010092 Ku MW, bioRxiv 2021 Feb;(): Ku MW, EMBO Mol Med 2021 Dec 7;13(12):e14459 Lee KS, bioRxiv 2022;(): Li K, mBio 2021 Aug 31;12(4):e0097021 Lin X, bioRxiv 2021 Dec;(): Liu R, bioRxiv 2021 Jan;(): Liu R, Proc Natl Acad Sci U S A 2021 Mar 23;118(12):e2026785118 Manangeeswaran M, Front Immunol 2022;13():919815 Mao T, bioRxiv 2021 Jun;(): Mao T, bioRxiv 2022;(): Marx S, bioRxiv 2021 Aug;(): McCray PB Jr, J Virol 2007 Jan;81(2):813-21 Mejia OR, bioRxiv 2021 Nov;(): Natekar JP, bioRxiv 2022 Apr;(): Noy-Porat T, bioRxiv 2021 Feb;(): Noy-Porat T, iScience 2021 May 21;24(5):102479 Oladunni FS, Nat Commun 2020 Nov 30;11(1):6122 Olivarria GM, bioRxiv 2021 Nov;(): Puhl AC, bioRxiv 2021;(): Puhl AC, bioRxiv 2021 Dec;(): Qin Z, Theranostics 2021;11(16):8076-8091 Radvak P, bioRxiv 2021 Jun;(): Robertson SJ, bioRxiv 2021 Sep;(): Rosenfeld R, Nat Commun 2021 Feb 11;12(1):944 Salzer R, bioRxiv 2021 May;(): Scaglione A, bioRxiv 2021 Jun;(): Seehusen F, bioRxiv 2021 Apr;(): Shapira T, bioRxiv 2021 May;(): Silvas J, bioRxiv 2021 Mar;(): Sims JJ, bioRxiv 2021 Apr;(): Smeyne RJ, bioRxiv 2022 Feb;(): Sohn SY, mBio 2021 Nov 2;():e0275621 Song E, J Exp Med 2021 Mar 1;218(3): Soni DK, bioRxiv 2020 Dec;(): Subramaniam S, bioRxiv 2021 Aug;(): Sun CP, PLoS Pathog 2021 Aug;17(8):e1009758 Su P, Mol Brain 2022 Aug 9;15(1):71 Tada T, Cell Rep 2020 Dec 22;33(12):108528 Tarres-Frexas F, bioRxiv 2021 Aug;(): Tatham L, bioRxiv 2022;(): Turan RD, Sci Rep 2021 Aug 4;11(1):15799 Ullah i, bioRxiv 2021 Mar;(): Van Dyke MC, bioRxiv 2021 May;(): Venzon M, bioRxiv 2021 Jul;(): Walls AC, Cell Rep 2022 Aug 30;40(9):111299 Wenzel J, Nat Neurosci 2021 Nov;24(11):1522-1533 White KM, Science 2021 Feb 26;371(6532):926-931 Winkler ES, bioRxiv 2020 Dec;(): Winkler ES, J Virol 2022 Jan 12;96(1):e0151121 Ying B, bioRxiv 2021 Aug;(): Ying B, bioRxiv 2022 Feb;(): Zhang L, bioRxiv 2022 Mar;(): Zhang L, EMBO Mol Med 2022 Sep 12;():e16109 Zhang X, Cell 2021 Apr 15;184(8):2229-2238.e13 Zheng J, bioRxiv 2020 Aug 10;(): Zheng J, Nature 2021 Jan;589(7843):603-607 Zheng M, Nat Immunol 2021 Jul;22(7):829-838 Zhu C, bioRxiv 2021 May;(): Zumla A, Nat Rev Drug Discov 2016 May;15(5):327-47 |
B6.C-Tg(CMV-cre)1Cgn/J | MGI:3613618 | congenic|mutant strain|transgenic | Kim H, bioRxiv 2022 Mar;(): | J:321922 | Gene|Pathology | B6.C-Tg(CMV-cre)1Cgn/Jcongenic|mutant strain|transgenic |
Kim H, bioRxiv 2022 Mar;(): |
|||||||||||
B6N.129-Ccr9tm1Lov/JmfJ | MGI:5644060 | congenic|mutant strain|targeted mutation | Schafer A, bioRxiv 2021 May;(): | J:308730 | Pathology|SARS-CoV-2-MA_virus|SARS-CoV-2_virus|SARS-CoV-MA_virus|SARS-CoV_virus | B6N.129-Ccr9tm1Lov/JmfJcongenic|mutant strain|targeted mutation |
Schafer A, bioRxiv 2021 May;(): |
|||||||||||
B6N.129-Ceacam1tm2Bcn/J | MGI:5887126 | congenic|mutant strain|targeted mutation | Hemmila E, J Virol 2004 Sep;78(18):10156-65 | J:92376 | Infection|Mouse_Hepatitis_virus | B6N.129-Ceacam1tm2Bcn/Jcongenic|mutant strain|targeted mutation |
Hemmila E, J Virol 2004 Sep;78(18):10156-65 |
|||||||||||
B6N.129S1-Tlr3tm1Flv/J | MGI:4355732 | congenic|mutant strain|targeted mutation | MGI:6433074 | Tlr3tm1Flv | MGI:2653138 | Targeted | Null/knockout | immune system respiratory system | MP:0005387 MP:0005388 | Totura AL, mBio 2015 May 26;6(3):e00638-15 | J:288471 | Infection|SARS-CoV-MA_virus | B6N.129S1-Tlr3tm1Flv/Jcongenic|mutant strain|targeted mutation |
MGI:6433074 | immune system respiratory system |
Totura AL, mBio 2015 May 26;6(3):e00638-15 |
||
B6N.129S2-Casp1tm1Flv/J | MGI:5004932 | congenic|mutant strain|targeted mutation | Duhalde Vega M, Sci Adv 2022 Sep 23;8(38):eabn6545 Wu J, Immunity 2021 Nov 9;54(11):2632-2649.e6 | J:331762 J:323769 | Mouse_Hepatitis_virus Gene|Pathology | B6N.129S2-Casp1tm1Flv/Jcongenic|mutant strain|targeted mutation |
Duhalde Vega M, Sci Adv 2022 Sep 23;8(38):eabn6545 Wu J, Immunity 2021 Nov 9;54(11):2632-2649.e6 |
|||||||||||
B6NCrSlc.Cg-Pla2g2dtm1.1Mhg | MGI:5521186 | congenic|mutant strain|targeted mutation | MGI:5520923 | Pla2g2dtm1.1Mhg | MGI:5517549 | Targeted | Null/knockout | cellular hematopoietic system homeostasis/metabolism immune system mortality/aging | MP:0005384 MP:0005397 MP:0005376 MP:0005387 MP:0010768 | Vijay R, J Exp Med 2015 Oct 19;212(11):1851-68 | J:229035 | Infection|SARS-CoV-MA_virus | B6NCrSlc.Cg-Pla2g2dtm1.1Mhgcongenic|mutant strain|targeted mutation |
MGI:5520923 | cellular hematopoietic system homeostasis/metabolism immune system mortality/aging |
Vijay R, J Exp Med 2015 Oct 19;212(11):1851-68 |
||
B6NTac.129(FVB)-Muc4tm1Unc/Rand | MGI:6423076 | congenic|mutant strain|targeted mutation | MGI:6423102 | Muc4tm1Unc | MGI:6416171 | Targeted | Null/knockout | Coronavirus infectious disease | DOID:0080599 | growth/size/body immune system respiratory system mortality/aging | MP:0005378 MP:0005387 MP:0005388 MP:0010768 | Plante JA, bioRxiv 2020;(): | J:287566 | Infection|SARS-CoV-MA_virus|Sex_bias | B6NTac.129(FVB)-Muc4tm1Unc/Randcongenic|mutant strain|targeted mutation |
MGI:6423102 | growth/size/body immune system respiratory system mortality/aging Coronavirus infectious disease |
Plante JA, bioRxiv 2020;(): |
B6.SJL-Ptprca Pepcb/BoyJ | MGI:2164701 | congenic|mutant strain | Musiu C, Cell Death Differ 2021 Sep 13;(): | J:313338 | Pathology|SARS-CoV-2_virus | B6.SJL-Ptprca Pepcb/BoyJcongenic|mutant strain |
Musiu C, Cell Death Differ 2021 Sep 13;(): |
|||||||||||
B6;SJL-Tg(KRT18-DPP4)3Pbmj/J | MGI:6455170 | mutant stock|transgenic | Li K, J Infect Dis 2016 Mar 1;213(5):712-22 | J:285467 | Infection|MERS-CoV_virus|Pathology | B6;SJL-Tg(KRT18-DPP4)3Pbmj/Jmutant stock|transgenic |
Li K, J Infect Dis 2016 Mar 1;213(5):712-22 |
|||||||||||
B6;SJL-Tg(SFTPC-DPP4)3Pbmj/J | MGI:6455169 | mutant stock|transgenic | Li K, J Infect Dis 2016 Mar 1;213(5):712-22 | J:285467 | Infection|MERS-CoV_virus|Pathology | B6;SJL-Tg(SFTPC-DPP4)3Pbmj/Jmutant stock|transgenic |
Li K, J Infect Dis 2016 Mar 1;213(5):712-22 |
|||||||||||
BALB/c | MGI:2161072 | strain family | Abdoli A, bioRxiv 2021 Jun;(): Abdoli A, bioRxiv 2022 Feb;(): Agnihothram S, mBio 2014 Mar 25;5(2):e00047-14 Agostini ML, mBio 2018 Mar 6;9(2): Alimohammadi R, bioRxiv 2022 Mar;(): Amanat F, bioRxiv 2021 apr;(): Amanat F, bioRxiv 2021 Aug;(): An Y, bioRxiv 2021 Mar;(): Ao Z, bioRxiv 2021 Dec;(): Baray JC, bioRxiv 2020;(): Barreiro A, bioRxiv 2021 Dec;(): Baxter VK, bioRxiv 2022 Feb;(): Bellier B, bioRxiv 2021 Sep;(): Borriello F, bioRxiv 2021 Sep;(): Brentville VA, bioRxiv 2021 Jun;(): Cantuti-Castelvetri L, Science 2020 Nov 13;370(6518):856-860 Capone S, bioRxiv 2020 Oct;(): Castano-Rodriguez C, mBio 2018 May 22;9(3): Channappanavar R, J Immunol 2017 May 15;198(10):4046-4053 Chapman AP, bioRxiv 2020;(): Chen C, bioRxiv 2022 Feb;(): Chen J, bioRxiv 2021 Nov;(): Chen WH, Hum Vaccin Immunother 2014;10(3):648-58 Chen WH, Vaccine 2020 Nov 3;38(47):7533-7541 Chevillard C, bioRxiv 2021 Sep;(): Choque-Guevara R, bioRxiv 2021 Nov;(): Cohen AA, Science 2021 Feb 12;371(6530):735-741 Compton SR, Virology 1994 Aug 15;203(1):197-201 Conforti A, bioRxiv 2021 Jun;(): Coria LM, bioRxiv 2021 Dec;(): Dai L, Cell 2020 Jun 28;(): Dangi T, bioRxiv 2021 Jun;(): Davenport BJ, bioRxiv 2021 Nov;(): Day CW, Virology 2009 Dec 20;395(2):210-22 Deming D, PLoS Med 2006 Dec;3(12):e525 de Wilde AH, Virus Res 2017 Jan 15;228():7-13 Dey A, bioRxiv 2021 Jan;(): Dietert K, PLoS One 2017;12(11):e0188251 Du L, Nat Commun 2016 Nov 22;7():13473 Du L, PLoS One 2013;8(12):e81587 Elia U, bioRxiv 2020;(): Erasmus JH, Sci Transl Med 2020 Aug 5;12(555): Fehr AR, mBio 2016 Dec 13;7(6): Feng L, Nat Commun 2020 Aug 21;11(1):4207 Fernandez-Castaneda A, bioRxiv 2022;(): Ferrantelli F, bioRxiv 2020 Dec;(): Fett C, J Virol 2013 Jun;87(12):6551-9 Fu D, PLoS Biol 2021 May;19(5):e3001209 Gao J, bioRxiv 2021 Apr;(): Gao Q, Science 2020 Jul 3;369(6499):77-81 Gawish R, bioRxiv 2021 Aug;(): Gonzalez-Dominguez I, bioRxiv 2022 Mar;(): Graham RL, Commun Biol 2018;1():179 Gu H, bioRxiv 2020;(): Gu H, Science 2020 Jul 30;(): Guo X, Immunology 2015 Aug;145(4):476-84 Guo Y, J Biol Chem 2021 Jan 29;():100346 Haabeth OAW, bioRxiv 2021 Apr;(): He Z, bioRxiv 2020;(): Huang Q, Nat Commun 2021 Feb 3;12(1):776 Hua X, JCI Insight 2018 Jun 7;3(11): Hwang M, Immunology 2015 Mar;144(3):374-386 Jangra S, bioRxiv 2020 Oct 23;(): Jiang S, bioRxiv 2021 Aug;(): Joyce MGl Chen WH, bioRxiv 2021 May;(): Kalnin KV, bioRxiv 2020;(): Kandeil A, PLoS One 2020;15(10):e0241471 Kang YF, bioRxiv 2020 Nov;(): Kato H, PLoS One 2019;14(10):e0223684 Khan MS, bioRxiv 2022 May;(): Khanolkar A, J Immunol 2010 Jul 15;185(2):1132-41 Kibler KV, bioRxiv 2021 Dec;(): Kim E, EBioMedicine 2020 May;55():102743 Kim MH, PLoS One 2019;14(7):e0220196 Kobiyama K, bioRxiv 2021 Mar;(): Kozlovskaya L, bioRxiv 2022 Feb;(): Kumaki Y, Antiviral Res 2011 Jan;89(1):75-82 Lan J, PLoS One 2014;9(11):e112602 Lapp SA, bioRxiv 2021 Apr;(): Liang Y, bioRxiv 2021;(): Liao HY, bioRxiv 2021 May;(): Li D, bioRxiv 2021 Jan;(): Li K, mBio 2021 Aug 31;12(4):e0097021 Li L, bioRxiv 2020 Dec;(): Li L, bioRxiv 2021 Jul;(): Lin WS, bioRxiv 2021 Nov;(): Lin X, bioRxiv 2021 Sep;(): Li SW, Sci Rep 2016 May 13;6():25754 Liu H, bioRxiv 2021 Oct;(): Liu S, bioRxiv 2022 Feb;(): Liu WJ, J Immunol 2017 Jan 15;198(2):873-882 Liu X, bioRxiv 2021 Feb;(): Liu Y, bioRxiv 2022 Feb;(): Liu YM, Cell Rep 2020 Aug 11;32(6):108016 Li W, Proc Natl Acad Sci U S A 2020 Nov 24;117(47):29832-29838 Li Y, bioRxiv 2020 Oct;(): Li Z, bioRxiv 2021 Aug;(): Lucchiari MA, J Gen Virol 1991 Jun;72(Pt 6):1317-22 Luo S, bioRxiv 2020;(): Lu RM, bioRxiv 2022 Apr;(): Lu S, bioRxiv 2022 Feb;(): Lv H, Cell Rep 2020 Jun 2;31(9):107725 Mamedov T, bioRxiv 2022 Apr;(): Martinez DR, Science 2021 Aug 27;373(6558):991-998 Mazumder S, bioRxiv 2020 Oct;(): McMillan CL, bioRxiv 2021 May;(): Menachery VD, J Virol 2018 Sep 1;92(17): Mohandas S, Indian J Med Res 2020 May;151(5):479-482 Montagutelli X, bioRxiv 2021 Mar;(): Mudrick HE, bioRxiv 2021 Apr;(): Muruato A, bioRxiv 2021 May;(): Nagai M, bioRxiv 2020 Dec;(): Nagai M, mBio 2021 Aug 31;12(4):e0159821 Nanishi E, bioRxiv 2021 May;(): Narayan R, bioRxiv 2022 Feb;(): Nieto-Torres JL, PLoS Pathog 2014 May;10(5):e1004077 Niu J, Antiviral Res 2020 Jan;173():104646 Norheim G, bioRxiv 2020 Dec;(): O'Keefe BR, J Virol 2010 Mar;84(5):2511-21 Park JG, bioRxiv 2021 Jan;(): Paschall AV, bioRxiv 2021;(): Petras M, bioRxiv 2020 Nov;(): Phatarphekar A, bioRxiv 2022 Jan;(): Pitcovski J, bioRxiv 2021 Jun;(): Pollet J, bioRxiv 2020 Nov;(): Pollet J, bioRxiv 2021 Jul;(): Qu L, bioRxiv 2021 Mar;(): Rappaport AR, bioRxiv 2021 Nov;(): Rauch S, bioRxiv 2020 Oct;(): Reed CC, bioRxiv 2021 Aug;(): Roberts A, PLoS Pathog 2007 Jan;3(1):e5 Salah S, bioRxiv 2022 May;(): Schafer A, bioRxiv 2021 Sep;(): Scheiblhofer S, bioRxiv 2021 Feb;(): Seephetdee C, bioRxiv 2022 Mar;(): Sekimukai H, Microbiol Immunol 2020 Jan;64(1):33-51 Seo YB, bioRxiv 2020;(): Seo YB, bioRxiv 2021 Nov;(): Shen L, J Virol 2019 Jun 15;93(12): Shi Y, J Virol 2021 Jan 7;(): Shoemaker RH, bioRxiv 2021 Sep;(): Somogyi E, bioRxiv 2020;(): Staquicini DI, bioRxiv 2021 Mar;(): Stark FC, bioRxiv 2022 Mar;(): Su D, bioRxiv 2021 May;(): Su D, bioRxiv 2022 May;(): Sun CP, PLoS Pathog 2021 Aug;17(8):e1009758 Sun S, bioRxiv 2020 Nov;(): Sun W, bioRxiv 2021 Jul;(): Sun Y, bioRxiv 2021 Jun;(): Sun YJ, bioRxiv 2021 Jan;(): Swart M, bioRxiv 2022 Mar;(): Tostanoski LH, bioRxiv 2021 Jun;(): Tscherne A, bioRxiv 2921 Jan;(): Tseng CT, PLoS One 2012;7(4):e35421 Turan RD, Sci Rep 2021 Aug 4;11(1):15799 Unoh Y, bioRxiv 2022;(): Valdes-Balbin Y, bioRxiv 2021 Feb;(): Vogel AB, bioRxiv 2020 Dec;(): Walls AC, bioRxiv 2021 Mar;(): Walls AC, bioRxiv 2022 Feb;(): Walls AC, Cell Rep 2022 Aug 30;40(9):111299 Wang J, Protein Cell 2020 Aug 4;(): Wen HJ, bioRxiv 2021 Apr;(): Wentworth DE, Emerg Infect Dis 2004 Jul;10(7):1293-6 White KM, Science 2021 Feb 26;371(6532):926-931 Williams RK, Proc Natl Acad Sci U S A 1991 Jul 1;88(13):5533-6 Wong LR, Nature 2022 May;605(7908):146-151 WOng LY, bioRxiv 2021 Apr;(): Wu K, bioRxiv 2021 Apr;(): Wu S, Nat Commun 2020 Aug 14;11(1):4081 Wu Y, bioRxiv 2022 Mar;(): Xu K, bioRxiv 2021 Feb;(): Yang J, Nature 2020 Jul 29;(): Yang R, EBioMedicine 2020 Jul 21;58():102890 Yang Y, bioRxiv 2021 Jun;(): Yuan Y, bioRxiv 2022 Feb;(): Yu J, bioRxiv 2021 Nov;(): Zabaleta N, bioRxiv 2021 Jan;(): Zang J, bioRxiv 2022 Feb;(): Zhang C, Nat Commun 2021 Jan 11;12(1):264 Zhang H, bioRxiv 2021-08;(): Zhang YN, bioRxiv 2021 Mar;(): Zhao H, Nat Commun 2020 Aug 25;11(1):4252 Zhao H, Sci Rep 2016 Feb 25;6():22008 Zhao S, bioRxiv 2021 May;(): Zhou R, bioRxiv 2021 Oct;(): Zhou Y, Antiviral Res 2015 Apr;116():76-84 Zhuang Z, J Exp Med 2021 Apr 5;218(4): Zhu L, bioRxiv 2020 Nov;(): | J:308653 J:321881 J:288639 J:291893 J:321926 J:304606 J:308583 J:302915 J:316767 J:295383 J:315723 J:321901 J:310112 J:310116 J:308658 J:297122 J:296388 J:291880 J:291593 J:296213 J:321898 J:315718 J:302246 J:302247 J:310119 J:315730 J:302244 J:19444 J:308652 J:316771 J:290261 J:308670 J:315715 J:288585 J:291598 J:286954 J:300435 J:291595 J:291617 J:291630 J:296197 J:291885 J:291863 J:300090 J:321759 J:299089 J:286952 J:308893 J:304619 J:291884 J:308587 J:324918 J:291631 J:295389 J:291864 J:291591 J:309633 J:304646 J:296195 J:302315 J:291882 J:291592 J:296553 J:308668 J:308726 J:296200 J:296974 J:296698 J:292831 J:325024 J:161935 J:316772 J:291871 J:291633 J:302719 J:321880 J:288030 J:291637 J:308711 J:308659 J:308661 J:299105 J:313329 J:298266 J:308625 J:313449 J:310109 J:291621 J:313441 J:321875 J:291594 J:302147 J:321879 J:300093 J:299936 J:296372 J:309204 J:27269 J:295380 J:324952 J:321856 J:291886 J:325040 J:309691 J:296690 J:308889 J:291883 J:291897 J:303189 J:304681 J:308714 J:299071 J:313440 J:308734 J:321883 J:291590 J:290254 J:298264 J:288029 J:299311 J:311912 J:296700 J:321755 J:308650 J:296705 J:308626 J:302934 J:315716 J:296387 J:308727 J:286408 J:324943 J:310117 J:302702 J:321929 J:291879 J:296069 J:313450 J:291875 J:300108 J:310120 J:296196 J:302940 J:321920 J:308731 J:324975 J:322631 J:296709 J:298260 J:308630 J:308645 J:299309 J:321921 J:308654 J:299308 J:291628 J:309630 J:321771 J:302155 J:298269 J:302930 J:321874 J:328107 J:291872 J:304675 J:286327 J:303457 J:25438 J:331760 J:304684 J:304623 J:300088 J:321907 J:302149 J:292665 J:291894 J:308671 J:321891 J:313463 J:299310 J:321848 J:300884 J:308588 J:303460 J:300091 J:286403 J:308891 J:313436 J:288032 J:308898 J:298147 | SARS-CoV-2_virus|Vaccine Vaccine|VOC_B.1.1.529_Omicron Infection SARS-CoV-MA_virus|Treatment SARS-CoV-2_virus|VOC_B.1.1.7_Alpha|VOC_B.1.351_Beta SARS-CoV-2_virus|Vaccine|VOC_B.1.1.7_Alpha|VOC_B.1.351_Beta|VOC_P.1_Gamma SARS-CoV-2-MA_virus|Vaccine Infection|SARS-CoV-2_virus Infection|SARS-CoV-MA_virus SARS-CoV-MA_virus|Sex_bias SARS-CoV-2_virus SARS-CoV-2-MA_virus|Treatment|VOC_B.1.1.529_Omicron|VOC_B.1.1.7_Alpha|VOC_B.1.351_Beta|VOC_B.1.617.2_Delta|VOC_P.1_Gamma SARS-CoV_virus|Vaccine Vaccine SARS-CoV-2_virus|Treatment Infection|Mouse_Hepatitis_virus MERS-CoV_virus|SARS-CoV-2_virus|SARS-CoV_virus|Vaccine SARS-CoV-2_virus|SARS-CoV_virus|Vaccine MERS-CoV_virus|SARS-CoV-2_virus|Vaccine Pathology|SARS-CoV-MA_virus MERS-CoV_virus|SARS-CoV-MA_virus|SARS-CoV_virus|Treatment MERS-CoV_virus|Pathology MERS-CoV_virus|Vaccine Pathology|SARS-CoV-2_virus SARS-CoV-MA_virus|Vaccine SARS-CoV-2-MA_virus SARS-CoV-2_virus|Vaccine|Variant|VOC_B.1.351_Beta|VOC_B.1.617.2_Delta|VOC_P.1_Gamma SARS-CoV-MA_virus|SARS-CoV_virus|Vaccine Infection|Pathology|SARS-CoV-2-MA_virus Infection|SARS-CoV-MA_virus|Vaccine Infection|Mouse_Hepatitis_virus|SARS-CoV-MA_virus Mouse_Hepatitis_virus Mouse_Hepatitis_virus|Pathology SARS-CoV-2_virus|Vaccine|VOC_B.1.1.529_Omicron|VOC_B.1.617.2_Delta MERS-CoV-MA_virus|SARS-CoV_virus|Treatment MERS-CoV_virus|SARS-CoV-2_virus|Treatment SARS-CoV_virus SARS-CoV-2_virus|Vaccine|VOC_B.1.617.2_Delta Infection|VOC_B.1.1.529_Omicron SARS-CoV-2-MA_virus|SARS-CoV-2_virus|Treatment SARS-CoV-2-MA_virus|Treatment SARS-CoV-2_virus|Treatment|VOC_B.1.1.529_Omicron Variant HCoV-OC43_virus|Infection|SARS-CoV-2_virus|SARS-CoV_virus SARS-CoV-2_virus|SARS-CoV_virus|Vaccine|VOC_B.1.351_Beta Infection|SARS-CoV-2_virus|VOC_B.1.351_Beta|VOC_P.1_Gamma SARS-CoV-2_virus|SARS-CoV-MA_virus SARS-CoV-MA_virus HCoV-OC43_virus|Infection HCoV-229E_virus|SARS-CoV_virus|Treatment SARS-CoV-2_virus|Vaccine|VOC_B.1.1.7_Alpha|VOC_B.1.351_Beta SARS-CoV-2_virus|Vaccine|VOC_B.1.351_Beta SARS-CoV-2_virus|Vaccine|VOC_B.1.1.529_Omicron|VOC_B.1.1.7_Alpha|VOC_B.1.351_Beta|VOC_B.1.617.2_Delta HCoV-OC43_virus|Treatment SARS-CoV-2_virus|Vaccine|VOC_B.1.351_Beta|VOC_B.1.617.2_Delta Vaccine|VOC_B.1.1.529_Omicron|VOC_B.1.1.7_Alpha|VOC_B.1.351_Beta|VOC_B.1.617.2_Delta|VOC_P.1_Gamma Comorbidity|SARS-CoV-2_virus|Vaccine|VOC_B.1.1.7_Alpha Treatment|VOC_P.1_Gamma Vaccine|Variant SARS-CoV-2_virus|Vaccine|Variant|VOC_B.1.351_Beta SARS-CoV-2-MA_virus|SARS-CoV-2_virus Infection|SARS-CoV_virus SARS-CoV-2_virus|Vaccine|VOC_B.1.1.529_Omicron|VOC_B.1.351_Beta|VOC_B.1.617.2_Delta SARS-CoV-2_virus|Vaccine|VOC_B.1.1.7_Alpha|VOC_B.1.351_Beta|VOC_B.1.617.2_Delta Vaccine|VOC_B.1.617.2_Delta MERS-CoV_virus|SARS-CoV-2_virus|SARS-CoV_virus|Treatment MERS-CoV_virus|SARS-CoV_virus|Treatment Infection|MERS-CoV_virus|SARS-CoV-MA_virus|SARS-CoV_virus|Treatment | BALB/cstrain family |
Abdoli A, bioRxiv 2021 Jun;(): Abdoli A, bioRxiv 2022 Feb;(): Agnihothram S, mBio 2014 Mar 25;5(2):e00047-14 Agostini ML, mBio 2018 Mar 6;9(2): Alimohammadi R, bioRxiv 2022 Mar;(): Amanat F, bioRxiv 2021 apr;(): Amanat F, bioRxiv 2021 Aug;(): An Y, bioRxiv 2021 Mar;(): Ao Z, bioRxiv 2021 Dec;(): Baray JC, bioRxiv 2020;(): Barreiro A, bioRxiv 2021 Dec;(): Baxter VK, bioRxiv 2022 Feb;(): Bellier B, bioRxiv 2021 Sep;(): Borriello F, bioRxiv 2021 Sep;(): Brentville VA, bioRxiv 2021 Jun;(): Cantuti-Castelvetri L, Science 2020 Nov 13;370(6518):856-860 Capone S, bioRxiv 2020 Oct;(): Castano-Rodriguez C, mBio 2018 May 22;9(3): Channappanavar R, J Immunol 2017 May 15;198(10):4046-4053 Chapman AP, bioRxiv 2020;(): Chen C, bioRxiv 2022 Feb;(): Chen J, bioRxiv 2021 Nov;(): Chen WH, Hum Vaccin Immunother 2014;10(3):648-58 Chen WH, Vaccine 2020 Nov 3;38(47):7533-7541 Chevillard C, bioRxiv 2021 Sep;(): Choque-Guevara R, bioRxiv 2021 Nov;(): Cohen AA, Science 2021 Feb 12;371(6530):735-741 Compton SR, Virology 1994 Aug 15;203(1):197-201 Conforti A, bioRxiv 2021 Jun;(): Coria LM, bioRxiv 2021 Dec;(): Dai L, Cell 2020 Jun 28;(): Dangi T, bioRxiv 2021 Jun;(): Davenport BJ, bioRxiv 2021 Nov;(): Day CW, Virology 2009 Dec 20;395(2):210-22 Deming D, PLoS Med 2006 Dec;3(12):e525 de Wilde AH, Virus Res 2017 Jan 15;228():7-13 Dey A, bioRxiv 2021 Jan;(): Dietert K, PLoS One 2017;12(11):e0188251 Du L, Nat Commun 2016 Nov 22;7():13473 Du L, PLoS One 2013;8(12):e81587 Elia U, bioRxiv 2020;(): Erasmus JH, Sci Transl Med 2020 Aug 5;12(555): Fehr AR, mBio 2016 Dec 13;7(6): Feng L, Nat Commun 2020 Aug 21;11(1):4207 Fernandez-Castaneda A, bioRxiv 2022;(): Ferrantelli F, bioRxiv 2020 Dec;(): Fett C, J Virol 2013 Jun;87(12):6551-9 Fu D, PLoS Biol 2021 May;19(5):e3001209 Gao J, bioRxiv 2021 Apr;(): Gao Q, Science 2020 Jul 3;369(6499):77-81 Gawish R, bioRxiv 2021 Aug;(): Gonzalez-Dominguez I, bioRxiv 2022 Mar;(): Graham RL, Commun Biol 2018;1():179 Gu H, bioRxiv 2020;(): Gu H, Science 2020 Jul 30;(): Guo X, Immunology 2015 Aug;145(4):476-84 Guo Y, J Biol Chem 2021 Jan 29;():100346 Haabeth OAW, bioRxiv 2021 Apr;(): He Z, bioRxiv 2020;(): Huang Q, Nat Commun 2021 Feb 3;12(1):776 Hua X, JCI Insight 2018 Jun 7;3(11): Hwang M, Immunology 2015 Mar;144(3):374-386 Jangra S, bioRxiv 2020 Oct 23;(): Jiang S, bioRxiv 2021 Aug;(): Joyce MGl Chen WH, bioRxiv 2021 May;(): Kalnin KV, bioRxiv 2020;(): Kandeil A, PLoS One 2020;15(10):e0241471 Kang YF, bioRxiv 2020 Nov;(): Kato H, PLoS One 2019;14(10):e0223684 Khan MS, bioRxiv 2022 May;(): Khanolkar A, J Immunol 2010 Jul 15;185(2):1132-41 Kibler KV, bioRxiv 2021 Dec;(): Kim E, EBioMedicine 2020 May;55():102743 Kim MH, PLoS One 2019;14(7):e0220196 Kobiyama K, bioRxiv 2021 Mar;(): Kozlovskaya L, bioRxiv 2022 Feb;(): Kumaki Y, Antiviral Res 2011 Jan;89(1):75-82 Lan J, PLoS One 2014;9(11):e112602 Lapp SA, bioRxiv 2021 Apr;(): Liang Y, bioRxiv 2021;(): Liao HY, bioRxiv 2021 May;(): Li D, bioRxiv 2021 Jan;(): Li K, mBio 2021 Aug 31;12(4):e0097021 Li L, bioRxiv 2020 Dec;(): Li L, bioRxiv 2021 Jul;(): Lin WS, bioRxiv 2021 Nov;(): Lin X, bioRxiv 2021 Sep;(): Li SW, Sci Rep 2016 May 13;6():25754 Liu H, bioRxiv 2021 Oct;(): Liu S, bioRxiv 2022 Feb;(): Liu WJ, J Immunol 2017 Jan 15;198(2):873-882 Liu X, bioRxiv 2021 Feb;(): Liu Y, bioRxiv 2022 Feb;(): Liu YM, Cell Rep 2020 Aug 11;32(6):108016 Li W, Proc Natl Acad Sci U S A 2020 Nov 24;117(47):29832-29838 Li Y, bioRxiv 2020 Oct;(): Li Z, bioRxiv 2021 Aug;(): Lucchiari MA, J Gen Virol 1991 Jun;72(Pt 6):1317-22 Luo S, bioRxiv 2020;(): Lu RM, bioRxiv 2022 Apr;(): Lu S, bioRxiv 2022 Feb;(): Lv H, Cell Rep 2020 Jun 2;31(9):107725 Mamedov T, bioRxiv 2022 Apr;(): Martinez DR, Science 2021 Aug 27;373(6558):991-998 Mazumder S, bioRxiv 2020 Oct;(): McMillan CL, bioRxiv 2021 May;(): Menachery VD, J Virol 2018 Sep 1;92(17): Mohandas S, Indian J Med Res 2020 May;151(5):479-482 Montagutelli X, bioRxiv 2021 Mar;(): Mudrick HE, bioRxiv 2021 Apr;(): Muruato A, bioRxiv 2021 May;(): Nagai M, bioRxiv 2020 Dec;(): Nagai M, mBio 2021 Aug 31;12(4):e0159821 Nanishi E, bioRxiv 2021 May;(): Narayan R, bioRxiv 2022 Feb;(): Nieto-Torres JL, PLoS Pathog 2014 May;10(5):e1004077 Niu J, Antiviral Res 2020 Jan;173():104646 Norheim G, bioRxiv 2020 Dec;(): O'Keefe BR, J Virol 2010 Mar;84(5):2511-21 Park JG, bioRxiv 2021 Jan;(): Paschall AV, bioRxiv 2021;(): Petras M, bioRxiv 2020 Nov;(): Phatarphekar A, bioRxiv 2022 Jan;(): Pitcovski J, bioRxiv 2021 Jun;(): Pollet J, bioRxiv 2020 Nov;(): Pollet J, bioRxiv 2021 Jul;(): Qu L, bioRxiv 2021 Mar;(): Rappaport AR, bioRxiv 2021 Nov;(): Rauch S, bioRxiv 2020 Oct;(): Reed CC, bioRxiv 2021 Aug;(): Roberts A, PLoS Pathog 2007 Jan;3(1):e5 Salah S, bioRxiv 2022 May;(): Schafer A, bioRxiv 2021 Sep;(): Scheiblhofer S, bioRxiv 2021 Feb;(): Seephetdee C, bioRxiv 2022 Mar;(): Sekimukai H, Microbiol Immunol 2020 Jan;64(1):33-51 Seo YB, bioRxiv 2020;(): Seo YB, bioRxiv 2021 Nov;(): Shen L, J Virol 2019 Jun 15;93(12): Shi Y, J Virol 2021 Jan 7;(): Shoemaker RH, bioRxiv 2021 Sep;(): Somogyi E, bioRxiv 2020;(): Staquicini DI, bioRxiv 2021 Mar;(): Stark FC, bioRxiv 2022 Mar;(): Su D, bioRxiv 2021 May;(): Su D, bioRxiv 2022 May;(): Sun CP, PLoS Pathog 2021 Aug;17(8):e1009758 Sun S, bioRxiv 2020 Nov;(): Sun S, bioRxiv 2020 Nov;(): Sun W, bioRxiv 2021 Jul;(): Sun Y, bioRxiv 2021 Jun;(): Sun YJ, bioRxiv 2021 Jan;(): Swart M, bioRxiv 2022 Mar;(): Tostanoski LH, bioRxiv 2021 Jun;(): Tscherne A, bioRxiv 2921 Jan;(): Tseng CT, PLoS One 2012;7(4):e35421 Turan RD, Sci Rep 2021 Aug 4;11(1):15799 Unoh Y, bioRxiv 2022;(): Valdes-Balbin Y, bioRxiv 2021 Feb;(): Vogel AB, bioRxiv 2020 Dec;(): Walls AC, bioRxiv 2021 Mar;(): Walls AC, bioRxiv 2022 Feb;(): Walls AC, Cell Rep 2022 Aug 30;40(9):111299 Wang J, Protein Cell 2020 Aug 4;(): Wen HJ, bioRxiv 2021 Apr;(): Wentworth DE, Emerg Infect Dis 2004 Jul;10(7):1293-6 White KM, Science 2021 Feb 26;371(6532):926-931 Williams RK, Proc Natl Acad Sci U S A 1991 Jul 1;88(13):5533-6 Wong LR, Nature 2022 May;605(7908):146-151 WOng LY, bioRxiv 2021 Apr;(): Wu K, bioRxiv 2021 Apr;(): Wu S, Nat Commun 2020 Aug 14;11(1):4081 Wu Y, bioRxiv 2022 Mar;(): Xu K, bioRxiv 2021 Feb;(): Yang J, Nature 2020 Jul 29;(): Yang R, EBioMedicine 2020 Jul 21;58():102890 Yang Y, bioRxiv 2021 Jun;(): Yuan Y, bioRxiv 2022 Feb;(): Yu J, bioRxiv 2021 Nov;(): Zabaleta N, bioRxiv 2021 Jan;(): Zang J, bioRxiv 2022 Feb;(): Zhang C, Nat Commun 2021 Jan 11;12(1):264 Zhang H, bioRxiv 2021-08;(): Zhang YN, bioRxiv 2021 Mar;(): Zhao H, Nat Commun 2020 Aug 25;11(1):4252 Zhao H, Sci Rep 2016 Feb 25;6():22008 Zhao S, bioRxiv 2021 May;(): Zhou R, bioRxiv 2021 Oct;(): Zhou Y, Antiviral Res 2015 Apr;116():76-84 Zhuang Z, J Exp Med 2021 Apr 5;218(4): Zhu L, bioRxiv 2020 Nov;(): |
|||||||||||
BALB/cAnNCr | MGI:2160915 | inbred strain | DeDiego ML, J Virol 2014 Jan;88(2):913-24 Khanolkar A, J Virol 2009 Sep;83(17):8946-56 | J:286180 J:153918 | Pathology|SARS-CoV-MA_virus|Treatment Mouse_Hepatitis_virus|Pathology | BALB/cAnNCrinbred strain |
DeDiego ML, J Virol 2014 Jan;88(2):913-24 Khanolkar A, J Virol 2009 Sep;83(17):8946-56 |
|||||||||||
BALB/cAnNCrl | MGI:2683685 | inbred strain | Barnard DL, Antivir Chem Chemother 2006;17(5):275-84 Brouwer PJM, Cell 2021 Mar 4;184(5):1188-1200.e19 Channappanavar R, J Clin Invest 2019 Jul 29;130():3625-3639 Frieman M, J Virol 2012 Jan;86(2):884-97 Jia W, Emerg Microbes Infect 2019;8(1):760-772 Polak K, bioRxiv 2020 Oct;(): Ying B, bioRxiv 2022 Feb;(): | J:288314 J:303464 J:288107 J:288640 J:286329 J:296676 J:321873 | SARS-CoV_virus|Treatment SARS-CoV-2_virus|Vaccine Infection|MERS-CoV-MA_virus|Treatment Infection|SARS-CoV-MA_virus MERS-CoV-MA_virus|MERS-CoV_virus|Vaccine Vaccine|VOC_B.1.1.529_Omicron | BALB/cAnNCrlinbred strain |
Barnard DL, Antivir Chem Chemother 2006;17(5):275-84 Brouwer PJM, Cell 2021 Mar 4;184(5):1188-1200.e19 Channappanavar R, J Clin Invest 2019 Jul 29;130():3625-3639 Frieman M, J Virol 2012 Jan;86(2):884-97 Jia W, Emerg Microbes Infect 2019;8(1):760-772 Polak K, bioRxiv 2020 Oct;(): Ying B, bioRxiv 2022 Feb;(): |
|||||||||||
BALB/cAnNHsd | MGI:2161082 | inbred strain | Bolles M, J Virol 2011 Dec;85(23):12201-15 Leist SR, Cell 2020 Sep 23;(): Menachery VD, Nat Med 2015 Dec;21(12):1508-13 Roberts A, Virus Res 2008 Apr;133(1):20-32 Rockx B, J Virol 2009 Jul;83(14):7062-74 Subbarao K, Trends Microbiol 2006 Jul;14(7):299-303 Wang Y, Invest Ophthalmol Vis Sci 1996 Jan;37(1):250-4 Wang Y, Invest Ophthalmol Vis Sci 2000 Sep;41(10):3011-8 | J:288593 J:296277 J:286371 J:286331 J:286406 J:286332 J:36900 J:64200 | SARS-CoV_virus|Vaccine Infection|Pathology|SARS-CoV-2-MA_virus Infection Infection|SARS-CoV_virus|Vaccine Pathology|SARS-CoV_virus SARS-CoV_virus Mouse_Hepatitis_virus Mouse_Hepatitis_virus|Pathology | BALB/cAnNHsdinbred strain |
Bolles M, J Virol 2011 Dec;85(23):12201-15 Leist SR, Cell 2020 Sep 23;(): Menachery VD, Nat Med 2015 Dec;21(12):1508-13 Roberts A, Virus Res 2008 Apr;133(1):20-32 Rockx B, J Virol 2009 Jul;83(14):7062-74 Subbarao K, Trends Microbiol 2006 Jul;14(7):299-303 Wang Y, Invest Ophthalmol Vis Sci 1996 Jan;37(1):250-4 Wang Y, Invest Ophthalmol Vis Sci 2000 Sep;41(10):3011-8 |
|||||||||||
BALB/cAnNTac | MGI:6200629 | inbred strain | Greenough TC, J Infect Dis 2005 Feb 15;191(4):507-14 Liu R, bioRxiv 2021 Jan;(): Liu R, Proc Natl Acad Sci U S A 2021 Mar 23;118(12):e2026785118 Roberts A, J Virol 2005 May;79(9):5833-8 Subbarao K, J Virol 2004 Apr;78(7):3572-7 | J:288263 J:299104 J:303465 J:286301 J:286300 | SARS-CoV_virus|Treatment SARS-CoV-2_virus|Vaccine Pathology|SARS-CoV_virus SARS-CoV_virus | BALB/cAnNTacinbred strain |
Greenough TC, J Infect Dis 2005 Feb 15;191(4):507-14 Liu R, bioRxiv 2021 Jan;(): Liu R, Proc Natl Acad Sci U S A 2021 Mar 23;118(12):e2026785118 Roberts A, J Virol 2005 May;79(9):5833-8 Subbarao K, J Virol 2004 Apr;78(7):3572-7 |
|||||||||||
BALB/cBy | MGI:2159790 | inbred strain | Bolles M, J Virol 2011 Dec;85(23):12201-15 | J:288593 | SARS-CoV_virus|Vaccine | BALB/cByinbred strain |
Bolles M, J Virol 2011 Dec;85(23):12201-15 |
|||||||||||
BALB/cByJ | MGI:2159771 | inbred strain | Barthold SW, Lab Anim Sci 1993 Aug;43(4):276-84 Walls AC, Cell Rep 2022 Aug 30;40(9):111299 | J:14457 J:328107 | Infection|Mouse_Hepatitis_virus SARS-CoV-2_virus|Vaccine|Variant|VOC_B.1.351_Beta | BALB/cByJinbred strain |
Barthold SW, Lab Anim Sci 1993 Aug;43(4):276-84 Walls AC, Cell Rep 2022 Aug 30;40(9):111299 |
|||||||||||
BALB/cCrl | MGI:2386653 | inbred strain | Kumaki Y, Antiviral Res 2017 Mar;139():1-12 | J:286953 | SARS-CoV-MA_virus|SARS-CoV_virus|Treatment | BALB/cCrlinbred strain |
Kumaki Y, Antiviral Res 2017 Mar;139():1-12 |
|||||||||||
BALB/cCrSlc | MGI:2161019 | inbred strain | Iwata-Yoshikawa N, J Virol 2014 Aug;88(15):8597-614 | J:288033 | SARS-CoV-MA_virus|Vaccine | BALB/cCrSlcinbred strain |
Iwata-Yoshikawa N, J Virol 2014 Aug;88(15):8597-614 |
|||||||||||
BALB/cJ | MGI:2159737 | inbred strain | Afkhami S, bioRxiv 2021 Jul;(): Alsoussi WB, J Immunol 2020 Jun 26;(): Arevalo AP, bioRxiv 2020 Nov;(): Corbett KS, Nature 2020 Oct;586(7830):567-571 Dalvie NC, bioRxiv 2021 Mar;(): De Albuquerque N, J Virol 2006 Nov;80(21):10382-94 Gawish R, Elife 2022 Jan 13;11():e74623 Hassan AO, Cell 2020 Jun 10;(): Hassan AO, Cell Rep 2021 Jul 27;36(4):109452 Hu Q, bioRxiv 2022 Mar;(): Rujas E, bioRxiv 2020;(): Sourimant J, bioRxiv 2021 May;(): Tummino TA, bioRxiv 2021 Mar;(): Walls AC, Cell 2020 Nov 25;183(5):1367-1382.e17 Wang L, Nat Commun 2015 Jul 28;6():7712 Zost SJ, Nature 2020 Jul 15;(): | J:308640 J:290255 J:296697 J:297398 J:302712 J:288204 J:318828 J:290258 J:309629 J:321924 J:296183 J:308735 J:303456 J:298609 J:291618 J:291899 | SARS-CoV-2_virus|Vaccine|VOC_B.1.1.7_Alpha|VOC_B.1.351_Beta SARS-CoV-2_virus|Treatment Mouse_Hepatitis_virus|Treatment MERS-CoV_virus|SARS-CoV-2_virus|Vaccine SARS-CoV-2_virus|Vaccine Mouse_Hepatitis_virus|Pathology Pathology|SARS-CoV-2-MA_virus Infection|SARS-CoV-2_virus|Treatment SARS-CoV-2_virus|Vaccine|VOC_B.1.1.529_Omicron|VOC_B.1.1.7_Alpha|VOC_B.1.351_Beta|VOC_B.1.617.2_Delta|VOC_P.1_Gamma MERS-CoV_virus|Vaccine SARS-CoV-2-MA_virus|SARS-CoV-2_virus|Treatment | BALB/cJinbred strain |
Afkhami S, bioRxiv 2021 Jul;(): Alsoussi WB, J Immunol 2020 Jun 26;(): Arevalo AP, bioRxiv 2020 Nov;(): Corbett KS, Nature 2020 Oct;586(7830):567-571 Dalvie NC, bioRxiv 2021 Mar;(): De Albuquerque N, J Virol 2006 Nov;80(21):10382-94 Gawish R, Elife 2022 Jan 13;11():e74623 Hassan AO, Cell 2020 Jun 10;(): Hassan AO, Cell Rep 2021 Jul 27;36(4):109452 Hu Q, bioRxiv 2022 Mar;(): Rujas E, bioRxiv 2020;(): Sourimant J, bioRxiv 2021 May;(): Tummino TA, bioRxiv 2021 Mar;(): Walls AC, Cell 2020 Nov 25;183(5):1367-1382.e17 Wang L, Nat Commun 2015 Jul 28;6():7712 Zost SJ, Nature 2020 Jul 15;(): |
|||||||||||
BALB/cJRj | MGI:6357755 | inbred strain | Lapuente D, bioRxiv 2021 Aug;(): | J:308581 | SARS-CoV-2_virus|Vaccine | BALB/cJRjinbred strain |
Lapuente D, bioRxiv 2021 Aug;(): |
|||||||||||
BALB/c-Kctd9em1Beij | MGI:6382781 | coisogenic|endonuclease-mediated mutation|mutant strain | MGI:6382782 | Kctd9em1Beij | MGI:6382731 | Endonuclease-mediated | Null/knockout | hematopoietic system homeostasis/metabolism immune system mortality/aging | MP:0005397 MP:0005376 MP:0005387 MP:0010768 | Zhang X, Front Immunol 2019;10():744 | J:281803 | Mouse_Hepatitis_virus | BALB/c-Kctd9em1Beijcoisogenic|endonuclease-mediated mutation|mutant strain |
MGI:6382782 | hematopoietic system homeostasis/metabolism immune system mortality/aging |
Zhang X, Front Immunol 2019;10():744 |
||
BALB/cN | MGI:2161229 | inbred strain | Kovacech B, bioRxiv 2021 Jun;(): | J:308649 | SARS-CoV-2_virus|VOC_B.1.1.7_Alpha|VOC_B.1.351_Beta | BALB/cNinbred strain |
Kovacech B, bioRxiv 2021 Jun;(): |
|||||||||||
BALB/cOlaHsd | MGI:3047778 | inbred strain | DeDiego ML, J Virol 2014 Jan;88(2):913-24 Hachim MY, Front Immunol 2020;11():1372 Jimenez-Guardeno JM, PLoS Pathog 2015 Oct;11(10):e1005215 Rothen DA, bioRxiv 2021 Sep;(): Spencer AJ, bioRxiv 2021 Jan;(): Spencer AJ, bioRxiv 2021 Jun;(): van der Ley PA, bioRxiv 2021 Aug;(): van Doremalen N, Nature 2020 Oct;586(7830):578-582 | J:286180 J:291898 J:291656 J:310118 J:302146 J:308644 J:309194 J:297406 | Pathology|SARS-CoV-MA_virus|Treatment Gene|SARS-CoV-2_virus|SARS-CoV-MA_virus|SARS-CoV_virus SARS-CoV-MA_virus SARS-CoV-2_virus|Vaccine|VOC_B.1.1.7_Alpha|VOC_B.1.351_Beta SARS-CoV-2_virus|Vaccine Vaccine|VOC_B.1.351_Beta|VOC_B.1.617.2_Delta | BALB/cOlaHsdinbred strain |
DeDiego ML, J Virol 2014 Jan;88(2):913-24 Hachim MY, Front Immunol 2020;11():1372 Jimenez-Guardeno JM, PLoS Pathog 2015 Oct;11(10):e1005215 Rothen DA, bioRxiv 2021 Sep;(): Spencer AJ, bioRxiv 2021 Jan;(): Spencer AJ, bioRxiv 2021 Jun;(): van der Ley PA, bioRxiv 2021 Aug;(): van Doremalen N, Nature 2020 Oct;586(7830):578-582 |
|||||||||||
BALB/c-Tg(Rela-luc)31Xen/Tac | MGI:6438428 | coisogenic|mutant strain|transgenic | Samsudin F, bioRxiv 2021 Nov;(): | J:313448 | Pathology|SARS-CoV-2_virus | BALB/c-Tg(Rela-luc)31Xen/Taccoisogenic|mutant strain|transgenic |
Samsudin F, bioRxiv 2021 Nov;(): |
|||||||||||
C.129S2-Cd1tm1Gru/J | MGI:2174232 | congenic|mutant strain|targeted mutation | Glass WG, J Immunol 2004 Sep 15;173(6):4030-9 | J:92752 | Infection|SARS-CoV_virus | C.129S2-Cd1tm1Gru/Jcongenic|mutant strain|targeted mutation |
Glass WG, J Immunol 2004 Sep 15;173(6):4030-9 |
|||||||||||
C.129S7(B6)-Rag1tm1Mom/J | MGI:2161492 | congenic|mutant strain|targeted mutation | Mao T, bioRxiv 2021 Jun;(): | J:308656 | Treatment|VOC_B.1.1.7_Alpha|VOC_B.1.351_Beta|VOC_P.1_Gamma | C.129S7(B6)-Rag1tm1Mom/Jcongenic|mutant strain|targeted mutation |
Mao T, bioRxiv 2021 Jun;(): |
|||||||||||
C.129X1-Ifngtm1Yiw | MGI:6430486 | congenic|mutant strain|targeted mutation | MGI:6430488 | Ifngtm1Yiw | MGI:3036127 | Targeted | Null/knockout | cellular homeostasis/metabolism immune system liver/biliary system mortality/aging | MP:0005384 MP:0005376 MP:0005387 MP:0005370 MP:0010768 | Kyuwa S, Virus Res 2002 Feb 26;83(1-2):169-77 | J:91691 | Infection|Mouse_Hepatitis_virus|Pathology | C.129X1-Ifngtm1Yiwcongenic|mutant strain|targeted mutation |
MGI:6430488 | cellular homeostasis/metabolism immune system liver/biliary system mortality/aging |
Kyuwa S, Virus Res 2002 Feb 26;83(1-2):169-77 |
||
C3H/HeJ | MGI:2159741 | inbred strain | Dhanyalayam D, bioRxiv 2021 Sep;(): Khanolkar A, J Immunol 2010 Jul 15;185(2):1132-41 | J:310121 J:161935 | Comorbidity|SARS-CoV-2_virus Mouse_Hepatitis_virus|Pathology | C3H/HeJinbred strain |
Dhanyalayam D, bioRxiv 2021 Sep;(): Khanolkar A, J Immunol 2010 Jul 15;185(2):1132-41 |
|||||||||||
C3H/HeJCr | MGI:2165380 | inbred strain | Hartwig SM, PLoS One 2014;9(3):e90720 Khanolkar A, J Virol 2009 Sep;83(17):8946-56 | J:291635 J:153918 | Mouse_Hepatitis_virus|Pathology | C3H/HeJCrinbred strain |
Hartwig SM, PLoS One 2014;9(3):e90720 Khanolkar A, J Virol 2009 Sep;83(17):8946-56 |
|||||||||||
C3H/HeNCr | MGI:2160592 | inbred strain | Hartwig SM, PLoS One 2014;9(3):e90720 Khanolkar A, J Virol 2009 Sep;83(17):8946-56 | J:291635 J:153918 | Mouse_Hepatitis_virus|Pathology | C3H/HeNCrinbred strain |
Hartwig SM, PLoS One 2014;9(3):e90720 Khanolkar A, J Virol 2009 Sep;83(17):8946-56 |
|||||||||||
C3H/St | MGI:2159861 | inbred strain | De Albuquerque N, J Virol 2006 Nov;80(21):10382-94 | J:288204 | Mouse_Hepatitis_virus|Pathology | C3H/Stinbred strain |
De Albuquerque N, J Virol 2006 Nov;80(21):10382-94 |
|||||||||||
C57BL/10ScNJ | MGI:2165217 | inbred strain | Khanolkar A, J Virol 2009 Sep;83(17):8946-56 Kumaki Y, Antiviral Res 2017 Mar;139():1-12 | J:153918 J:286953 | Mouse_Hepatitis_virus|Pathology SARS-CoV-MA_virus|SARS-CoV_virus|Treatment | C57BL/10ScNJinbred strain |
Khanolkar A, J Virol 2009 Sep;83(17):8946-56 Kumaki Y, Antiviral Res 2017 Mar;139():1-12 |
|||||||||||
C57BL/10SnJ | MGI:2159909 | inbred strain | Greer CD, bioRxiv 2021 Aug;(): Khanolkar A, J Virol 2009 Sep;83(17):8946-56 | J:308745 J:153918 | SARS-CoV-2_virus|Vaccine Mouse_Hepatitis_virus|Pathology | C57BL/10SnJinbred strain |
Greer CD, bioRxiv 2021 Aug;(): Khanolkar A, J Virol 2009 Sep;83(17):8946-56 |
|||||||||||
C57BL/6 | MGI:2159769 | strain family | Ahan RE, bioRxiv 2021 Jul;(): Alimohammadi R, bioRxiv 2022 Mar;(): Almanza G, bioRxiv 2021;(): An Y, bioRxiv 2021 Mar;(): Bleau C, J Virol 2015 Oct;89(19):9896-908 Brechbuhl J, bioRxiv 2021 Mar;(): Brentville VA, bioRxiv 2021 Jun;(): Cao L, bioRxiv 2021;(): Castro JT, bioRxiv 2021 Sep;(): Chandrasekar SS, Vaccines (Basel) 2021 Feb 6;9(2): Channappanavar R, J Immunol 2017 May 15;198(10):4046-4053 Chen J, bioRxiv 2021 Nov;(): Conforti A, bioRxiv 2021 Jun;(): Coria LM, bioRxiv 2021 Dec;(): Counoupas C, bioRxiv 2020 Dec;(): Counoupas C, bioRxiv 2021;(): Dangi T, bioRxiv 2021 Jun;(): Dietert K, PLoS One 2017;12(11):e0188251 Erasmus JH, Sci Transl Med 2020 Aug 5;12(555): Ferrantelli F, bioRxiv 2020 Dec;(): Francis DM, bioRxiv 2021 Aug;(): Gale EC, bioRxiv 2021 Apr;(): Gale EC, bioRxiv 2021 Jul;(): Gawish R, bioRxiv 2021 Aug;(): Gerbre MS, bioRxiv 2021 Nov;(): Glass WG, J Immunol 2004 Apr 1;172(7):4018-25 Gray LT, bioRxiv 2021 May;(): Gu M, bioRxiv 2021 Apr;(): Guo Q, Cell Host Microbe 2021 Feb 10;29(2):222-235.e4 Hachim MY, Front Immunol 2020;11():1372 Hassler L, bioRxiv 2021 Mar;(): Hauser BM, bioRxiv 2021 Mar;(): Hawman DW, bioRxiv 2021 Dec;(): Heer CD, J Biol Chem 2020 Dec 25;295(52):17986-17996 He L, bioRxiv 2020;(): Hennighausen L, Cell Rep 2020 Sep 29;32(13):108199 Huang Q, Nat Commun 2021 Feb 3;12(1):776 Jackson MR, bioRxiv 2021 Mar;(): Jiang S, bioRxiv 2021 Aug;(): Joyce MGl Chen WH, bioRxiv 2021 May;(): Keyaerts E, Antimicrob Agents Chemother 2009 Aug;53(8):3416-21 Khanolkar A, J Immunol 2010 Jul 15;185(2):1132-41 Kim E, EBioMedicine 2020 May;55():102743 Kobiyama K, bioRxiv 2021 Mar;(): Koester ST, PLoS One 2021;16(3):e0248730 Lam JH, bioRxiv 2021 Jan;(): Lapuente D, bioRxiv 2021 Aug;(): Lartey NL, bioRxiv 2021 Apr;(): Lei L, PLoS One 2013;8(4):e61166 Liang Y, Zool Res 2020 Oct 12;():1-29 Li JQ, bioRxiv 2020 Oct;(): Li L, bioRxiv 2021 Jul;(): Liu A, J Pathol 2021 Jan;253(1):17-30 Liu J, bioRxiv 2021 May;(): Long Y, bioRxiv 2021 Apr;(): Luo S, bioRxiv 2020;(): Mohandas S, Indian J Med Res 2020 May;151(5):479-482 Montagutelli X, bioRxiv 2021 Mar;(): Nicolai L, bioRxiv 2021 Jun;(): Niu J, Antiviral Res 2020 Jan;173():104646 Paidi RK, J Immunol 2021 Nov 15;207(10):2521-2533 Pan P, Nat Commun 2021 Aug 2;12(1):4664 Perez-Shibayama C, PLoS One 2013;8(11):e81442 Raha AA, Biosci Rep 2020 Dec 23;40(12): Ryu JK, bioRxiv 2021;(): Ryu S, bioRxiv 2020;(): Sanchez S, bioRxiv 2021 Apr;(): Seephetdee C, bioRxiv 2021 Mar;(): Soni S, PLoS One 2021;16(2):e0247510 Subramani J, bioRxiv 2021 Aug;(): Sun Y, bioRxiv 2021 Jun;(): Tong J, bioRxiv 2021 Feb;(): Tseng CT, PLoS One 2012;7(4):e35421 Volpatti LR, bioRxiv 2021 Apr;(): Vo T, bioRxiv 2020 Nov;(): Wang W, bioRxiv 2020 Dec;(): Wang Y, FASEB J 2021 Mar;35(3):e21419 Wheeler DL, J Clin Invest 2018 Mar 1;128(3):931-943 Wong LR, Nature 2022 May;605(7908):146-151 WOng LY, bioRxiv 2021 Apr;(): Yang C, bioRxiv 2020;(): Yang J, Nature 2020 Jul 29;(): Yi C, Cell Mol Immunol 2020 Jun;17(6):621-630 Zabaleta N, bioRxiv 2021 Jan;(): Zhuang Z, J Exp Med 2021 Apr 5;218(4): | J:308572 J:321926 J:311920 J:302915 J:291878 J:303458 J:308658 J:311925 J:310123 J:302249 J:291593 J:315718 J:308652 J:316771 J:298265 J:308747 J:308670 J:291595 J:291885 J:299089 J:314179 J:303466 J:308622 J:308587 J:313462 J:88677 J:308736 J:303468 J:308901 J:291898 J:302921 J:302933 J:316766 J:300100 J:295372 J:297407 J:302315 J:302714 J:308668 J:308726 J:288028 J:161935 J:291871 J:302719 J:303461 J:300448 J:308581 J:304620 J:291629 J:296738 J:296674 J:308625 J:301197 J:308729 J:304618 J:295380 J:291897 J:303189 J:308623 J:290254 J:331805 J:313326 J:291632 J:313516 J:311923 J:295364 J:303470 J:302706 J:303459 J:308746 J:308645 J:302154 J:291628 J:304615 J:296710 J:299103 J:309535 J:291614 J:331760 J:304684 J:296070 J:292665 J:291876 J:299310 J:308898 | SARS-CoV-2_virus|Treatment SARS-CoV-2_virus|Vaccine SARS-CoV-2_virus|VOC_B.1.351_Beta|VOC_B.1.617.2_Delta Infection|Mouse_Hepatitis_virus Gene SARS-CoV-2_virus|Treatment|VOC_B.1.617.2_Delta SARS-CoV-MA_virus|Sex_bias SARS-CoV-2_virus|SARS-CoV_virus|Vaccine MERS-CoV_virus|Pathology SARS-CoV-2_virus|Vaccine|VOC_B.1.351_Beta SARS-CoV-2-MA_virus Mouse_Hepatitis_virus Pathology|SARS-CoV-2_virus Gene|SARS-CoV-2_virus|SARS-CoV-MA_virus|SARS-CoV_virus SARS-CoV-2_virus|Vaccine|VOC_B.1.1.7_Alpha|VOC_B.1.351_Beta Infection|Mouse_Hepatitis_virus|SARS-CoV-2_virus Infection|SARS-CoV-2_virus Pathology Treatment Mouse_Hepatitis_virus|Pathology MERS-CoV_virus|SARS-CoV-2_virus|Vaccine Infection|Pathology|SARS-CoV-2_virus Comorbidity|Gene Vaccine Infection|SARS-CoV-2_virus|VOC_B.1.351_Beta|VOC_P.1_Gamma HCoV-OC43_virus|Infection SARS-CoV-2_virus|Vaccine|VOC_B.1.1.7_Alpha|VOC_B.1.351_Beta|VOC_B.1.617.2_Delta|VOC_P.1_Gamma Comorbidity|SARS-CoV-2_virus|Vaccine|VOC_B.1.1.7_Alpha SARS-CoV_virus|Vaccine Infection SARS-CoV-2-MA_virus|Treatment | C57BL/6strain family |
Ahan RE, bioRxiv 2021 Jul;(): Alimohammadi R, bioRxiv 2022 Mar;(): Almanza G, bioRxiv 2021;(): An Y, bioRxiv 2021 Mar;(): Bleau C, J Virol 2015 Oct;89(19):9896-908 Brechbuhl J, bioRxiv 2021 Mar;(): Brentville VA, bioRxiv 2021 Jun;(): Cao L, bioRxiv 2021;(): Castro JT, bioRxiv 2021 Sep;(): Chandrasekar SS, Vaccines (Basel) 2021 Feb 6;9(2): Channappanavar R, J Immunol 2017 May 15;198(10):4046-4053 Chen J, bioRxiv 2021 Nov;(): Conforti A, bioRxiv 2021 Jun;(): Coria LM, bioRxiv 2021 Dec;(): Counoupas C, bioRxiv 2020 Dec;(): Counoupas C, bioRxiv 2021;(): Dangi T, bioRxiv 2021 Jun;(): Dietert K, PLoS One 2017;12(11):e0188251 Erasmus JH, Sci Transl Med 2020 Aug 5;12(555): Ferrantelli F, bioRxiv 2020 Dec;(): Francis DM, bioRxiv 2021 Aug;(): Gale EC, bioRxiv 2021 Apr;(): Gale EC, bioRxiv 2021 Jul;(): Gawish R, bioRxiv 2021 Aug;(): Gerbre MS, bioRxiv 2021 Nov;(): Glass WG, J Immunol 2004 Apr 1;172(7):4018-25 Gray LT, bioRxiv 2021 May;(): Gu M, bioRxiv 2021 Apr;(): Guo Q, Cell Host Microbe 2021 Feb 10;29(2):222-235.e4 Hachim MY, Front Immunol 2020;11():1372 Hassler L, bioRxiv 2021 Mar;(): Hauser BM, bioRxiv 2021 Mar;(): Hawman DW, bioRxiv 2021 Dec;(): Heer CD, J Biol Chem 2020 Dec 25;295(52):17986-17996 He L, bioRxiv 2020;(): Hennighausen L, Cell Rep 2020 Sep 29;32(13):108199 Huang Q, Nat Commun 2021 Feb 3;12(1):776 Jackson MR, bioRxiv 2021 Mar;(): Jiang S, bioRxiv 2021 Aug;(): Joyce MGl Chen WH, bioRxiv 2021 May;(): Keyaerts E, Antimicrob Agents Chemother 2009 Aug;53(8):3416-21 Khanolkar A, J Immunol 2010 Jul 15;185(2):1132-41 Kim E, EBioMedicine 2020 May;55():102743 Kobiyama K, bioRxiv 2021 Mar;(): Koester ST, PLoS One 2021;16(3):e0248730 Lam JH, bioRxiv 2021 Jan;(): Lapuente D, bioRxiv 2021 Aug;(): Lartey NL, bioRxiv 2021 Apr;(): Lei L, PLoS One 2013;8(4):e61166 Liang Y, Zool Res 2020 Oct 12;():1-29 Li JQ, bioRxiv 2020 Oct;(): Li L, bioRxiv 2021 Jul;(): Liu A, J Pathol 2021 Jan;253(1):17-30 Liu J, bioRxiv 2021 May;(): Long Y, bioRxiv 2021 Apr;(): Luo S, bioRxiv 2020;(): Mohandas S, Indian J Med Res 2020 May;151(5):479-482 Montagutelli X, bioRxiv 2021 Mar;(): Nicolai L, bioRxiv 2021 Jun;(): Niu J, Antiviral Res 2020 Jan;173():104646 Paidi RK, J Immunol 2021 Nov 15;207(10):2521-2533 Pan P, Nat Commun 2021 Aug 2;12(1):4664 Perez-Shibayama C, PLoS One 2013;8(11):e81442 Raha AA, Biosci Rep 2020 Dec 23;40(12): Ryu JK, bioRxiv 2021;(): Ryu S, bioRxiv 2020;(): Sanchez S, bioRxiv 2021 Apr;(): Seephetdee C, bioRxiv 2021 Mar;(): Soni S, PLoS One 2021;16(2):e0247510 Subramani J, bioRxiv 2021 Aug;(): Sun Y, bioRxiv 2021 Jun;(): Tong J, bioRxiv 2021 Feb;(): Tseng CT, PLoS One 2012;7(4):e35421 Volpatti LR, bioRxiv 2021 Apr;(): Vo T, bioRxiv 2020 Nov;(): Wang W, bioRxiv 2020 Dec;(): Wang Y, FASEB J 2021 Mar;35(3):e21419 Wheeler DL, J Clin Invest 2018 Mar 1;128(3):931-943 Wong LR, Nature 2022 May;605(7908):146-151 WOng LY, bioRxiv 2021 Apr;(): Yang C, bioRxiv 2020;(): Yang J, Nature 2020 Jul 29;(): Yi C, Cell Mol Immunol 2020 Jun;17(6):621-630 Zabaleta N, bioRxiv 2021 Jan;(): Zhuang Z, J Exp Med 2021 Apr 5;218(4): |
|||||||||||
C57BL/6-Ace2em1(ACE2)Yowa | MGI:6431338 | coisogenic|endonuclease-mediated mutation|mutant strain | MGI:6431340 | Ace2em1(ACE2)Yowa | MGI:6431336 | Endonuclease-mediated | Humanized sequence|Null/knockout|Reporter | COVID-19 | DOID:0080600 | cardiovascular system homeostasis/metabolism immune system respiratory system | MP:0005385 MP:0005376 MP:0005387 MP:0005388 | Sun SH, Cell Host Microbe 2020;20():1-10 | J:288243 | Infection|Pathology|SARS-CoV-2_virus | C57BL/6-Ace2em1(ACE2)Yowacoisogenic|endonuclease-mediated mutation|mutant strain |
MGI:6431340 | cardiovascular system homeostasis/metabolism immune system respiratory system COVID-19 |
Sun SH, Cell Host Microbe 2020;20():1-10 |
C57BL/6-Ace2em1Cya | MGI:6500741 | coisogenic|endonuclease-mediated mutation|mutant strain | MGI:6500742 | Ace2em1Cya | MGI:6500740 | Endonuclease-mediated | Null/knockout | cellular digestive/alimentary system growth/size/body homeostasis/metabolism immune system | MP:0005384 MP:0005381 MP:0005378 MP:0005376 MP:0005387 | Yu W, Biochem Biophys Res Commun 2020 Dec 17;533(4):1276-1282 | J:299383 | Gene | C57BL/6-Ace2em1Cyacoisogenic|endonuclease-mediated mutation|mutant strain |
MGI:6500742 | cellular digestive/alimentary system growth/size/body homeostasis/metabolism immune system |
Yu W, Biochem Biophys Res Commun 2020 Dec 17;533(4):1276-1282 |
||
C57BL/6(FVB)-Ceacam1tm1.1Fta | MGI:5496838 | mutant strain|targeted mutation | MGI:5496535 | Ceacam1tm1.1Fta | MGI:5496530 | Targeted | Inserted expressed sequence | immune system mortality/aging | MP:0005387 MP:0010768 | Hirai A, J Virol 2010 Jul;84(13):6654-66 | J:198335 | Infection|Mouse_Hepatitis_virus | C57BL/6(FVB)-Ceacam1tm1.1Ftamutant strain|targeted mutation |
MGI:5496535 | immune system mortality/aging |
Hirai A, J Virol 2010 Jul;84(13):6654-66 |
||
C57BL/6-Gt(ROSA)26Sorem1(DPP4)Yowa | MGI:6403445 | coisogenic|endonuclease-mediated mutation|mutant strain | MGI:6403447 | Gt(ROSA)26Sorem1(DPP4)Yowa | MGI:6403442 | Endonuclease-mediated | Humanized sequence|Inserted expressed sequence|Reporter | Middle East respiratory syndrome | DOID:0080642 | immune system nervous system | MP:0005387 MP:0003631 | Fan C, Viruses 2018 Aug 23;10(9): | J:279060 | Infection|MERS-CoV_virus|Pathology|Treatment | C57BL/6-Gt(ROSA)26Sorem1(DPP4)Yowacoisogenic|endonuclease-mediated mutation|mutant strain |
MGI:6403447 | immune system nervous system Middle East respiratory syndrome |
Fan C, Viruses 2018 Aug 23;10(9): |
C57BL/6-Irf5tm1Ppr/J | MGI:5291921 | coisogenic|mutant strain|targeted mutation | Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 | J:296686 | Pathology|SARS-CoV-2_virus|Treatment | C57BL/6-Irf5tm1Ppr/Jcoisogenic|mutant strain|targeted mutation |
Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 |
|||||||||||
C57BL/6J | MGI:3028467 | inbred strain | MGI:2166311 | cardiovascular system endocrine/exocrine glands growth/size/body homeostasis/metabolism immune system muscle nervous system | MP:0005385 MP:0005379 MP:0005378 MP:0005376 MP:0005387 MP:0005369 MP:0003631 | Afkhami S, bioRxiv 2021 Jul;(): Alsoussi WB, J Immunol 2020 Jun 26;(): Anand G, bioRxiv 2020 Dec;(): Benard A, Nat Commun 2021 Feb 18;12(1):1112 Biering SB, bioRxiv 2021 Dec;(): Bilinska K, bioRxiv 2021 Apr;(): Borriello F, bioRxiv 2021 Sep;(): Brady M, bioRxiv 2021 Aug;(): Brooks SD, bioRxiv 2021;(): Cao X, bioRxiv 2020 Dec;(): Chaparian RR, bioRxiv 2021 Apr;(): Chen JS, J Virol 2021 Jan 13;(): Chen Y, bioRxiv 2021 Nov;(): Chong Z, bioRxiv 2022;(): Colunga Biancatelli R, Am J Physiol Lung Cell Mol Physiol 2021 Jun;(): Corbett KS, Nature 2020 Oct;586(7830):567-571 Das Sarma J, J Virol 2000 Oct;74(19):9206-13 De Albuquerque N, J Virol 2006 Nov;80(21):10382-94 Deng Q, bioRxiv 2020;(): Deng X, J Virol 2014 Oct 15;88(20):11886-98 dos Santos Pereira Andrade AC, bioRxiv 2021 May;(): Eldi P, bioRxiv 2021 Sep;(): Gawish R, Elife 2022 Jan 13;11():e74623 Geng T, bioRxiv 2021 Jun;(): Gralinski LE, mBio 2013 Aug 6;4(4): Gralinski LE, PLoS Genet 2015 Oct;11(10):e1005504 Hachim MY, Front Immunol 2020;11():1372 Han K, Am J Respir Cell Mol Biol 2021 Jan;64(1):79-88 Houtman JJ, J Neurovirol 1996 APR;2(2):101-110 Jia L, bioRxiv 2022 Feb;(): Joag V, J Immunol 2021 Mar 1;206(5):931-935 Josset L, RNA Biol 2014;11(7):875-90 Khaddaj-Mallat R, bioRxiv 2021 May;(): Kim E, Proc Natl Acad Sci U S A 2021 Aug 24;118(34):e2102435118 Kim TY, bioRxiv 2020 Dec;(): King RG, bioRxiv 2020;(): Kumaki Y, Antiviral Res 2017 Mar;139():1-12 Leist SR, Cell 2020 Sep 23;(): Li S, JCI Insight 2021 Jan 25;6(2): Madar-Balakirski N, bioRxiv 2021 Jul;(): Mandal P, PLoS One 2021;16(7):e0246270 Pewe L, J Virol 1997 Oct;71(10):7640-7 Radvak P, bioRxiv 2021 Jun;(): Roberts A, Virus Res 2008 Apr;133(1):20-32 Salvi V, bioRxiv 2021 Apr;(): Salvi V, JCI Insight 2021 Sep 22;6(18):e150542 Salzer R, bioRxiv 2021 May;(): Sarver DC, Biochem Biophys Res Commun 2021 Jan 29;538():92-96 Satta S, Theranostics 2022;12(6):2639-2657 Schafer A, mBio 2022 Aug 30;13(4):e0145422 Sepe S, bioRxiv 2021 Jun;(): Sheahan TP, Sci Transl Med 2020 Apr 29;12(541): Shirato K, bioRxiv 2021 Jul;(): Sims JJ, bioRxiv 2021 Apr;(): Subbarao K, Trends Microbiol 2006 Jul;14(7):299-303 Sun CP, PLoS Pathog 2021 Aug;17(8):e1009758 Szurgot I, Sci Rep 2021 Feb 4;11(1):3125 Tsai SJ, bioRxiv 2020 Nov;(): Vanderheiden A, bioRxiv 2021 May;(): Vanderheiden A, mBio 2021 Nov 9;():e0274921 Wang H, bioRxiv 2021 Jul;(): Wang J, Protein Cell 2020 Aug 4;(): White KM, Science 2021 Feb 26;371(6532):926-931 Xiong H, G3 (Bethesda) 2014 Jun 5;4(8):1429-44 Xu H, bioRxiv 2020;(): Zhou B, Nature 2021 Apr;592(7852):122-127 Zhuang X, bioRxiv 2021 Jun 28;(): | J:308640 J:290255 J:298270 J:303473 J:316773 J:304622 J:310116 J:308577 J:311924 J:298259 J:308713 J:300110 J:315729 J:321761 J:309512 J:297398 J:64499 J:288204 J:296182 J:214600 J:308662 J:310113 J:318828 J:308624 J:288556 J:268979 J:291898 J:331824 J:33974 J:321887 J:303898 J:276026 J:308715 J:313327 J:299070 J:296068 J:286953 J:296277 J:302826 J:308635 J:308899 J:42952 J:308643 J:286331 J:304651 J:313336 J:308749 J:309632 J:331825 J:327836 J:309195 J:286320 J:308576 J:304613 J:286332 J:322631 J:302250 J:296707 J:308718 J:317454 J:308641 J:291872 J:303457 J:276183 J:295377 J:305777 J:303203 | SARS-CoV-2_virus|Vaccine|VOC_B.1.1.7_Alpha|VOC_B.1.351_Beta SARS-CoV-2_virus|Treatment Pathology|SARS-CoV-2_virus SARS-CoV-2_virus Gene SARS-CoV-2_virus|Vaccine Infection|SARS-CoV-2_virus SARS-CoV-2_virus|Treatment|VOC_B.1.1.529_Omicron|VOC_B.1.351_Beta MERS-CoV_virus|SARS-CoV-2_virus|Vaccine Mouse_Hepatitis_virus|Pathology SARS-CoV-2_virus|Sex_bias Mouse_Hepatitis_virus Pathology|SARS-CoV-2-MA_virus Infection|Pathology|SARS-CoV-MA_virus Infection|SARS-CoV-MA_virus Gene|SARS-CoV-2_virus|SARS-CoV-MA_virus|SARS-CoV_virus Infection|Pathology|SARS-CoV-2_virus SARS-CoV-2_virus|Vaccine|VOC_B.1.1.529_Omicron SARS-CoV-MA_virus SARS-CoV-MA_virus|SARS-CoV_virus|Treatment Infection|Pathology|SARS-CoV-2-MA_virus Pathology|SARS-CoV-2_virus|VOC_B.1.1.7_Alpha|VOC_B.1.351_Beta Infection|SARS-CoV_virus|Vaccine Comorbidity SARS-CoV-2_virus|Variant SARS-CoV-2-MA_virus|SARS-CoV-MA_virus Comorbidity|Gene MERS-CoV_virus|SARS-CoV-2_virus|SARS-CoV-MA_virus|SARS-CoV_virus|Treatment SARS-CoV_virus SARS-CoV-2-MA_virus|SARS-CoV-2_virus|VOC_B.1.351_Beta Infection|SARS-CoV-2-MA_virus|VOC_B.1.351_Beta SARS-CoV-2-MA_virus|SARS-CoV-2_virus Treatment | C57BL/6Jinbred strain |
MGI:2166311 | cardiovascular system endocrine/exocrine glands growth/size/body homeostasis/metabolism immune system muscle nervous system |
Afkhami S, bioRxiv 2021 Jul;(): Alsoussi WB, J Immunol 2020 Jun 26;(): Anand G, bioRxiv 2020 Dec;(): Benard A, Nat Commun 2021 Feb 18;12(1):1112 Biering SB, bioRxiv 2021 Dec;(): Bilinska K, bioRxiv 2021 Apr;(): Borriello F, bioRxiv 2021 Sep;(): Brady M, bioRxiv 2021 Aug;(): Brooks SD, bioRxiv 2021;(): Cao X, bioRxiv 2020 Dec;(): Chaparian RR, bioRxiv 2021 Apr;(): Chen JS, J Virol 2021 Jan 13;(): Chen Y, bioRxiv 2021 Nov;(): Chong Z, bioRxiv 2022;(): Colunga Biancatelli R, Am J Physiol Lung Cell Mol Physiol 2021 Jun;(): Corbett KS, Nature 2020 Oct;586(7830):567-571 Das Sarma J, J Virol 2000 Oct;74(19):9206-13 De Albuquerque N, J Virol 2006 Nov;80(21):10382-94 Deng Q, bioRxiv 2020;(): Deng X, J Virol 2014 Oct 15;88(20):11886-98 dos Santos Pereira Andrade AC, bioRxiv 2021 May;(): Eldi P, bioRxiv 2021 Sep;(): Gawish R, Elife 2022 Jan 13;11():e74623 Geng T, bioRxiv 2021 Jun;(): Gralinski LE, mBio 2013 Aug 6;4(4): Gralinski LE, PLoS Genet 2015 Oct;11(10):e1005504 Hachim MY, Front Immunol 2020;11():1372 Han K, Am J Respir Cell Mol Biol 2021 Jan;64(1):79-88 Houtman JJ, J Neurovirol 1996 APR;2(2):101-110 Jia L, bioRxiv 2022 Feb;(): Joag V, J Immunol 2021 Mar 1;206(5):931-935 Josset L, RNA Biol 2014;11(7):875-90 Khaddaj-Mallat R, bioRxiv 2021 May;(): Kim E, Proc Natl Acad Sci U S A 2021 Aug 24;118(34):e2102435118 Kim TY, bioRxiv 2020 Dec;(): King RG, bioRxiv 2020;(): Kumaki Y, Antiviral Res 2017 Mar;139():1-12 Leist SR, Cell 2020 Sep 23;(): Li S, JCI Insight 2021 Jan 25;6(2): Madar-Balakirski N, bioRxiv 2021 Jul;(): Mandal P, PLoS One 2021;16(7):e0246270 Pewe L, J Virol 1997 Oct;71(10):7640-7 Radvak P, bioRxiv 2021 Jun;(): Roberts A, Virus Res 2008 Apr;133(1):20-32 Salvi V, bioRxiv 2021 Apr;(): Salvi V, JCI Insight 2021 Sep 22;6(18):e150542 Salzer R, bioRxiv 2021 May;(): Sarver DC, Biochem Biophys Res Commun 2021 Jan 29;538():92-96 Satta S, Theranostics 2022;12(6):2639-2657 Schafer A, mBio 2022 Aug 30;13(4):e0145422 Sepe S, bioRxiv 2021 Jun;(): Sheahan TP, Sci Transl Med 2020 Apr 29;12(541): Shirato K, bioRxiv 2021 Jul;(): Sims JJ, bioRxiv 2021 Apr;(): Subbarao K, Trends Microbiol 2006 Jul;14(7):299-303 Sun CP, PLoS Pathog 2021 Aug;17(8):e1009758 Szurgot I, Sci Rep 2021 Feb 4;11(1):3125 Tsai SJ, bioRxiv 2020 Nov;(): Vanderheiden A, bioRxiv 2021 May;(): Vanderheiden A, mBio 2021 Nov 9;():e0274921 Wang H, bioRxiv 2021 Jul;(): Wang J, Protein Cell 2020 Aug 4;(): White KM, Science 2021 Feb 26;371(6532):926-931 Xiong H, G3 (Bethesda) 2014 Jun 5;4(8):1429-44 Xu H, bioRxiv 2020;(): Zhou B, Nature 2021 Apr;592(7852):122-127 Zhuang X, bioRxiv 2021 Jun 28;(): |
||||||
C57BL/6J-Ace2em1Guru/Mmjax | MGI:6763024 | coisogenic|endonuclease-mediated mutation|mutant strain | Gurumurthy CB, Nat Protoc 2020 Dec;15(12):3777-3787 | J:298750 | SARS-CoV-2_virus | C57BL/6J-Ace2em1Guru/Mmjaxcoisogenic|endonuclease-mediated mutation|mutant strain |
Gurumurthy CB, Nat Protoc 2020 Dec;15(12):3777-3787 |
|||||||||||
C57BL/6J-Ace2em2Guru/Mmjax | MGI:6763026 | coisogenic|endonuclease-mediated mutation|mutant strain | Gurumurthy CB, Nat Protoc 2020 Dec;15(12):3777-3787 | J:298750 | SARS-CoV-2_virus | C57BL/6J-Ace2em2Guru/Mmjaxcoisogenic|endonuclease-mediated mutation|mutant strain |
Gurumurthy CB, Nat Protoc 2020 Dec;15(12):3777-3787 |
|||||||||||
C57BL/6J-Dpp4em1Rba | MGI:6400424 | coisogenic|endonuclease-mediated mutation|mutant strain | MGI:6400425 MGI:6400427 | Dpp4em1Rba | MGI:6400423 | Endonuclease-mediated | Humanized sequence | Middle East respiratory syndrome | DOID:0080642 | cardiovascular system growth/size/body hematopoietic system homeostasis/metabolism immune system respiratory system mortality/aging | MP:0005385 MP:0005378 MP:0005397 MP:0005376 MP:0005387 MP:0005388 MP:0010768 | Cockrell AS, Nat Microbiol 2016 Nov 28;2():16226 Leist SR, PLoS One 2019;14(7):e0220126 Sheahan TP, Sci Transl Med 2020 Apr 29;12(541): | J:279834 J:279723 J:286320 | MERS-CoV_virus MERS-CoV_virus|Pathology MERS-CoV_virus|SARS-CoV-2_virus|SARS-CoV-MA_virus|SARS-CoV_virus|Treatment | C57BL/6J-Dpp4em1Rbacoisogenic|endonuclease-mediated mutation|mutant strain |
MGI:6400425 MGI:6400427 | cardiovascular system growth/size/body hematopoietic system homeostasis/metabolism immune system respiratory system mortality/aging Middle East respiratory syndrome |
Cockrell AS, Nat Microbiol 2016 Nov 28;2():16226 Leist SR, PLoS One 2019;14(7):e0220126 Sheahan TP, Sci Transl Med 2020 Apr 29;12(541): |
C57BL/6J-Lystbg-J/J | MGI:2163994 | coisogenic|mutant strain|spontaneous mutation | Glass WG, J Immunol 2004 Sep 15;173(6):4030-9 | J:92752 | Infection|SARS-CoV_virus | C57BL/6J-Lystbg-J/Jcoisogenic|mutant strain|spontaneous mutation |
Glass WG, J Immunol 2004 Sep 15;173(6):4030-9 |
|||||||||||
C57BL/6J-Tg(CAG-ACE2)GT5-027Cyt/J | MGI:6711187 | coisogenic|mutant strain|transgenic | Tsai C-Y, bioRxiv 2021;(): | J:305559 | SARS-CoV-2_virus | C57BL/6J-Tg(CAG-ACE2)GT5-027Cyt/Jcoisogenic|mutant strain|transgenic |
Tsai C-Y, bioRxiv 2021;(): |
|||||||||||
C57BL/6J-Ticam1Lps2/J | MGI:3051113 | chemically induced mutation|coisogenic|mutant strain | MGI:5520919 | Ticam1Lps2 | MGI:2679794 | Chemically induced (ENU) | Not Specified | cardiovascular system hematopoietic system homeostasis/metabolism immune system respiratory system mortality/aging | MP:0005385 MP:0005397 MP:0005376 MP:0005387 MP:0005388 MP:0010768 | Totura AL, mBio 2015 May 26;6(3):e00638-15 | J:288471 | Infection|SARS-CoV-MA_virus | C57BL/6J-Ticam1Lps2/Jchemically induced mutation|coisogenic|mutant strain |
MGI:5520919 | cardiovascular system hematopoietic system homeostasis/metabolism immune system respiratory system mortality/aging |
Totura AL, mBio 2015 May 26;6(3):e00638-15 |
||
(C57BL/6J x C3H/HeJ)F1/J | MGI:5654213 | F1 hybrid | Corbett KS, Nature 2020 Oct;586(7830):567-571 | J:297398 | MERS-CoV_virus|SARS-CoV-2_virus|Vaccine | (C57BL/6J x C3H/HeJ)F1/JF1 hybrid |
Corbett KS, Nature 2020 Oct;586(7830):567-571 |
|||||||||||
C57BL/6-Mcph1Tg(HLA-A2.1)1Enge/J | MGI:2164434 | mutant strain|transgenic | Carter B, bioRxiv 2021 May;(): | J:308712 | SARS-CoV-2_virus|Vaccine | C57BL/6-Mcph1Tg(HLA-A2.1)1Enge/Jmutant strain|transgenic |
Carter B, bioRxiv 2021 May;(): |
|||||||||||
C57BL/6N | MGI:2159965 | inbred strain | Cantuti-Castelvetri L, Science 2020 Nov 13;370(6518):856-860 Rai P, bioRxiv 2021 Jun;(): | J:297122 J:308665 | Infection|SARS-CoV-2_virus Pathology|SARS-CoV-2_virus | C57BL/6Ninbred strain |
Cantuti-Castelvetri L, Science 2020 Nov 13;370(6518):856-860 Rai P, bioRxiv 2021 Jun;(): |
|||||||||||
C57BL/6NCr | MGI:2160593 | inbred strain | Fang Z, bioRxiv 2022 Mar;(): Khanolkar A, J Virol 2009 Sep;83(17):8946-56 | J:324933 J:153918 | Vaccine|VOC_B.1.1.529_Omicron Mouse_Hepatitis_virus|Pathology | C57BL/6NCrinbred strain |
Fang Z, bioRxiv 2022 Mar;(): Khanolkar A, J Virol 2009 Sep;83(17):8946-56 |
|||||||||||
C57BL/6NCrl | MGI:2683688 | inbred strain | De Gasparo R, bioRxiv 2021 Jan;(): Rujas E, bioRxiv 2020;(): Sariol A, Proc Natl Acad Sci U S A 2020 Sep 29;117(39):24464-24474 | J:300432 J:296183 J:298608 | SARS-CoV-2_virus|Treatment Mouse_Hepatitis_virus | C57BL/6NCrlinbred strain |
De Gasparo R, bioRxiv 2021 Jan;(): Rujas E, bioRxiv 2020;(): Sariol A, Proc Natl Acad Sci U S A 2020 Sep 29;117(39):24464-24474 |
|||||||||||
C57BL/6NCrSlc | MGI:5295404 | inbred strain | Nishikawa T, bioRxiv 2021 Jan;(): | J:300443 | SARS-CoV-2-MA_virus|Vaccine | C57BL/6NCrSlcinbred strain |
Nishikawa T, bioRxiv 2021 Jan;(): |
|||||||||||
C57BL/6N-Gsdmdem4Fcw/J | MGI:6196335 | coisogenic|endonuclease-mediated mutation|mutant strain | Wu J, Immunity 2021 Nov 9;54(11):2632-2649.e6 | J:323769 | Gene|Pathology | C57BL/6N-Gsdmdem4Fcw/Jcoisogenic|endonuclease-mediated mutation|mutant strain |
Wu J, Immunity 2021 Nov 9;54(11):2632-2649.e6 |
|||||||||||
C57BL/6NJ | MGI:3056279 | inbred strain | Hachim MY, Front Immunol 2020;11():1372 Schafer A, bioRxiv 2021 May;(): Schafer A, mBio 2022 Aug 30;13(4):e0145422 | J:291898 J:308730 J:327836 | Gene|SARS-CoV-2_virus|SARS-CoV-MA_virus|SARS-CoV_virus Pathology|SARS-CoV-2-MA_virus|SARS-CoV-2_virus|SARS-CoV-MA_virus|SARS-CoV_virus SARS-CoV-2-MA_virus|SARS-CoV-MA_virus | C57BL/6NJinbred strain |
Hachim MY, Front Immunol 2020;11():1372 Schafer A, bioRxiv 2021 May;(): Schafer A, mBio 2022 Aug 30;13(4):e0145422 |
|||||||||||
C57BL/6-Tg(CAG-DPP4)4Yuzh | MGI:6402444 | coisogenic|mutant strain|transgenic | MGI:6402445 | Tg(CAG-DPP4)4Yuzh | MGI:6402443 | Transgenic | Humanized sequence|Inserted expressed sequence | Middle East respiratory syndrome | DOID:0080642 | behavior/neurological cardiovascular system hematopoietic system homeostasis/metabolism immune system liver/biliary system nervous system renal/urinary system respiratory system mortality/aging | MP:0005386 MP:0005385 MP:0005397 MP:0005376 MP:0005387 MP:0005370 MP:0003631 MP:0005367 MP:0005388 MP:0010768 | Zhao G, PLoS One 2015;10(12):e0145561 | J:286175 | Infection|MERS-CoV_virus | C57BL/6-Tg(CAG-DPP4)4Yuzhcoisogenic|mutant strain|transgenic |
MGI:6402445 | behavior/neurological cardiovascular system hematopoietic system homeostasis/metabolism immune system liver/biliary system nervous system renal/urinary system respiratory system mortality/aging Middle East respiratory syndrome |
Zhao G, PLoS One 2015;10(12):e0145561 |
CAST/EiJ | MGI:2159793 | inbred strain|wild-derived | MGI:2659102 | cellular immune system nervous system mortality/aging | MP:0005384 MP:0005387 MP:0003631 MP:0010768 | Gralinski LE, PLoS Genet 2015 Oct;11(10):e1005504 Josset L, RNA Biol 2014;11(7):875-90 Peng X, mBio 2010 Oct 26;1(5): Peng X, mBio 2011;2(6): Xiong H, G3 (Bethesda) 2014 Jun 5;4(8):1429-44 | J:268979 J:276026 J:276986 J:276989 J:276183 | Infection|SARS-CoV-MA_virus SARS-CoV-MA_virus | CAST/EiJinbred strain|wild-derived |
MGI:2659102 | cellular immune system nervous system mortality/aging |
Gralinski LE, PLoS Genet 2015 Oct;11(10):e1005504 Josset L, RNA Biol 2014;11(7):875-90 Peng X, mBio 2010 Oct 26;1(5): Peng X, mBio 2011;2(6): Xiong H, G3 (Bethesda) 2014 Jun 5;4(8):1429-44 |
||||||
C.B10-H2b/LilMcdJ | MGI:2161599 | congenic|major histocompatibility congenic|mutant strain | Khanolkar A, J Virol 2009 Sep;83(17):8946-56 | J:153918 | Mouse_Hepatitis_virus|Pathology | C.B10-H2b/LilMcdJcongenic|major histocompatibility congenic|mutant strain |
Khanolkar A, J Virol 2009 Sep;83(17):8946-56 |
|||||||||||
CBA/J | MGI:2159756 | inbred strain | Khanolkar A, J Virol 2009 Sep;83(17):8946-56 | J:153918 | Mouse_Hepatitis_virus|Pathology | CBA/Jinbred strain |
Khanolkar A, J Virol 2009 Sep;83(17):8946-56 |
|||||||||||
CC001/UncJ | MGI:5649079 | recombinant inbred (RI) | Graham JB, bioRxiv 2020 Sep 21;(): | J:296262 | SARS-CoV-MA_virus | CC001/UncJrecombinant inbred (RI) |
Graham JB, bioRxiv 2020 Sep 21;(): |
|||||||||||
CC003/Unc | MGI:6188583 | recombinant inbred (RI) | Gralinski LE, G3 (Bethesda) 2017 Jun 7;7(6):1653-1663 | J:270045 | Pathology|SARS-CoV-MA_virus | CC003/Uncrecombinant inbred (RI) |
Gralinski LE, G3 (Bethesda) 2017 Jun 7;7(6):1653-1663 |
|||||||||||
CC004/TauUncJ | MGI:5649082 | recombinant inbred (RI) | Graham JB, bioRxiv 2020 Sep 21;(): | J:296262 | SARS-CoV-MA_virus | CC004/TauUncJrecombinant inbred (RI) |
Graham JB, bioRxiv 2020 Sep 21;(): |
|||||||||||
CC006/TauUncJ | MGI:5649237 | recombinant inbred (RI) | Graham JB, bioRxiv 2020 Sep 21;(): | J:296262 | SARS-CoV-MA_virus | CC006/TauUncJrecombinant inbred (RI) |
Graham JB, bioRxiv 2020 Sep 21;(): |
|||||||||||
CC010/GeniUncJ | MGI:5649239 | recombinant inbred (RI) | Graham JB, bioRxiv 2020 Sep 21;(): | J:296262 | SARS-CoV-MA_virus | CC010/GeniUncJrecombinant inbred (RI) |
Graham JB, bioRxiv 2020 Sep 21;(): |
|||||||||||
CC011/Unc | MGI:5749398 | recombinant inbred (RI) | Schafer A, mBio 2022 Aug 30;13(4):e0145422 | J:327836 | SARS-CoV-2-MA_virus|SARS-CoV-MA_virus | CC011/Uncrecombinant inbred (RI) |
Schafer A, mBio 2022 Aug 30;13(4):e0145422 |
|||||||||||
CC011/UncJ | MGI:5649240 | recombinant inbred (RI) | Graham JB, bioRxiv 2020 Sep 21;(): | J:296262 | SARS-CoV-MA_virus | CC011/UncJrecombinant inbred (RI) |
Graham JB, bioRxiv 2020 Sep 21;(): |
|||||||||||
CC012/GeniUncJ | MGI:5694080 | recombinant inbred (RI) | Graham JB, bioRxiv 2020 Sep 21;(): | J:296262 | SARS-CoV-MA_virus | CC012/GeniUncJrecombinant inbred (RI) |
Graham JB, bioRxiv 2020 Sep 21;(): |
|||||||||||
CC013/GeniUncJ | MGI:5649241 | recombinant inbred (RI) | Graham JB, bioRxiv 2020 Sep 21;(): | J:296262 | SARS-CoV-MA_virus | CC013/GeniUncJrecombinant inbred (RI) |
Graham JB, bioRxiv 2020 Sep 21;(): |
|||||||||||
CC014/UncJ | MGI:5659477 | recombinant inbred (RI) | Graham JB, bioRxiv 2020 Sep 21;(): | J:296262 | SARS-CoV-MA_virus | CC014/UncJrecombinant inbred (RI) |
Graham JB, bioRxiv 2020 Sep 21;(): |
|||||||||||
CC015/UncJ | MGI:5659478 | recombinant inbred (RI) | Graham JB, bioRxiv 2020 Sep 21;(): | J:296262 | SARS-CoV-MA_virus | CC015/UncJrecombinant inbred (RI) |
Graham JB, bioRxiv 2020 Sep 21;(): |
|||||||||||
CC016/GeniUncJ | MGI:5659479 | recombinant inbred (RI) | Graham JB, bioRxiv 2020 Sep 21;(): | J:296262 | SARS-CoV-MA_virus | CC016/GeniUncJrecombinant inbred (RI) |
Graham JB, bioRxiv 2020 Sep 21;(): |
|||||||||||
CC017/Unc | MGI:6188571 | recombinant inbred (RI) | Schafer A, mBio 2022 Aug 30;13(4):e0145422 | J:327836 | SARS-CoV-2-MA_virus|SARS-CoV-MA_virus | CC017/Uncrecombinant inbred (RI) |
Schafer A, mBio 2022 Aug 30;13(4):e0145422 |
|||||||||||
CC018/UncJ | MGI:5649243 | recombinant inbred (RI) | Graham JB, bioRxiv 2020 Sep 21;(): | J:296262 | SARS-CoV-MA_virus | CC018/UncJrecombinant inbred (RI) |
Graham JB, bioRxiv 2020 Sep 21;(): |
|||||||||||
CC019/TauUncJ | MGI:5649244 | recombinant inbred (RI) | Graham JB, bioRxiv 2020 Sep 21;(): | J:296262 | SARS-CoV-MA_virus | CC019/TauUncJrecombinant inbred (RI) |
Graham JB, bioRxiv 2020 Sep 21;(): |
|||||||||||
CC023/GeniUncJ | MGI:5659483 | recombinant inbred (RI) | Graham JB, bioRxiv 2020 Sep 21;(): | J:296262 | SARS-CoV-MA_virus | CC023/GeniUncJrecombinant inbred (RI) |
Graham JB, bioRxiv 2020 Sep 21;(): |
|||||||||||
CC024/GeniUncJ | MGI:5649245 | recombinant inbred (RI) | Graham JB, bioRxiv 2020 Sep 21;(): | J:296262 | SARS-CoV-MA_virus | CC024/GeniUncJrecombinant inbred (RI) |
Graham JB, bioRxiv 2020 Sep 21;(): |
|||||||||||
CC025/GeniUncJ | MGI:5649246 | recombinant inbred (RI) | Graham JB, bioRxiv 2020 Sep 21;(): | J:296262 | SARS-CoV-MA_virus | CC025/GeniUncJrecombinant inbred (RI) |
Graham JB, bioRxiv 2020 Sep 21;(): |
|||||||||||
CC026/GeniUncJ | MGI:5649247 | recombinant inbred (RI) | Graham JB, bioRxiv 2020 Sep 21;(): | J:296262 | SARS-CoV-MA_virus | CC026/GeniUncJrecombinant inbred (RI) |
Graham JB, bioRxiv 2020 Sep 21;(): |
|||||||||||
CC028/GeniUncJ | MGI:5659485 | recombinant inbred (RI) | Graham JB, bioRxiv 2020 Sep 21;(): | J:296262 | SARS-CoV-MA_virus | CC028/GeniUncJrecombinant inbred (RI) |
Graham JB, bioRxiv 2020 Sep 21;(): |
|||||||||||
CC029/UncJ | MGI:5659486 | recombinant inbred (RI) | Graham JB, bioRxiv 2020 Sep 21;(): | J:296262 | SARS-CoV-MA_virus | CC029/UncJrecombinant inbred (RI) |
Graham JB, bioRxiv 2020 Sep 21;(): |
|||||||||||
CC030/GeniUncJ | MGI:5659487 | recombinant inbred (RI) | Graham JB, bioRxiv 2020 Sep 21;(): | J:296262 | SARS-CoV-MA_virus | CC030/GeniUncJrecombinant inbred (RI) |
Graham JB, bioRxiv 2020 Sep 21;(): |
|||||||||||
CC032/GeniUncJ | MGI:5649248 | recombinant inbred (RI) | Graham JB, bioRxiv 2020 Sep 21;(): | J:296262 | SARS-CoV-MA_virus | CC032/GeniUncJrecombinant inbred (RI) |
Graham JB, bioRxiv 2020 Sep 21;(): |
|||||||||||
CC033/GeniUncJ | MGI:5659488 | recombinant inbred (RI) | Graham JB, bioRxiv 2020 Sep 21;(): | J:296262 | SARS-CoV-MA_virus | CC033/GeniUncJrecombinant inbred (RI) |
Graham JB, bioRxiv 2020 Sep 21;(): |
|||||||||||
CC034/Unc | MGI:6188554 | recombinant inbred (RI) | Graham JB, bioRxiv 2020 Sep 21;(): | J:296262 | SARS-CoV-MA_virus | CC034/Uncrecombinant inbred (RI) |
Graham JB, bioRxiv 2020 Sep 21;(): |
|||||||||||
CC037/TauUncJ | MGI:5649249 | recombinant inbred (RI) | Graham JB, bioRxiv 2020 Sep 21;(): | J:296262 | SARS-CoV-MA_virus | CC037/TauUncJrecombinant inbred (RI) |
Graham JB, bioRxiv 2020 Sep 21;(): |
|||||||||||
CC038/GeniUncJ | MGI:5659491 | recombinant inbred (RI) | Graham JB, bioRxiv 2020 Sep 21;(): | J:296262 | SARS-CoV-MA_virus | CC038/GeniUncJrecombinant inbred (RI) |
Graham JB, bioRxiv 2020 Sep 21;(): |
|||||||||||
CC039/UncJ | MGI:5659492 | recombinant inbred (RI) | Graham JB, bioRxiv 2020 Sep 21;(): | J:296262 | SARS-CoV-MA_virus | CC039/UncJrecombinant inbred (RI) |
Graham JB, bioRxiv 2020 Sep 21;(): |
|||||||||||
CC041/TauUncJ | MGI:5649251 | recombinant inbred (RI) | Graham JB, bioRxiv 2020 Sep 21;(): | J:296262 | SARS-CoV-MA_virus | CC041/TauUncJrecombinant inbred (RI) |
Graham JB, bioRxiv 2020 Sep 21;(): |
|||||||||||
CC042/GeniUncJ | MGI:5649255 | recombinant inbred (RI) | Graham JB, bioRxiv 2020 Sep 21;(): | J:296262 | SARS-CoV-MA_virus | CC042/GeniUncJrecombinant inbred (RI) |
Graham JB, bioRxiv 2020 Sep 21;(): |
|||||||||||
CC043/GeniUncJ | MGI:5649256 | recombinant inbred (RI) | Graham JB, bioRxiv 2020 Sep 21;(): | J:296262 | SARS-CoV-MA_virus | CC043/GeniUncJrecombinant inbred (RI) |
Graham JB, bioRxiv 2020 Sep 21;(): |
|||||||||||
CC046/UncJ | MGI:5659495 | recombinant inbred (RI) | Graham JB, bioRxiv 2020 Sep 21;(): | J:296262 | SARS-CoV-MA_virus | CC046/UncJrecombinant inbred (RI) |
Graham JB, bioRxiv 2020 Sep 21;(): |
|||||||||||
CC052/GeniUncJ | MGI:5659498 | recombinant inbred (RI) | Graham JB, bioRxiv 2020 Sep 21;(): | J:296262 | SARS-CoV-MA_virus | CC052/GeniUncJrecombinant inbred (RI) |
Graham JB, bioRxiv 2020 Sep 21;(): |
|||||||||||
CC053/Unc | MGI:6188536 | recombinant inbred (RI) | MGI:6402903 | severe acute respiratory syndrome | DOID:2945 | immune system mortality/aging | MP:0005387 MP:0010768 | Gralinski LE, G3 (Bethesda) 2017 Jun 7;7(6):1653-1663 | J:270045 | Pathology|SARS-CoV-MA_virus | CC053/Uncrecombinant inbred (RI) |
MGI:6402903 | immune system mortality/aging severe acute respiratory syndrome |
Gralinski LE, G3 (Bethesda) 2017 Jun 7;7(6):1653-1663 |
||||
CC055/TauUncJ | MGI:5659644 | recombinant inbred (RI) | Graham JB, bioRxiv 2020 Sep 21;(): | J:296262 | SARS-CoV-MA_virus | CC055/TauUncJrecombinant inbred (RI) |
Graham JB, bioRxiv 2020 Sep 21;(): |
|||||||||||
CC056/GeniUncJ | MGI:5816616 | mutant strain|recombinant inbred (RI) | Graham JB, bioRxiv 2020 Sep 21;(): | J:296262 | SARS-CoV-MA_virus | CC056/GeniUncJmutant strain|recombinant inbred (RI) |
Graham JB, bioRxiv 2020 Sep 21;(): |
|||||||||||
CC057/UncJ | MGI:5659646 | recombinant inbred (RI) | Graham JB, bioRxiv 2020 Sep 21;(): | J:296262 | SARS-CoV-MA_virus | CC057/UncJrecombinant inbred (RI) |
Graham JB, bioRxiv 2020 Sep 21;(): |
|||||||||||
CC058/UncJ | MGI:5659649 | recombinant inbred (RI) | Graham JB, bioRxiv 2020 Sep 21;(): | J:296262 | SARS-CoV-MA_virus | CC058/UncJrecombinant inbred (RI) |
Graham JB, bioRxiv 2020 Sep 21;(): |
|||||||||||
CC059/TauUncJ | MGI:5659650 | recombinant inbred (RI) | Graham JB, bioRxiv 2020 Sep 21;(): | J:296262 | SARS-CoV-MA_virus | CC059/TauUncJrecombinant inbred (RI) |
Graham JB, bioRxiv 2020 Sep 21;(): |
|||||||||||
CC060/UncJ | MGI:5659652 | recombinant inbred (RI) | Graham JB, bioRxiv 2020 Sep 21;(): | J:296262 | SARS-CoV-MA_virus | CC060/UncJrecombinant inbred (RI) |
Graham JB, bioRxiv 2020 Sep 21;(): |
|||||||||||
CC061/GeniUncJ | MGI:5649258 | recombinant inbred (RI) | Graham JB, bioRxiv 2020 Sep 21;(): | J:296262 | SARS-CoV-MA_virus | CC061/GeniUncJrecombinant inbred (RI) |
Graham JB, bioRxiv 2020 Sep 21;(): |
|||||||||||
CC062/UncJ | MGI:5906018 | recombinant inbred (RI) | Graham JB, bioRxiv 2020 Sep 21;(): | J:296262 | SARS-CoV-MA_virus | CC062/UncJrecombinant inbred (RI) |
Graham JB, bioRxiv 2020 Sep 21;(): |
|||||||||||
CC065/UncJ | MGI:5659659 | recombinant inbred (RI) | Graham JB, bioRxiv 2020 Sep 21;(): | J:296262 | SARS-CoV-MA_virus | CC065/UncJrecombinant inbred (RI) |
Graham JB, bioRxiv 2020 Sep 21;(): |
|||||||||||
CC068/TauUncJ | MGI:5649259 | recombinant inbred (RI) | Graham JB, bioRxiv 2020 Sep 21;(): | J:296262 | SARS-CoV-MA_virus | CC068/TauUncJrecombinant inbred (RI) |
Graham JB, bioRxiv 2020 Sep 21;(): |
|||||||||||
CC071/TauUncJ | MGI:5659663 | recombinant inbred (RI) | Graham JB, bioRxiv 2020 Sep 21;(): | J:296262 | SARS-CoV-MA_virus | CC071/TauUncJrecombinant inbred (RI) |
Graham JB, bioRxiv 2020 Sep 21;(): |
|||||||||||
CC074/UncJ | MGI:5659666 | recombinant inbred (RI) | Graham JB, bioRxiv 2020 Sep 21;(): | J:296262 | SARS-CoV-MA_virus | CC074/UncJrecombinant inbred (RI) |
Graham JB, bioRxiv 2020 Sep 21;(): |
|||||||||||
C.C3-H2k/LilMcdJ | MGI:2163605 | congenic|major histocompatibility congenic|mutant strain | Khanolkar A, J Virol 2009 Sep;83(17):8946-56 | J:153918 | Mouse_Hepatitis_virus|Pathology | C.C3-H2k/LilMcdJcongenic|major histocompatibility congenic|mutant strain |
Khanolkar A, J Virol 2009 Sep;83(17):8946-56 |
|||||||||||
C.Cg-Cd19tm1(cre)Cgn Ighb/J | MGI:2174231 | congenic|mutant strain|targeted mutation | Kotagiri P, EBioMedicine 2022 Feb 18;77():103878 | J:322643 | SARS-CoV-2_virus | C.Cg-Cd19tm1(cre)Cgn Ighb/Jcongenic|mutant strain|targeted mutation |
Kotagiri P, EBioMedicine 2022 Feb 18;77():103878 |
|||||||||||
C.Cg-Tg(K18-ACE2)2Prlmn/J | MGI:6479852 | congenic|mutant strain|transgenic | McCray PB Jr, J Virol 2007 Jan;81(2):813-21 | J:283648 | Infection|SARS-CoV_virus | C.Cg-Tg(K18-ACE2)2Prlmn/Jcongenic|mutant strain|transgenic |
McCray PB Jr, J Virol 2007 Jan;81(2):813-21 |
|||||||||||
CC RIX | MGI:6501148 | strain family | Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Schafer A, bioRxiv 2021 May;(): | J:303526 J:308730 | Infection|SARS-CoV-2-MA_virus Pathology|SARS-CoV-2-MA_virus|SARS-CoV-2_virus|SARS-CoV-MA_virus|SARS-CoV_virus | CC RIXstrain family |
Graham JB, PLoS Pathog 2021 Jan;17(1):e1009287 Schafer A, bioRxiv 2021 May;(): |
|||||||||||
CD-1 | MGI:5649524 | outbred stock | Borriello F, bioRxiv 2021 Sep;(): Chadchan SB, Biol Reprod 2021 Feb 11;104(2):336-343 Dai W, Science 2020 Jun 19;368(6497):1331-1335 Falach R, bioRxiv 2020 Nov;(): Fernandez-Castaneda A, bioRxiv 2022;(): Grandi A, bioRxiv 2021 Jul;(): Hassler L, bioRxiv 2021 Mar;(): King RG, bioRxiv 2020;(): Rice A, bioRxiv 2021 Mar;(): Rice A, bioRxiv 2021 Nov;(): Rice A, Sci Rep 2021 Jul 21;11(1):14917 Spencer AJ, bioRxiv 2021 Jan;(): Tummino TA, bioRxiv 2021 Mar;(): | J:310116 J:302245 J:290792 J:296678 J:321759 J:308639 J:302921 J:296068 J:303210 J:315738 J:308902 J:302146 J:303456 | SARS-CoV-2_virus|Vaccine Gene SARS-CoV_virus|Treatment Comorbidity|Infection|SARS-CoV-2_virus Pathology|SARS-CoV-2_virus SARS-CoV-2_virus|Treatment | CD-1outbred stock |
Borriello F, bioRxiv 2021 Sep;(): Chadchan SB, Biol Reprod 2021 Feb 11;104(2):336-343 Dai W, Science 2020 Jun 19;368(6497):1331-1335 Falach R, bioRxiv 2020 Nov;(): Fernandez-Castaneda A, bioRxiv 2022;(): Grandi A, bioRxiv 2021 Jul;(): Hassler L, bioRxiv 2021 Mar;(): King RG, bioRxiv 2020;(): Rice A, bioRxiv 2021 Mar;(): Rice A, bioRxiv 2021 Nov;(): Rice A, Sci Rep 2021 Jul 21;11(1):14917 Spencer AJ, bioRxiv 2021 Jan;(): Tummino TA, bioRxiv 2021 Mar;(): |
|||||||||||
Crl:CD-1 | MGI:5652673 | outbred stock | Wang Y, Invest Ophthalmol Vis Sci 1996 Jan;37(1):250-4 Wang Y, Invest Ophthalmol Vis Sci 2000 Sep;41(10):3011-8 | J:36900 J:64200 | Mouse_Hepatitis_virus Mouse_Hepatitis_virus|Pathology | Crl:CD-1outbred stock |
Wang Y, Invest Ophthalmol Vis Sci 1996 Jan;37(1):250-4 Wang Y, Invest Ophthalmol Vis Sci 2000 Sep;41(10):3011-8 |
|||||||||||
DBA/1J | MGI:2159759 | inbred strain | Shen ZT, Sci Rep 2016 Jun 28;6():28672 | J:291625 | SARS-CoV_virus | DBA/1Jinbred strain |
Shen ZT, Sci Rep 2016 Jun 28;6():28672 |
|||||||||||
DBA/2J | MGI:2684695 | inbred strain | Hassan AO, Cell 2020 Jun 10;(): Khanolkar A, J Virol 2009 Sep;83(17):8946-56 | J:290258 J:153918 | Infection|SARS-CoV-2_virus|Treatment Mouse_Hepatitis_virus|Pathology | DBA/2Jinbred strain |
Hassan AO, Cell 2020 Jun 10;(): Khanolkar A, J Virol 2009 Sep;83(17):8946-56 |
|||||||||||
FVB-Tg(Cdh5-tTA)D5Lbjn/J | MGI:4839338 | coisogenic|mutant strain|transgenic | Wu J, Immunity 2021 Nov 9;54(11):2632-2649.e6 | J:323769 | Gene|Pathology | FVB-Tg(Cdh5-tTA)D5Lbjn/Jcoisogenic|mutant strain|transgenic |
Wu J, Immunity 2021 Nov 9;54(11):2632-2649.e6 |
|||||||||||
ICR | MGI:2160272 | strain family | Rao L, Proc Natl Acad Sci U S A 2020 Nov 3;117(44):27141-27147 Sagawa T, Environ Res 2021 Apr;195():110722 Spencer AJ, bioRxiv 2021 Jan;(): | J:297098 J:305462 J:302146 | SARS-CoV-2_virus|Treatment Comorbidity|Gene SARS-CoV-2_virus|Vaccine | ICRstrain family |
Rao L, Proc Natl Acad Sci U S A 2020 Nov 3;117(44):27141-27147 Sagawa T, Environ Res 2021 Apr;195():110722 Spencer AJ, bioRxiv 2021 Jan;(): |
|||||||||||
ICR-Tg(Ace2-ACE2)1Cqin/J | MGI:6401293 | mutant stock|transgenic | Yang XH, Comp Med 2007 Oct;57(5):450-9 | J:141460 | Infection|SARS-CoV_virus | ICR-Tg(Ace2-ACE2)1Cqin/Jmutant stock|transgenic |
Yang XH, Comp Med 2007 Oct;57(5):450-9 |
|||||||||||
NOD.Cg-Prkdcscid Il2rgtm1Wjl Ace2tm1(ACE2)Dwnt/J | MGI:6865656 | congenic|mutant strain|spontaneous mutation|targeted mutation | Zhou B, bioRxiv 2020;(): | J:296356 | Infection|SARS-CoV-2_virus | NOD.Cg-Prkdcscid Il2rgtm1Wjl Ace2tm1(ACE2)Dwnt/Jcongenic|mutant strain|spontaneous mutation|targeted mutation |
Zhou B, bioRxiv 2020;(): |
|||||||||||
NOD.Cg-Rag1tm1Mom Il2rgtm1Wjl/SzJ | MGI:3804477 | congenic|targeted mutation | Halwe S, bioRxiv 2021 Jun;(): | J:308648 | SARS-CoV-2_virus|Treatment|VOC_B.1.1.7_Alpha|VOC_B.1.351_Beta | NOD.Cg-Rag1tm1Mom Il2rgtm1Wjl/SzJcongenic|targeted mutation |
Halwe S, bioRxiv 2021 Jun;(): |
|||||||||||
NOD/ShiLtJ | MGI:2162056 | inbred strain | Gralinski LE, PLoS Genet 2015 Oct;11(10):e1005504 Josset L, RNA Biol 2014;11(7):875-90 Xiong H, G3 (Bethesda) 2014 Jun 5;4(8):1429-44 | J:268979 J:276026 J:276183 | Infection|SARS-CoV-MA_virus SARS-CoV-MA_virus | NOD/ShiLtJinbred strain |
Gralinski LE, PLoS Genet 2015 Oct;11(10):e1005504 Josset L, RNA Biol 2014;11(7):875-90 Xiong H, G3 (Bethesda) 2014 Jun 5;4(8):1429-44 |
|||||||||||
NZB/BlNJ | MGI:2180844 | inbred strain | Khanolkar A, J Virol 2009 Sep;83(17):8946-56 | J:153918 | Mouse_Hepatitis_virus|Pathology | NZB/BlNJinbred strain |
Khanolkar A, J Virol 2009 Sep;83(17):8946-56 |
|||||||||||
NZO/HlLtJ | MGI:2173835 | inbred strain | MGI:5902927 | immune system | MP:0005387 | Gralinski LE, PLoS Genet 2015 Oct;11(10):e1005504 Josset L, RNA Biol 2014;11(7):875-90 Xiong H, G3 (Bethesda) 2014 Jun 5;4(8):1429-44 | J:268979 J:276026 J:276183 | Infection|SARS-CoV-MA_virus SARS-CoV-MA_virus | NZO/HlLtJinbred strain |
MGI:5902927 | immune system |
Gralinski LE, PLoS Genet 2015 Oct;11(10):e1005504 Josset L, RNA Biol 2014;11(7):875-90 Xiong H, G3 (Bethesda) 2014 Jun 5;4(8):1429-44 |
||||||
PWK/PhJ | MGI:2160654 | inbred strain|wild-derived | MGI:5902923 | immune system mortality/aging | MP:0005387 MP:0010768 | Gralinski LE, PLoS Genet 2015 Oct;11(10):e1005504 Josset L, RNA Biol 2014;11(7):875-90 Peng X, mBio 2010 Oct 26;1(5): Peng X, mBio 2011;2(6): Xiong H, G3 (Bethesda) 2014 Jun 5;4(8):1429-44 | J:268979 J:276026 J:276986 J:276989 J:276183 | Infection|SARS-CoV-MA_virus SARS-CoV-MA_virus | PWK/PhJinbred strain|wild-derived |
MGI:5902923 | immune system mortality/aging |
Gralinski LE, PLoS Genet 2015 Oct;11(10):e1005504 Josset L, RNA Biol 2014;11(7):875-90 Peng X, mBio 2010 Oct 26;1(5): Peng X, mBio 2011;2(6): Xiong H, G3 (Bethesda) 2014 Jun 5;4(8):1429-44 |
||||||
SJL | MGI:2159833 | strain family | Compton SR, Virology 1994 Aug 15;203(1):197-201 | J:19444 | Infection|Mouse_Hepatitis_virus | SJLstrain family |
Compton SR, Virology 1994 Aug 15;203(1):197-201 |
|||||||||||
SJL/J | MGI:2159739 | inbred strain | MGI:3719417 | Ceacam1Hv2-r | MGI:3053078 | Spontaneous | immune system | MP:0005387 | Barthold SW, Lab Anim Sci 1993 Aug;43(4):276-84 Dveksler GS, J Virol 1993 Jan;67(1):1-8 Stohlman SA, J Immunol 1980 Apr;124(4):1733-9 Williams RK, Proc Natl Acad Sci U S A 1991 Jul 1;88(13):5533-6 Yokomori K, J Virol 1992 Dec;66(12):6931-8 | J:14457 J:92495 J:25384 J:25438 J:3241 | Infection|Mouse_Hepatitis_virus Mouse_Hepatitis_virus | SJL/Jinbred strain |
MGI:3719417 | immune system |
Barthold SW, Lab Anim Sci 1993 Aug;43(4):276-84 Dveksler GS, J Virol 1993 Jan;67(1):1-8 Stohlman SA, J Immunol 1980 Apr;124(4):1733-9 Williams RK, Proc Natl Acad Sci U S A 1991 Jul 1;88(13):5533-6 Yokomori K, J Virol 1992 Dec;66(12):6931-8 |
|||
STOCK Hopxtm2.1(cre/ERT2)Joe/J | MGI:5320285 | mutant stock|targeted mutation | Tang AT, PLoS Biol 2023 Feb;21(2):e3001989 | J:337814 | Pathology|SARS-CoV-2_virus|VOC_B.1.1.529_Omicron | STOCK Hopxtm2.1(cre/ERT2)Joe/Jmutant stock|targeted mutation |
Tang AT, PLoS Biol 2023 Feb;21(2):e3001989 |
|||||||||||
STOCK Tg(Actl6b-Cre)4092Jiwu/J | MGI:5699265 | mutant stock|transgenic | Tang AT, PLoS Biol 2023 Feb;21(2):e3001989 | J:337814 | Pathology|SARS-CoV-2_virus|VOC_B.1.1.529_Omicron | STOCK Tg(Actl6b-Cre)4092Jiwu/Jmutant stock|transgenic |
Tang AT, PLoS Biol 2023 Feb;21(2):e3001989 |
|||||||||||
STOCK Tg(Mx1-cre)1Cgn/J | MGI:2162199 | mutant stock|transgenic | Bombaci G, Life Sci Alliance 2022 Jun;5(6):e202101226 | J:331827 | SARS-CoV-2_virus | STOCK Tg(Mx1-cre)1Cgn/Jmutant stock|transgenic |
Bombaci G, Life Sci Alliance 2022 Jun;5(6):e202101226 |
|||||||||||
Swiss albino | MGI:5652853 | outbred stock | Saleh AA, bioRxiv 2021 Mar;(): | J:302705 | SARS-CoV-2_virus|Vaccine | Swiss albinooutbred stock |
Saleh AA, bioRxiv 2021 Mar;(): |
|||||||||||
Swiss Webster | MGI:2160840 | outbred stock | Lai CY, bioRxiv 2021 Mar;(): Staquicini DI, bioRxiv 2021 Mar;(): | J:302709 J:302940 | SARS-CoV-2_virus|Vaccine | Swiss Websteroutbred stock |
Lai CY, bioRxiv 2021 Mar;(): Staquicini DI, bioRxiv 2021 Mar;(): |
|||||||||||
WSB/EiJ | MGI:2160667 | inbred strain|wild-derived | MGI:5818477 | immune system mortality/aging | MP:0005387 MP:0010768 | Gralinski LE, PLoS Genet 2015 Oct;11(10):e1005504 Josset L, RNA Biol 2014;11(7):875-90 Peng X, mBio 2010 Oct 26;1(5): Peng X, mBio 2011;2(6): Xiong H, G3 (Bethesda) 2014 Jun 5;4(8):1429-44 | J:268979 J:276026 J:276986 J:276989 J:276183 | Infection|SARS-CoV-MA_virus SARS-CoV-MA_virus | WSB/EiJinbred strain|wild-derived |
MGI:5818477 | immune system mortality/aging |
Gralinski LE, PLoS Genet 2015 Oct;11(10):e1005504 Josset L, RNA Biol 2014;11(7):875-90 Peng X, mBio 2010 Oct 26;1(5): Peng X, mBio 2011;2(6): Xiong H, G3 (Bethesda) 2014 Jun 5;4(8):1429-44 |
Alleles for Laboratory Mouse Strains Used in Coronavirus Research
Alleles for laboratory mouse strains used in coronavirus research along with mouse phenotype categories and human disease terms and relevant references. Under each reference is a list of keywords for the research areas and the viruses mentioned in the publication. A virus name appended with ‘MA’ indicates that the virus is a mouse adapted strain.
Mouse alleles names are linked to allele detail pages at MGI. Human disease terms are linked to the Disease Ontology Browser at MGI. References are linked to the reference detail pages at MGI.
1-allele | 2-mgi | 3-type | 4-subtypes | 5-geno-id | 6-do-term | 7-do-id | 8-mp-term | 9-mp-id | 10-cite | 11-jnum | 12-tags | Allele | Genotype Details | Human Disease and Mouse Phenotype Categories | References | Keywords |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ace2em1(ACE2)Gpt | MGI:6452437 | Endonuclease-mediated | Inserted expressed sequence | Li C, Cell 2022 Apr 14;185(8):1389-1401.e18 Liu D, Proc Natl Acad Sci U S A 2023 Jan 24;120(4):e2202820120 | J:324335 J:340364 | SARS-CoV-2_virus|Treatment|VOC_B.1.1.529_Omicron SARS-CoV-2_virus|VOC_B.1.351_Beta | Ace2em1(ACE2)GptEndonuclease-mediated |
Li C, Cell 2022 Apr 14;185(8):1389-1401.e18 Liu D, Proc Natl Acad Sci U S A 2023 Jan 24;120(4):e2202820120 |
|||||||
Ace2em1(ACE2)Mlkn | MGI:6842318 | Endonuclease-mediated | Conditional ready|Humanized sequence|Inserted expressed sequence|Null/knockout | Tang AT, bioRxiv 2021 Dec;(): Tang AT, PLoS Biol 2023 Feb;21(2):e3001989 | J:315719 J:337814 | Pathology|SARS-CoV-2_virus Pathology|SARS-CoV-2_virus|VOC_B.1.1.529_Omicron | Ace2em1(ACE2)MlknEndonuclease-mediated |
Tang AT, bioRxiv 2021 Dec;(): Tang AT, PLoS Biol 2023 Feb;21(2):e3001989 |
|||||||
Ace2em1(ACE2)Rlu | MGI:7524682 | Endonuclease-mediated | Humanized sequence|Inserted expressed sequence | Romero MJ, Front Immunol 2023;14():1241448 | J:339692 | SARS-CoV-2_virus | Ace2em1(ACE2)RluEndonuclease-mediated |
Romero MJ, Front Immunol 2023;14():1241448 |
|||||||
Ace2em1(ACE2)Yowa | MGI:6431336 | Endonuclease-mediated | Humanized sequence|Null/knockout|Reporter | MGI:6431340 | COVID-19 | DOID:0080600 | cardiovascular system homeostasis/metabolism immune system respiratory system | MP:0005385 MP:0005376 MP:0005387 MP:0005388 | Sun SH, Cell Host Microbe 2020;20():1-10 Wu Y, Science 2020 Jun 12;368(6496):1274-1278 Singh A, Virol Sin 2020 Jun;35(3):290-304 Johansen MD, Mucosal Immunol 2020 Aug 20;(): Munoz-Fontela C, Nature 2020 Sep 23;(): Ye Q, bioRxiv 2020 Nov;(): Pinto D, bioRxiv 2020 Apr 9;(): Zhu L, bioRxiv 2020 Nov;(): Gurumurthy CB, Nat Protoc 2020 Dec;15(12):3777-3787 Chen J, bioRxiv 2021 Nov;(): | J:288243 J:290802 J:295349 J:295350 J:295351 J:296708 J:297123 J:298147 J:298750 J:315718 | Infection|Pathology|SARS-CoV-2_virus SARS-CoV-2_virus|Treatment MERS-CoV-MA_virus|MERS-CoV_virus|SARS-CoV-2-MA_virus|SARS-CoV-2_virus|SARS-CoV_virus MERS-CoV-MA_virus|MERS-CoV_virus|SARS-CoV-2-MA_virus|SARS-CoV-2_virus|SARS-CoV-MA_virus|SARS-CoV_virus SARS-CoV-2-MA_virus|SARS-CoV-2_virus|SARS-CoV_virus Pathology|SARS-CoV-2_virus SARS-CoV-2-MA_virus|SARS-CoV-2_virus|Treatment SARS-CoV-2_virus SARS-CoV-2_virus|Vaccine | Ace2em1(ACE2)YowaEndonuclease-mediated |
MGI:6431340 | cardiovascular system homeostasis/metabolism immune system respiratory system COVID-19 |
Sun SH, Cell Host Microbe 2020;20():1-10 Wu Y, Science 2020 Jun 12;368(6496):1274-1278 Singh A, Virol Sin 2020 Jun;35(3):290-304 Johansen MD, Mucosal Immunol 2020 Aug 20;(): Munoz-Fontela C, Nature 2020 Sep 23;(): Ye Q, bioRxiv 2020 Nov;(): Pinto D, bioRxiv 2020 Apr 9;(): Zhu L, bioRxiv 2020 Nov;(): Gurumurthy CB, Nat Protoc 2020 Dec;15(12):3777-3787 Chen J, bioRxiv 2021 Nov;(): |
Ace2em1Cya | MGI:6500740 | Endonuclease-mediated | Null/knockout | MGI:6500742 | cellular digestive/alimentary system growth/size/body homeostasis/metabolism immune system | MP:0005384 MP:0005381 MP:0005378 MP:0005376 MP:0005387 | Yu W, Biochem Biophys Res Commun 2020 Dec 17;533(4):1276-1282 | J:299383 | Gene | Ace2em1CyaEndonuclease-mediated |
MGI:6500742 | cellular digestive/alimentary system growth/size/body homeostasis/metabolism immune system |
Yu W, Biochem Biophys Res Commun 2020 Dec 17;533(4):1276-1282 |
||
Ace2em1Diam | MGI:7398548 | Endonuclease-mediated | Null/knockout | Winkler ES, J Virol 2022 Jan 12;96(1):e0151121 | J:331773 | Infection|SARS-CoV-2_virus|VOC_B.1.1.7_Alpha|VOC_B.1.351_Beta | Ace2em1DiamEndonuclease-mediated |
Winkler ES, J Virol 2022 Jan 12;96(1):e0151121 |
|||||||
Ace2em1Guru | MGI:6763023 | Endonuclease-mediated | Humanized sequence | Gurumurthy CB, Nat Protoc 2020 Dec;15(12):3777-3787 | J:298750 | SARS-CoV-2_virus | Ace2em1GuruEndonuclease-mediated |
Gurumurthy CB, Nat Protoc 2020 Dec;15(12):3777-3787 |
|||||||
Ace2em1Mccc | MGI:7468713 | Endonuclease-mediated | Humanized sequence | Nakandakari-Higa S, Front Immunol 2022;13():1007080 | J:335150 | Infection|SARS-CoV-2_virus|VOC_B.1.1.529_Omicron | Ace2em1McccEndonuclease-mediated |
Nakandakari-Higa S, Front Immunol 2022;13():1007080 |
|||||||
Ace2em1Qhs | MGI:6415670 | Endonuclease-mediated | Null/knockout | Jia H, Nat Commun 2020 Oct 14;11(1):5165 | J:296535 | SARS-CoV-2_virus | Ace2em1QhsEndonuclease-mediated |
Jia H, Nat Commun 2020 Oct 14;11(1):5165 |
|||||||
Ace2em1Smoc | MGI:6415213 | Endonuclease-mediated | Null/knockout | Qin WH, Cell Mol Gastroenterol Hepatol 2021;12(4):1514-1516.e4 | J:319435 | Gene|Infection | Ace2em1SmocEndonuclease-mediated |
Qin WH, Cell Mol Gastroenterol Hepatol 2021;12(4):1514-1516.e4 |
|||||||
Ace2em2(ACE2/GFP)Mlkn | MGI:6842319 | Endonuclease-mediated | Conditional ready|Humanized sequence|Inserted expressed sequence|Null/knockout|Reporter | Tang AT, bioRxiv 2021 Dec;(): | J:315719 | Pathology|SARS-CoV-2_virus | Ace2em2(ACE2/GFP)MlknEndonuclease-mediated |
Tang AT, bioRxiv 2021 Dec;(): |
|||||||
Ace2em2(ACE2)Gpt | MGI:6452442 | Endonuclease-mediated | Inserted expressed sequence | MGI:6514876 | growth/size/body immune system respiratory system | MP:0005378 MP:0005387 MP:0005388 | Wu X, bioRxiv 2021 Feb;(): | J:302150 | SARS-CoV-2_virus|Treatment | Ace2em2(ACE2)GptEndonuclease-mediated |
MGI:6514876 | growth/size/body immune system respiratory system |
Wu X, bioRxiv 2021 Feb;(): |
||
Ace2em2(ACE2)Mlkn | MGI:7507528 | Endonuclease-mediated | Conditional ready|Humanized sequence|Inserted expressed sequence|Null/knockout | Tang AT, PLoS Biol 2023 Feb;21(2):e3001989 | J:337814 | Pathology|SARS-CoV-2_virus|VOC_B.1.1.529_Omicron | Ace2em2(ACE2)MlknEndonuclease-mediated |
Tang AT, PLoS Biol 2023 Feb;21(2):e3001989 |
|||||||
Ace2em2Guru | MGI:6763025 | Endonuclease-mediated | Humanized sequence | Gurumurthy CB, Nat Protoc 2020 Dec;15(12):3777-3787 | J:298750 | SARS-CoV-2_virus | Ace2em2GuruEndonuclease-mediated |
Gurumurthy CB, Nat Protoc 2020 Dec;15(12):3777-3787 |
|||||||
Ace2em2Mccc | MGI:7468714 | Endonuclease-mediated | Humanized sequence | Nakandakari-Higa S, Front Immunol 2022;13():1007080 | J:335150 | Infection|SARS-CoV-2_virus|VOC_B.1.1.529_Omicron | Ace2em2McccEndonuclease-mediated |
Nakandakari-Higa S, Front Immunol 2022;13():1007080 |
|||||||
Ace2em2Shyy | MGI:6406965 | Endonuclease-mediated | Not Specified | Jia H, Nat Commun 2020 Oct 14;11(1):5165 | J:296535 | SARS-CoV-2_virus | Ace2em2ShyyEndonuclease-mediated |
Jia H, Nat Commun 2020 Oct 14;11(1):5165 |
|||||||
Ace2em#Yngh | MGI:5752578 | Endonuclease-mediated | Null/knockout | Jia H, Nat Commun 2020 Oct 14;11(1):5165 | J:296535 | SARS-CoV-2_virus | Ace2em#YnghEndonuclease-mediated |
Jia H, Nat Commun 2020 Oct 14;11(1):5165 |
|||||||
Ace2tm1(ACE2)Dwnt | MGI:6469881 | Targeted | Humanized sequence|Inserted expressed sequence | Zhou B, bioRxiv 2020;(): Zhou B, Nature 2021 Apr;592(7852):122-127 Ulrich L, bioRxiv 2021 Jun;(): Winkler ES, J Virol 2022 Jan 12;96(1):e0151121 | J:296356 J:305777 J:308620 J:331773 | Infection|SARS-CoV-2_virus Infection|SARS-CoV-2_virus|VOC_B.1.1.7_Alpha|VOC_B.1.351_Beta | Ace2tm1(ACE2)DwntTargeted |
Zhou B, bioRxiv 2020;(): Zhou B, Nature 2021 Apr;592(7852):122-127 Ulrich L, bioRxiv 2021 Jun;(): Winkler ES, J Virol 2022 Jan 12;96(1):e0151121 |
|||||||
Ace2tm1a(KOMP)Wtsi | MGI:4820112 | Targeted | Conditional ready|Null/knockout|Reporter | Jia H, Nat Commun 2020 Oct 14;11(1):5165 | J:296535 | SARS-CoV-2_virus | Ace2tm1a(KOMP)WtsiTargeted |
Jia H, Nat Commun 2020 Oct 14;11(1):5165 |
|||||||
Ace2tm1c(KOMP)Wtsi | MGI:6415205 | Targeted | Conditional ready | Jia H, Nat Commun 2020 Oct 14;11(1):5165 | J:296535 | SARS-CoV-2_virus | Ace2tm1c(KOMP)WtsiTargeted |
Jia H, Nat Commun 2020 Oct 14;11(1):5165 |
|||||||
Ace2tm1Cof | MGI:3665270 | Targeted | Null/knockout | Ji H, Hypertension 2020 Aug;76(2):478-487 Jia H, Nat Commun 2020 Oct 14;11(1):5165 | J:290256 J:296535 | Gene SARS-CoV-2_virus | Ace2tm1CofTargeted |
Ji H, Hypertension 2020 Aug;76(2):478-487 Jia H, Nat Commun 2020 Oct 14;11(1):5165 |
|||||||
Ace2tm1Hira | MGI:3794966 | Targeted | Null/knockout | Jia H, Nat Commun 2020 Oct 14;11(1):5165 Wang Y, FASEB J 2021 Mar;35(3):e21419 | J:296535 J:309535 | SARS-CoV-2_virus Gene | Ace2tm1HiraTargeted |
Jia H, Nat Commun 2020 Oct 14;11(1):5165 |
|||||||
Ace2tm1Lex | MGI:5007005 | Targeted | Null/knockout | Jia H, Nat Commun 2020 Oct 14;11(1):5165 Bilinska K, bioRxiv 2021 Apr;(): | J:296535 J:304622 | SARS-CoV-2_virus Gene | Ace2tm1LexTargeted |
Jia H, Nat Commun 2020 Oct 14;11(1):5165 |
|||||||
Ace2tm1Pngr | MGI:2661723 | Targeted | Null/knockout | MGI:5912243 MGI:6402915 | cardiovascular system immune system | MP:0005385 MP:0005387 | Kuba K, Nat Med 2005 Aug;11(8):875-9 Mullick JB, Cell Mol Bioeng 2020 Jul 27;():1-11 Jia H, Nat Commun 2020 Oct 14;11(1):5165 Gawish R, Elife 2022 Jan 13;11():e74623 | J:286299 J:294026 J:296535 J:318828 | Infection|SARS-CoV_virus SARS-CoV-2_virus|SARS-CoV_virus SARS-CoV-2_virus Pathology|SARS-CoV-2-MA_virus | Ace2tm1PngrTargeted |
MGI:5912243 MGI:6402915 | cardiovascular system immune system |
Kuba K, Nat Med 2005 Aug;11(8):875-9 Mullick JB, Cell Mol Bioeng 2020 Jul 27;():1-11 Jia H, Nat Commun 2020 Oct 14;11(1):5165 Gawish R, Elife 2022 Jan 13;11():e74623 |
||
Acetm4Keb | MGI:2665017 | Targeted | Null/knockout | Wysocki J, J Am Soc Nephrol 2020 Sep;31(9):1941-1943 | J:294060 | SARS-CoV-2_virus | Acetm4KebTargeted |
Wysocki J, J Am Soc Nephrol 2020 Sep;31(9):1941-1943 |
|||||||
Acetm7Keb | MGI:3783350 | Targeted | Modified isoform(s) | Wysocki J, J Am Soc Nephrol 2020 Sep;31(9):1941-1943 | J:294060 | SARS-CoV-2_virus | Acetm7KebTargeted |
Wysocki J, J Am Soc Nephrol 2020 Sep;31(9):1941-1943 |
|||||||
Adartm1.1Phs | MGI:3828307 | Targeted | Conditional ready|No functional change | Adamska JZ, Cell Rep 2023 Jan 31;42(1):112038 | J:333092 | Gene|VOC_B.1.351_Beta | Adartm1.1PhsTargeted |
Adamska JZ, Cell Rep 2023 Jan 31;42(1):112038 |
|||||||
Aicdatm1.1(cre/ERT2)Crey | MGI:4437052 | Targeted | Inducible|Null/knockout|Recombinase | Gregoire C, bioRxiv 2021 Dec;(): | J:316768 | SARS-CoV-2_virus | Aicdatm1.1(cre/ERT2)CreyTargeted |
Gregoire C, bioRxiv 2021 Dec;(): |
|||||||
Aicdatm1Hon | MGI:2156156 | Targeted | Null/knockout | Luo Y, Signal Transduct Target Ther 2022 Jan 4;7(1):7 | J:333746 | SARS-CoV-2_virus|Vaccine | Aicdatm1HonTargeted |
Luo Y, Signal Transduct Target Ther 2022 Jan 4;7(1):7 |
|||||||
Aim2tm1.1Vmd | MGI:5428935 | Targeted | Null/knockout | Zheng M, J Biol Chem 2020 Oct 9;295(41):14040-14052 | J:298138 | Mouse_Hepatitis_virus | Aim2tm1.1VmdTargeted |
Zheng M, J Biol Chem 2020 Oct 9;295(41):14040-14052 |
|||||||
Ano9em1Uoh | MGI:7428505 | Endonuclease-mediated | Conditional ready | Kim H, bioRxiv 2022 Mar;(): | J:321922 | Gene|Pathology | Ano9em1UohEndonuclease-mediated |
Kim H, bioRxiv 2022 Mar;(): |
|||||||
Apaf1tm1Her | MGI:1860245 | Targeted | Null/knockout | Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 | J:296686 | Pathology|SARS-CoV-2_virus|Treatment | Apaf1tm1HerTargeted |
Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 |
|||||||
Apoetm2(APOE*3)Mae | MGI:2157240 | Targeted | Humanized sequence|Inserted expressed sequence|Modified isoform(s)|Null/knockout | Rhea EM, Nat Neurosci 2021 Mar;24(3):368-378 | J:305558 | SARS-CoV-2_virus | Apoetm2(APOE*3)MaeTargeted |
Rhea EM, Nat Neurosci 2021 Mar;24(3):368-378 |
|||||||
Apoetm3(APOE*4)Mae | MGI:2158398 | Targeted | Humanized sequence|Inserted expressed sequence | Rhea EM, Nat Neurosci 2021 Mar;24(3):368-378 | J:305558 | SARS-CoV-2_virus | Apoetm3(APOE*4)MaeTargeted |
Rhea EM, Nat Neurosci 2021 Mar;24(3):368-378 |
|||||||
Apptm3.1Tcs | MGI:5637817 | Targeted | Humanized sequence | Magusali N, bioRxiv 2021 Mar;(): | J:303205 | Comorbidity | Apptm3.1TcsTargeted |
Magusali N, bioRxiv 2021 Mar;(): |
|||||||
Atg5tm1Myok | MGI:3663625 | Targeted | Conditional ready|No functional change | Zhao Z, Autophagy 2007 Nov-Dec;3(6):581-5 | J:282479 | Mouse_Hepatitis_virus | Atg5tm1MyokTargeted |
Zhao Z, Autophagy 2007 Nov-Dec;3(6):581-5 |
|||||||
B2mtm1Unc | MGI:1857133 | Targeted | Null/knockout | Brentville VA, bioRxiv 2021 Jun;(): Houtman JJ, J Neurovirol 1996 APR;2(2):101-110 Lavi E, Pathobiology 1999 Mar-Apr;67(2):75-83 | J:308658 J:33974 J:54035 | SARS-CoV-2_virus|Vaccine Mouse_Hepatitis_virus Mouse_Hepatitis_virus|Pathology | B2mtm1UncTargeted |
Brentville VA, bioRxiv 2021 Jun;(): Houtman JJ, J Neurovirol 1996 APR;2(2):101-110 Lavi E, Pathobiology 1999 Mar-Apr;67(2):75-83 |
|||||||
Batf3tm1Kmm | MGI:3817232 | Targeted | Null/knockout | Ndeupen S, bioRxiv 2021 Aug;(): | J:308580 | SARS-CoV-2_virus|Vaccine | Batf3tm1KmmTargeted |
Ndeupen S, bioRxiv 2021 Aug;(): |
|||||||
Bcl6tm1.1Dent | MGI:5518542 | Targeted | Conditional ready|No functional change | Chen JS, bioRxiv 2021 Jun;(): | J:308655 | SARS-CoV-2_virus|VOC_B.1.351_Beta | Bcl6tm1.1DentTargeted |
Chen JS, bioRxiv 2021 Jun;(): |
|||||||
Bsgtm1(BSG)Smoc | MGI:6430241 | Targeted | Humanized sequence|Inserted expressed sequence | Geng J, bioRxiv 2021 May;(): | J:308748 | SARS-CoV-2_virus | Bsgtm1(BSG)SmocTargeted |
Geng J, bioRxiv 2021 May;(): |
|||||||
C3tm1Crr | MGI:1861799 | Targeted | Null/knockout | MGI:3799624 | homeostasis/metabolism immune system nervous system vision/eye | MP:0005376 MP:0005387 MP:0003631 MP:0005391 | Gralinski LE, mBio 2018 Oct 9;9(5): | J:286325 | Pathology|SARS-CoV-MA_virus | C3tm1CrrTargeted |
MGI:3799624 | homeostasis/metabolism immune system nervous system vision/eye |
Gralinski LE, mBio 2018 Oct 9;9(5): |
||
C4btm1Crr | MGI:1889070 | Targeted | Null/knockout | MGI:5296003 | homeostasis/metabolism immune system renal/urinary system | MP:0005376 MP:0005387 MP:0005367 | Gralinski LE, mBio 2018 Oct 9;9(5): | J:286325 | Pathology|SARS-CoV-MA_virus | C4btm1CrrTargeted |
MGI:5296003 | homeostasis/metabolism immune system renal/urinary system |
Gralinski LE, mBio 2018 Oct 9;9(5): |
||
C5ar1tm1.1(C5AR1)Cmac | MGI:6449073 | Targeted | Humanized sequence|Inserted expressed sequence|Null/knockout | Carvelli J, Nature 2020 Jul 29;(): | J:291890 | Pathology|SARS-CoV-2_virus|Treatment | C5ar1tm1.1(C5AR1)CmacTargeted |
Carvelli J, Nature 2020 Jul 29;(): |
|||||||
Casp1tm1Flv | MGI:2158744 | Targeted | Null/knockout | Zheng M, J Biol Chem 2020 Oct 9;295(41):14040-14052 Wu J, Immunity 2021 Nov 9;54(11):2632-2649.e6 Duhalde Vega M, Sci Adv 2022 Sep 23;8(38):eabn6545 Zalinger ZB, J Neurovirol 2017 Dec;23(6):845-854 | J:298138 J:323769 J:331762 J:331829 | Mouse_Hepatitis_virus Gene|Pathology | Casp1tm1FlvTargeted |
Zheng M, J Biol Chem 2020 Oct 9;295(41):14040-14052 Wu J, Immunity 2021 Nov 9;54(11):2632-2649.e6 Duhalde Vega M, Sci Adv 2022 Sep 23;8(38):eabn6545 Zalinger ZB, J Neurovirol 2017 Dec;23(6):845-854 |
|||||||
Casp1tm1Gne | MGI:5882087 | Targeted | Null/knockout | Kim E, Proc Natl Acad Sci U S A 2021 Aug 24;118(34):e2102435118 | J:313327 | SARS-CoV-2_virus|Vaccine | Casp1tm1GneTargeted |
Kim E, Proc Natl Acad Sci U S A 2021 Aug 24;118(34):e2102435118 |
|||||||
Casp1tm1Sesh | MGI:1927822 | Targeted | Null/knockout | Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 | J:296686 | Pathology|SARS-CoV-2_virus|Treatment | Casp1tm1SeshTargeted |
Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 |
|||||||
Casp3tm1Flv | MGI:2158753 | Targeted | Null/knockout | Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 | J:296686 | Pathology|SARS-CoV-2_virus|Treatment | Casp3tm1FlvTargeted |
Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 |
|||||||
Casp4del | MGI:5473345 | Spontaneous | Null/knockout | Zheng M, J Biol Chem 2020 Oct 9;295(41):14040-14052 | J:298138 | Mouse_Hepatitis_virus | Casp4delSpontaneous |
Zheng M, J Biol Chem 2020 Oct 9;295(41):14040-14052 |
|||||||
Casp4tm1.1Vmd | MGI:5468949 | Targeted | Null/knockout | Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 | J:296686 | Pathology|SARS-CoV-2_virus|Treatment | Casp4tm1.1VmdTargeted |
Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 |
|||||||
Casp4tm1Yuan | MGI:2159366 | Targeted | Null/knockout | Eltobgy M, bioRxiv 2021;(): Eltobgy MM, Proc Natl Acad Sci U S A 2022 May 24;119(21):e2202012119 | J:311911 J:331823 | Gene|SARS-CoV-2-MA_virus Gene|SARS-CoV-2-MA_virus|SARS-CoV-2_virus | Casp4tm1YuanTargeted |
Eltobgy M, bioRxiv 2021;(): Eltobgy MM, Proc Natl Acad Sci U S A 2022 May 24;119(21):e2202012119 |
|||||||
Casp7tm1Flv | MGI:3603317 | Targeted | Null/knockout | Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 | J:296686 | Pathology|SARS-CoV-2_virus|Treatment | Casp7tm1FlvTargeted |
Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 |
|||||||
Casp8tm1.1Raz | MGI:5546196 | Targeted | Null/knockout | Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Zheng M, J Biol Chem 2020 Oct 9;295(41):14040-14052 | J:296686 J:298138 | Pathology|SARS-CoV-2_virus|Treatment Mouse_Hepatitis_virus | Casp8tm1.1RazTargeted |
Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Zheng M, J Biol Chem 2020 Oct 9;295(41):14040-14052 |
|||||||
Ccl2tm1Rol | MGI:2175911 | Targeted | Null/knockout | Held KS, Virology 2004 Nov 24;329(2):251-60 | J:102446 | Infection|Mouse_Hepatitis_virus | Ccl2tm1RolTargeted |
Held KS, Virology 2004 Nov 24;329(2):251-60 |
|||||||
Ccr1tm1Gao | MGI:1931850 | Targeted | Null/knockout | MGI:3614443 | Coronavirus infectious disease | DOID:0080599 | cardiovascular system cellular hematopoietic system homeostasis/metabolism immune system respiratory system mortality/aging | MP:0005385 MP:0005384 MP:0005397 MP:0005376 MP:0005387 MP:0005388 MP:0010768 | Sheahan T, PLoS Pathog 2008 Dec;4(12):e1000240 | J:162707 | Pathology|SARS-CoV-MA_virus | Ccr1tm1GaoTargeted |
MGI:3614443 | cardiovascular system cellular hematopoietic system homeostasis/metabolism immune system respiratory system mortality/aging Coronavirus infectious disease |
Sheahan T, PLoS Pathog 2008 Dec;4(12):e1000240 |
Ccr2tm1Ifc | MGI:2158213 | Targeted | Null/knockout | MGI:3580323 | cellular hematopoietic system immune system nervous system skeleton neoplasm mortality/aging | MP:0005384 MP:0005397 MP:0005387 MP:0003631 MP:0005390 MP:0002006 MP:0010768 | Chen BP, J Immunol 2001 Oct 15;167(8):4585-92 | J:106738 | Mouse_Hepatitis_virus|Pathology | Ccr2tm1IfcTargeted |
MGI:3580323 | cellular hematopoietic system immune system nervous system skeleton neoplasm mortality/aging |
Chen BP, J Immunol 2001 Oct 15;167(8):4585-92 |
||
Ccr2tm1Mae | MGI:2158345 | Targeted | Null/knockout | MGI:3841005 | age related macular degeneration Coronavirus infectious disease | DOID:10871 DOID:0080599 | behavior/neurological cardiovascular system hematopoietic system immune system nervous system pigmentation respiratory system vision/eye | MP:0005386 MP:0005385 MP:0005397 MP:0005387 MP:0003631 MP:0001186 MP:0005388 MP:0005391 | Held KS, Virology 2004 Nov 24;329(2):251-60 Glass WG, Virology 2001 Sep 15;288(1):8-17 Sheahan T, PLoS Pathog 2008 Dec;4(12):e1000240 | J:102446 J:102561 J:162707 | Infection|Mouse_Hepatitis_virus Mouse_Hepatitis_virus Pathology|SARS-CoV-MA_virus | Ccr2tm1MaeTargeted |
MGI:3841005 | behavior/neurological cardiovascular system hematopoietic system immune system nervous system pigmentation respiratory system vision/eye age related macular degeneration Coronavirus infectious disease |
Held KS, Virology 2004 Nov 24;329(2):251-60 Glass WG, Virology 2001 Sep 15;288(1):8-17 Sheahan T, PLoS Pathog 2008 Dec;4(12):e1000240 |
Ccr5tm1Kuz | MGI:1861911 | Targeted | Null/knockout | MGI:4418655 | Coronavirus infectious disease | DOID:0080599 | behavior/neurological cardiovascular system immune system nervous system respiratory system vision/eye mortality/aging | MP:0005386 MP:0005385 MP:0005387 MP:0003631 MP:0005388 MP:0005391 MP:0010768 | Sheahan T, PLoS Pathog 2008 Dec;4(12):e1000240 | J:162707 | Pathology|SARS-CoV-MA_virus | Ccr5tm1KuzTargeted |
MGI:4418655 | behavior/neurological cardiovascular system immune system nervous system respiratory system vision/eye mortality/aging Coronavirus infectious disease |
Sheahan T, PLoS Pathog 2008 Dec;4(12):e1000240 |
Ccr9tm1Lov | MGI:3654108 | Targeted | Null/knockout | Schafer A, bioRxiv 2021 May;(): Schafer A, mBio 2022 Aug 30;13(4):e0145422 | J:308730 J:327836 | Pathology|SARS-CoV-2-MA_virus|SARS-CoV-2_virus|SARS-CoV-MA_virus|SARS-CoV_virus SARS-CoV-2-MA_virus|SARS-CoV-MA_virus | Ccr9tm1LovTargeted |
Schafer A, bioRxiv 2021 May;(): Schafer A, mBio 2022 Aug 30;13(4):e0145422 |
|||||||
Cd19tm1(cre)Cgn | MGI:1931143 | Targeted | Recombinase | Cervantes-Barragan L, J Immunol 2009 Jan 15;182(2):1099-106 Atkinson JR, J Virol 2017 Dec 1;91(23): Kotagiri P, EBioMedicine 2022 Feb 18;77():103878 Luo Y, Signal Transduct Target Ther 2022 Jan 4;7(1):7 Sarden N, Sci Transl Med 2022 Dec 7;14(674):eabq6682 | J:143484 J:253411 J:322643 J:333746 J:336666 | Mouse_Hepatitis_virus SARS-CoV-2_virus SARS-CoV-2_virus|Vaccine Comorbidity|SARS-CoV-2_virus | Cd19tm1(cre)CgnTargeted |
Cervantes-Barragan L, J Immunol 2009 Jan 15;182(2):1099-106 Atkinson JR, J Virol 2017 Dec 1;91(23): Kotagiri P, EBioMedicine 2022 Feb 18;77():103878 Luo Y, Signal Transduct Target Ther 2022 Jan 4;7(1):7 Sarden N, Sci Transl Med 2022 Dec 7;14(674):eabq6682 |
|||||||
Cd1tm1Gru | MGI:1857482 | Targeted | Null/knockout | Johansen MD, Mucosal Immunol 2020 Aug 20;(): Glass WG, J Immunol 2004 Sep 15;173(6):4030-9 | J:295350 J:92752 | MERS-CoV-MA_virus|MERS-CoV_virus|SARS-CoV-2-MA_virus|SARS-CoV-2_virus|SARS-CoV-MA_virus|SARS-CoV_virus Infection|SARS-CoV_virus | Cd1tm1GruTargeted |
Johansen MD, Mucosal Immunol 2020 Aug 20;(): Glass WG, J Immunol 2004 Sep 15;173(6):4030-9 |
|||||||
Cd274tm1Lpc | MGI:3043876 | Targeted | Null/knockout | Phares TW, J Immunol 2009 May 1;182(9):5430-8 Phares TW, J Immunol 2010 Nov 1;185(9):5607-18 Phares TW, J Neuroinflammation 2012 Dec 14;9():269 | J:147948 J:165192 J:331800 | Mouse_Hepatitis_virus Gene|Mouse_Hepatitis_virus | Cd274tm1LpcTargeted |
Phares TW, J Immunol 2009 May 1;182(9):5430-8 Phares TW, J Immunol 2010 Nov 1;185(9):5607-18 Phares TW, J Neuroinflammation 2012 Dec 14;9():269 |
|||||||
Cd47tm1Fpl | MGI:1861955 | Targeted | Null/knockout | Wenzek C, iScience 2022 Dec 22;25(12):105540 | J:331693 | SARS-CoV-2_virus | Cd47tm1FplTargeted |
Wenzek C, iScience 2022 Dec 22;25(12):105540 |
|||||||
Cd4tm1Litt | MGI:1857281 | Targeted | Null/knockout | Brentville VA, bioRxiv 2021 Jun;(): | J:308658 | SARS-CoV-2_virus|Vaccine | Cd4tm1LittTargeted |
Brentville VA, bioRxiv 2021 Jun;(): |
|||||||
Cd4tm1Mak | MGI:1857144 | Targeted | Null/knockout | Heemskerk MH, Eur J Immunol 1995 Apr;25(4):1109-12 Chakravarty D, J Virol 2020 Jul 1;94(14): Yang J, Nature 2020 Jul 29;(): | J:112983 J:290222 J:292665 | Mouse_Hepatitis_virus Mouse_Hepatitis_virus|Pathology SARS-CoV-2_virus|Vaccine | Cd4tm1MakTargeted |
Heemskerk MH, Eur J Immunol 1995 Apr;25(4):1109-12 Chakravarty D, J Virol 2020 Jul 1;94(14): Yang J, Nature 2020 Jul 29;(): |
|||||||
Cd79atm1(cre)Reth | MGI:3687451 | Targeted | Null/knockout|Recombinase | Kotagiri P, EBioMedicine 2022 Feb 18;77():103878 | J:322643 | SARS-CoV-2_virus | Cd79atm1(cre)RethTargeted |
Kotagiri P, EBioMedicine 2022 Feb 18;77():103878 |
|||||||
Cd8atm1Mak | MGI:1857149 | Targeted | Null/knockout | Yang J, Nature 2020 Jul 29;(): | J:292665 | SARS-CoV-2_virus|Vaccine | Cd8atm1MakTargeted |
Yang J, Nature 2020 Jul 29;(): |
|||||||
Ceacam1Hv2-r | MGI:3053078 | Spontaneous | MGI:3719417 | immune system | MP:0005387 | Peng G, J Biol Chem 2017 Feb 10;292(6):2174-2181 Yokomori K, J Virol 1992 Dec;66(12):6931-8 Dveksler GS, J Virol 1991 Dec;65(12):6881-91 Dveksler GS, J Virol 1993 Jan;67(1):1-8 | J:240703 J:3241 J:701 J:92495 | Mouse_Hepatitis_virus Infection|Mouse_Hepatitis_virus | Ceacam1Hv2-rSpontaneous |
MGI:3719417 | immune system |
Peng G, J Biol Chem 2017 Feb 10;292(6):2174-2181 Yokomori K, J Virol 1992 Dec;66(12):6931-8 Dveksler GS, J Virol 1991 Dec;65(12):6881-91 Dveksler GS, J Virol 1993 Jan;67(1):1-8 |
|||
Ceacam1Hv2-s | MGI:3027072 | Spontaneous | MGI:3719418 | immune system | MP:0005387 | Peng G, J Biol Chem 2017 Feb 10;292(6):2174-2181 Yokomori K, J Virol 1992 Dec;66(12):6931-8 Dveksler GS, J Virol 1991 Dec;65(12):6881-91 Dveksler GS, J Virol 1993 Jan;67(1):1-8 | J:240703 J:3241 J:701 J:92495 | Mouse_Hepatitis_virus Infection|Mouse_Hepatitis_virus | Ceacam1Hv2-sSpontaneous |
MGI:3719418 | immune system |
Peng G, J Biol Chem 2017 Feb 10;292(6):2174-2181 Yokomori K, J Virol 1992 Dec;66(12):6931-8 Dveksler GS, J Virol 1991 Dec;65(12):6881-91 Dveksler GS, J Virol 1993 Jan;67(1):1-8 |
|||
Ceacam1tm1.1Fta | MGI:5496530 | Targeted | Inserted expressed sequence | MGI:5496535 | immune system mortality/aging | MP:0005387 MP:0010768 | Hirai A, J Virol 2010 Jul;84(13):6654-66 | J:198335 | Infection|Mouse_Hepatitis_virus | Ceacam1tm1.1FtaTargeted |
MGI:5496535 | immune system mortality/aging |
Hirai A, J Virol 2010 Jul;84(13):6654-66 |
||
Ceacam1tm1Bcn | MGI:2180785 | Targeted | Null/knockout | MGI:2656211 | immune system mortality/aging | MP:0005387 MP:0010768 | Blau DM, J Virol 2001 Sep;75(17):8173-86 Hemmila E, J Virol 2004 Sep;78(18):10156-65 | J:70815 J:92376 | Infection|Mouse_Hepatitis_virus | Ceacam1tm1BcnTargeted |
MGI:2656211 | immune system mortality/aging |
Blau DM, J Virol 2001 Sep;75(17):8173-86 Hemmila E, J Virol 2004 Sep;78(18):10156-65 |
||
Ceacam1tm2Bcn | MGI:3053071 | Targeted | Null/knockout | MGI:3053437 | digestive/alimentary system homeostasis/metabolism immune system neoplasm | MP:0005381 MP:0005376 MP:0005387 MP:0002006 | Miura TA, J Virol 2008 Jan;82(2):755-63 Hemmila E, J Virol 2004 Sep;78(18):10156-65 | J:130131 J:92376 | Mouse_Hepatitis_virus Infection|Mouse_Hepatitis_virus | Ceacam1tm2BcnTargeted |
MGI:3053437 | digestive/alimentary system homeostasis/metabolism immune system neoplasm |
Miura TA, J Virol 2008 Jan;82(2):755-63 Hemmila E, J Virol 2004 Sep;78(18):10156-65 |
||
Ces1ctm1.1Loc | MGI:4938302 | Targeted | Null/knockout | Sheahan TP, Sci Transl Med 2017 Jun 28;9(396): Sheahan TP, Nat Commun 2020 Jan 10;11(1):222 Pruijssers AJ, Cell Rep 2020 Jul 21;32(3):107940 Martinez DR, bioRxiv 2021 Jan;(): Zhu C, Nat Commun 2022 Aug 3;13(1):4503 | J:286362 J:286402 J:298752 J:302135 J:335969 | MERS-CoV_virus|SARS-CoV_virus|Treatment MERS-CoV_virus|Treatment SARS-CoV-2-MA_virus|SARS-CoV-2_virus|Treatment SARS-CoV-2_virus|Treatment | Ces1ctm1.1LocTargeted |
Sheahan TP, Sci Transl Med 2017 Jun 28;9(396): Sheahan TP, Nat Commun 2020 Jan 10;11(1):222 Pruijssers AJ, Cell Rep 2020 Jul 21;32(3):107940 Martinez DR, bioRxiv 2021 Jan;(): Zhu C, Nat Commun 2022 Aug 3;13(1):4503 |
|||||||
Cfbtm1Hrc | MGI:1861129 | Targeted | Null/knockout | MGI:3771614 | immune system | MP:0005387 | Gralinski LE, mBio 2018 Oct 9;9(5): | J:286325 | Pathology|SARS-CoV-MA_virus | Cfbtm1HrcTargeted |
MGI:3771614 | immune system |
Gralinski LE, mBio 2018 Oct 9;9(5): |
||
Ciitatm1Ccum | MGI:1857456 | Targeted | Null/knockout | Chen JS, bioRxiv 2021 Jun;(): | J:308655 | SARS-CoV-2_virus|VOC_B.1.351_Beta | Ciitatm1CcumTargeted |
Chen JS, bioRxiv 2021 Jun;(): |
|||||||
Cmpk2tm1c(KOMP)Wtsi | MGI:6753388 | Targeted | Conditional ready | Xian H, Immunity 2021 Jul 13;54(7):1463-1477.e11 | J:308159 | Pathology|SARS-CoV-2_virus|Treatment | Cmpk2tm1c(KOMP)WtsiTargeted |
Xian H, Immunity 2021 Jul 13;54(7):1463-1477.e11 |
|||||||
Commd10Tg(Vav1-icre)A2Kio | MGI:2449949 | Transgenic | Null/knockout|Recombinase | Pfaender S, Nat Microbiol 2020 Jul 23;(): | J:291868 | Gene|HCoV-229E_virus|HCoV-OC43_virus|MERS-CoV_virus|Mouse_Hepatitis_virus|SARS-CoV-2_virus|SARS-CoV_virus | Commd10Tg(Vav1-icre)A2KioTransgenic |
Pfaender S, Nat Microbiol 2020 Jul 23;(): |
|||||||
Csf1tm1.1(CSF1)Flv | MGI:5296679 | Targeted | Humanized sequence|Inserted expressed sequence | Sefik E, bioRxiv 2021;(): | J:311907 | SARS-CoV-2_virus | Csf1tm1.1(CSF1)FlvTargeted |
Sefik E, bioRxiv 2021;(): |
|||||||
Csf2/Il3tm1.1(CSF2,IL3)Flv | MGI:4887881 | Targeted | Humanized sequence|Inserted expressed sequence | Sefik E, bioRxiv 2021;(): | J:311907 | SARS-CoV-2_virus | Csf2/Il3tm1.1(CSF2,IL3)FlvTargeted |
Sefik E, bioRxiv 2021;(): |
|||||||
Cx3cr1tm1Litt | MGI:2670351 | Targeted | Null/knockout|Reporter | Wheeler DL, J Clin Invest 2018 Mar 1;128(3):931-943 | J:291614 | Mouse_Hepatitis_virus | Cx3cr1tm1LittTargeted |
Wheeler DL, J Clin Invest 2018 Mar 1;128(3):931-943 |
|||||||
Cx3cr1tm2.1(cre/ERT2)Litt | MGI:5450813 | Targeted | Inducible|Recombinase|Reporter | Verma AK, mBio 2021 Oct 26;12(5):e0196921 | J:313438 | Mouse_Hepatitis_virus | Cx3cr1tm2.1(cre/ERT2)LittTargeted |
Verma AK, mBio 2021 Oct 26;12(5):e0196921 |
|||||||
Cxcl10tm1Adl | MGI:2180678 | Targeted | Null/knockout | Stiles LN, J Immunol 2006 Dec 15;177(12):8372-80 | J:140673 | Mouse_Hepatitis_virus | Cxcl10tm1AdlTargeted |
Stiles LN, J Immunol 2006 Dec 15;177(12):8372-80 |
|||||||
Cxcl13tm1Cys | MGI:2384500 | Targeted | Null/knockout|Reporter | Phares TW, Brain Behav Immun 2016 May;54():128-139 | J:316468 | Mouse_Hepatitis_virus | Cxcl13tm1CysTargeted |
Phares TW, Brain Behav Immun 2016 May;54():128-139 |
|||||||
Cxcl5tm1Gscw | MGI:4819800 | Targeted | Null/knockout | Liang Y, Zool Res 2020 Oct 12;():1-29 | J:296738 | Infection|Pathology|SARS-CoV-2_virus | Cxcl5tm1GscwTargeted |
Liang Y, Zool Res 2020 Oct 12;():1-29 |
|||||||
Cxcr3tm1Dgen | MGI:3604545 | Targeted | Null/knockout|Reporter | McDermott JE, BMC Syst Biol 2016 Sep 23;10(1):93 | J:288523 | Pathology|SARS-CoV-MA_virus | Cxcr3tm1DgenTargeted |
McDermott JE, BMC Syst Biol 2016 Sep 23;10(1):93 |
|||||||
Cxcr6tm1Litt | MGI:3613526 | Targeted | Null/knockout|Reporter | Schafer A, mBio 2022 Aug 30;13(4):e0145422 | J:327836 | SARS-CoV-2-MA_virus|SARS-CoV-MA_virus | Cxcr6tm1LittTargeted |
Schafer A, mBio 2022 Aug 30;13(4):e0145422 |
|||||||
Dpp4em1Rba | MGI:6400423 | Endonuclease-mediated | Humanized sequence | MGI:6400425 | Middle East respiratory syndrome | DOID:0080642 | cardiovascular system growth/size/body hematopoietic system homeostasis/metabolism immune system respiratory system mortality/aging | MP:0005385 MP:0005378 MP:0005397 MP:0005376 MP:0005387 MP:0005388 MP:0010768 | Leist SR, PLoS One 2019;14(7):e0220126 Cockrell AS, Nat Microbiol 2016 Nov 28;2():16226 Leist SR, Methods Mol Biol 2020;2099():137-159 Sheahan TP, Sci Transl Med 2020 Apr 29;12(541): Sheahan TP, Nat Commun 2020 Jan 10;11(1):222 Menachery VD, mBio 2017 Aug 22;8(4): Singh A, Virol Sin 2020 Jun;35(3):290-304 Johansen MD, Mucosal Immunol 2020 Aug 20;(): Gutierrez-Alvarez J, J Virol 2021 Jan 13;95(3): | J:279723 J:279834 J:285962 J:286320 J:286402 J:287147 J:295349 J:295350 J:300138 | MERS-CoV_virus|Pathology MERS-CoV_virus MERS-CoV_virus|SARS-CoV-2_virus|SARS-CoV-MA_virus|SARS-CoV_virus|Treatment MERS-CoV_virus|Treatment Infection|MERS-CoV_virus MERS-CoV-MA_virus|MERS-CoV_virus|SARS-CoV-2-MA_virus|SARS-CoV-2_virus|SARS-CoV_virus MERS-CoV-MA_virus|MERS-CoV_virus|SARS-CoV-2-MA_virus|SARS-CoV-2_virus|SARS-CoV-MA_virus|SARS-CoV_virus | Dpp4em1RbaEndonuclease-mediated |
MGI:6400425 | cardiovascular system growth/size/body hematopoietic system homeostasis/metabolism immune system respiratory system mortality/aging Middle East respiratory syndrome |
Leist SR, PLoS One 2019;14(7):e0220126 Cockrell AS, Nat Microbiol 2016 Nov 28;2():16226 Leist SR, Methods Mol Biol 2020;2099():137-159 Sheahan TP, Sci Transl Med 2020 Apr 29;12(541): Sheahan TP, Nat Commun 2020 Jan 10;11(1):222 Menachery VD, mBio 2017 Aug 22;8(4): Singh A, Virol Sin 2020 Jun;35(3):290-304 Johansen MD, Mucosal Immunol 2020 Aug 20;(): Gutierrez-Alvarez J, J Virol 2021 Jan 13;95(3): |
Dpp4tm1.1(DPP4)Pbmj | MGI:6400999 | Targeted | Humanized sequence|Inserted expressed sequence | MGI:6401000 | Middle East respiratory syndrome | DOID:0080642 | cardiovascular system homeostasis/metabolism immune system respiratory system mortality/aging | MP:0005385 MP:0005376 MP:0005387 MP:0005388 MP:0010768 | Li K, Proc Natl Acad Sci U S A 2017 Apr 11;114(15):E3119-E3128 Leist SR, Methods Mol Biol 2020;2099():137-159 Jia W, Emerg Microbes Infect 2019;8(1):760-772 Li K, mBio 2020 Apr 7;11(2): Channappanavar R, J Clin Invest 2019 Jul 29;130():3625-3639 Singh A, Virol Sin 2020 Jun;35(3):290-304 Johansen MD, Mucosal Immunol 2020 Aug 20;(): Yuan L, Emerg Microbes Infect 2020 Dec;9(1):949-961 Gutierrez-Alvarez J, J Virol 2021 Jan 13;95(3): Zheng J, J Clin Invest 2021 Jun 1;131(11): Gutierrez-Alvarez J, Proc Natl Acad Sci U S A 2021 Oct 26;118(43):e2111075118 | J:242025 J:285962 J:286329 J:287921 J:288107 J:295349 J:295350 J:300104 J:300138 J:311966 J:315826 | Infection|MERS-CoV_virus|Pathology MERS-CoV_virus MERS-CoV-MA_virus|MERS-CoV_virus|Vaccine Infection|MERS-CoV-MA_virus|Treatment MERS-CoV-MA_virus|MERS-CoV_virus|SARS-CoV-2-MA_virus|SARS-CoV-2_virus|SARS-CoV_virus MERS-CoV-MA_virus|MERS-CoV_virus|SARS-CoV-2-MA_virus|SARS-CoV-2_virus|SARS-CoV-MA_virus|SARS-CoV_virus MERS-CoV_virus|SARS-CoV-2_virus|SARS-CoV_virus Comorbidity|MERS-CoV_virus MERS-CoV_virus|Vaccine | Dpp4tm1.1(DPP4)PbmjTargeted |
MGI:6401000 | cardiovascular system homeostasis/metabolism immune system respiratory system mortality/aging Middle East respiratory syndrome |
Li K, Proc Natl Acad Sci U S A 2017 Apr 11;114(15):E3119-E3128 Leist SR, Methods Mol Biol 2020;2099():137-159 Jia W, Emerg Microbes Infect 2019;8(1):760-772 Li K, mBio 2020 Apr 7;11(2): Channappanavar R, J Clin Invest 2019 Jul 29;130():3625-3639 Singh A, Virol Sin 2020 Jun;35(3):290-304 Johansen MD, Mucosal Immunol 2020 Aug 20;(): Yuan L, Emerg Microbes Infect 2020 Dec;9(1):949-961 Gutierrez-Alvarez J, J Virol 2021 Jan 13;95(3): Zheng J, J Clin Invest 2021 Jun 1;131(11): Gutierrez-Alvarez J, Proc Natl Acad Sci U S A 2021 Oct 26;118(43):e2111075118 |
Dpp4tm1(DPP4)Vlcg | MGI:5788094 | Targeted | Inserted expressed sequence|Null/knockout | MGI:6400455 MGI:6435210 | Middle East respiratory syndrome | DOID:0080642 | immune system respiratory system cellular hematopoietic system homeostasis/metabolism | MP:0005387 MP:0005388 MP:0005384 MP:0005397 MP:0005376 | Pascal KE, Proc Natl Acad Sci U S A 2015 Jul 14;112(28):8738-43 Coleman CM, J Virol 2017 Jan 01;91(1): Leist SR, Methods Mol Biol 2020;2099():137-159 Kulcsar KA, JCI Insight 2019 Oct 17;4(20): Singh A, Virol Sin 2020 Jun;35(3):290-304 | J:223728 J:238079 J:285962 J:286238 J:295349 | Infection|MERS-CoV_virus|Treatment MERS-CoV_virus|Pathology MERS-CoV_virus Comorbidity|MERS-CoV_virus|Pathology MERS-CoV-MA_virus|MERS-CoV_virus|SARS-CoV-2-MA_virus|SARS-CoV-2_virus|SARS-CoV_virus | Dpp4tm1(DPP4)VlcgTargeted |
MGI:6400455 MGI:6435210 | immune system respiratory system Middle East respiratory syndrome cellular hematopoietic system homeostasis/metabolism |
Pascal KE, Proc Natl Acad Sci U S A 2015 Jul 14;112(28):8738-43 Coleman CM, J Virol 2017 Jan 01;91(1): Leist SR, Methods Mol Biol 2020;2099():137-159 Kulcsar KA, JCI Insight 2019 Oct 17;4(20): Singh A, Virol Sin 2020 Jun;35(3):290-304 |
Ebi3Gt716Lex | MGI:3793965 | Gene trapped | Null/knockout|Reporter | MGI:6442003 | hematopoietic system immune system nervous system mortality/aging | MP:0005397 MP:0005387 MP:0003631 MP:0010768 | Tirotta E, J Neuroimmunol 2013 Jan 15;254(1-2):110-6 | J:286951 | Infection|Mouse_Hepatitis_virus | Ebi3Gt716LexGene trapped |
MGI:6442003 | hematopoietic system immune system nervous system mortality/aging |
Tirotta E, J Neuroimmunol 2013 Jan 15;254(1-2):110-6 |
||
Edil3Tg(Sox2-cre)1Amc | MGI:2656539 | Transgenic | Null/knockout|Recombinase | Tang AT, bioRxiv 2021 Dec;(): Tang AT, PLoS Biol 2023 Feb;21(2):e3001989 | J:315719 J:337814 | Pathology|SARS-CoV-2_virus Pathology|SARS-CoV-2_virus|VOC_B.1.1.529_Omicron | Edil3Tg(Sox2-cre)1AmcTransgenic |
Tang AT, bioRxiv 2021 Dec;(): Tang AT, PLoS Biol 2023 Feb;21(2):e3001989 |
|||||||
EgfrMhdadsk5 | MGI:2682255 | Chemically induced (ENU) | Venkataraman T, J Virol 2017 Jun 15;91(12): | J:243599 | Pathology|SARS-CoV-MA_virus | EgfrMhdadsk5Chemically induced (ENU) |
Venkataraman T, J Virol 2017 Jun 15;91(12): |
||||||||
Eif2ak2tm1Cwe | MGI:2182566 | Targeted | Null/knockout | Kindler E, PLoS Pathog 2017 Feb;13(2):e1006195 | J:291588 | HCoV-229E_virus|Mouse_Hepatitis_virus | Eif2ak2tm1CweTargeted |
Kindler E, PLoS Pathog 2017 Feb;13(2):e1006195 |
|||||||
Elanetm1Sds | MGI:2182771 | Targeted | Null/knockout | Kim E, Proc Natl Acad Sci U S A 2021 Aug 24;118(34):e2102435118 | J:313327 | SARS-CoV-2_virus|Vaccine | Elanetm1SdsTargeted |
Kim E, Proc Natl Acad Sci U S A 2021 Aug 24;118(34):e2102435118 |
|||||||
Eportm1.1(EGFP/icre)Uk | MGI:3052727 | Targeted | Null/knockout|Recombinase|Reporter | Lam LKM, Sci Transl Med 2021 Oct 20;13(616):eabj1008 | J:325468 | SARS-CoV-2_virus | Eportm1.1(EGFP/icre)UkTargeted |
Lam LKM, Sci Transl Med 2021 Oct 20;13(616):eabj1008 |
|||||||
Faddtm1Mak | MGI:2159360 | Targeted | Null/knockout | Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 | J:296686 | Pathology|SARS-CoV-2_virus|Treatment | Faddtm1MakTargeted |
Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 |
|||||||
Faddtm1Mpa | MGI:3700154 | Targeted | Conditional ready|No functional change | Wenzel J, Nat Neurosci 2021 Nov;24(11):1522-1533 | J:323957 | Pathology|SARS-CoV-2_virus|VOC_B.1.351_Beta | Faddtm1MpaTargeted |
Wenzel J, Nat Neurosci 2021 Nov;24(11):1522-1533 |
|||||||
Fcgrttm1Dcr | MGI:3511510 | Targeted | Null/knockout | Halwe S, bioRxiv 2021 Jun;(): | J:308648 | SARS-CoV-2_virus|Treatment|VOC_B.1.1.7_Alpha|VOC_B.1.351_Beta | Fcgrttm1DcrTargeted |
Halwe S, bioRxiv 2021 Jun;(): |
|||||||
Fgatm1Jld | MGI:2152976 | Targeted | Null/knockout | Ryu JK, bioRxiv 2021;(): | J:311923 | SARS-CoV-2_virus|Treatment | Fgatm1JldTargeted |
Ryu JK, bioRxiv 2021;(): |
|||||||
Fggtm2Jld | MGI:3046446 | Targeted | Ryu JK, bioRxiv 2021;(): | J:311923 | SARS-CoV-2_virus|Treatment | Fggtm2JldTargeted |
Ryu JK, bioRxiv 2021;(): |
||||||||
Fgl2tm1Pam | MGI:3582343 | Targeted | Null/knockout|Reporter | MGI:3583696 MGI:3583697 | autoimmune glomerulonephritis | DOID:0040094 | cardiovascular system homeostasis/metabolism immune system mortality/aging cellular growth/size/body hematopoietic system renal/urinary system | MP:0005385 MP:0005376 MP:0005387 MP:0010768 MP:0005384 MP:0005378 MP:0005397 MP:0005367 | Marsden PA, J Clin Invest 2003 Jul;112(1):58-66 | J:99453 | Mouse_Hepatitis_virus | Fgl2tm1PamTargeted |
MGI:3583696 MGI:3583697 | cardiovascular system homeostasis/metabolism immune system mortality/aging cellular growth/size/body hematopoietic system renal/urinary system autoimmune glomerulonephritis |
Marsden PA, J Clin Invest 2003 Jul;112(1):58-66 |
Foxg1tm1.1(cre)Ddmo | MGI:5818697 | Targeted | Recombinase | Tang AT, bioRxiv 2021 Dec;(): Tang AT, PLoS Biol 2023 Feb;21(2):e3001989 | J:315719 J:337814 | Pathology|SARS-CoV-2_virus Pathology|SARS-CoV-2_virus|VOC_B.1.1.529_Omicron | Foxg1tm1.1(cre)DdmoTargeted |
Tang AT, bioRxiv 2021 Dec;(): Tang AT, PLoS Biol 2023 Feb;21(2):e3001989 |
|||||||
Foxp3tm2Ayr | MGI:3574964 | Targeted | No functional change|Reporter | Zhao J, J Exp Med 2011 Aug 1;208(8):1571-7 | J:177608 | Mouse_Hepatitis_virus | Foxp3tm2AyrTargeted |
Zhao J, J Exp Med 2011 Aug 1;208(8):1571-7 |
|||||||
Foxp3tm2Tch | MGI:3699400 | Targeted | Reporter | Zhao J, PLoS Pathog 2014 Aug;10(8):e1004279 Sariol A, J Immunol 2022 Apr 15;208(8):1989-1997 | J:247329 J:324704 | Mouse_Hepatitis_virus Infection|Mouse_Hepatitis_virus | Foxp3tm2TchTargeted |
Zhao J, PLoS Pathog 2014 Aug;10(8):e1004279 Sariol A, J Immunol 2022 Apr 15;208(8):1989-1997 |
|||||||
Foxp3tm3(HBEGF/GFP)Ayr | MGI:3698131 | Targeted | Inserted expressed sequence|Reporter | Uraki R, PLoS Pathog 2021 Dec;17(12):e1010085 | J:327784 | SARS-CoV-2_virus | Foxp3tm3(HBEGF/GFP)AyrTargeted |
Uraki R, PLoS Pathog 2021 Dec;17(12):e1010085 |
|||||||
Foxp3tm9(EGFP/cre/ERT2)Ayr | MGI:4950935 | Targeted | Inducible|Recombinase|Reporter | Sariol A, J Immunol 2022 Apr 15;208(8):1989-1997 | J:324704 | Infection|Mouse_Hepatitis_virus | Foxp3tm9(EGFP/cre/ERT2)AyrTargeted |
Sariol A, J Immunol 2022 Apr 15;208(8):1989-1997 |
|||||||
Gbp2tm1.1Kpf | MGI:5475104 | Targeted | Null/knockout|Reporter | Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 | J:296686 | Pathology|SARS-CoV-2_virus|Treatment | Gbp2tm1.1KpfTargeted |
Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 |
|||||||
Gsdmdem1Tdk | MGI:6342025 | Endonuclease-mediated | Null/knockout | Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Zheng M, J Biol Chem 2020 Oct 9;295(41):14040-14052 Eltobgy MM, Proc Natl Acad Sci U S A 2022 May 24;119(21):e2202012119 | J:296686 J:298138 J:331823 | Pathology|SARS-CoV-2_virus|Treatment Mouse_Hepatitis_virus Gene|SARS-CoV-2-MA_virus|SARS-CoV-2_virus | Gsdmdem1TdkEndonuclease-mediated |
Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Zheng M, J Biol Chem 2020 Oct 9;295(41):14040-14052 Eltobgy MM, Proc Natl Acad Sci U S A 2022 May 24;119(21):e2202012119 |
|||||||
Gsdmdem4Fcw | MGI:6196334 | Endonuclease-mediated | Null/knockout | Wu J, Immunity 2021 Nov 9;54(11):2632-2649.e6 | J:323769 | Gene|Pathology | Gsdmdem4FcwEndonuclease-mediated |
Wu J, Immunity 2021 Nov 9;54(11):2632-2649.e6 |
|||||||
Gsdmetm1a(KOMP)Wtsi | MGI:4363231 | Targeted | Conditional ready|Null/knockout|Reporter | Zheng M, J Biol Chem 2020 Oct 9;295(41):14040-14052 | J:298138 | Mouse_Hepatitis_virus | Gsdmetm1a(KOMP)WtsiTargeted |
Zheng M, J Biol Chem 2020 Oct 9;295(41):14040-14052 |
|||||||
Gt(ROSA)26Sorem1(CAG-ACE2)Mlkn | MGI:6842323 | Endonuclease-mediated | Conditional ready|Humanized sequence|Inserted expressed sequence | Tang AT, bioRxiv 2021 Dec;(): Tang AT, PLoS Biol 2023 Feb;21(2):e3001989 | J:315719 J:337814 | Pathology|SARS-CoV-2_virus Pathology|SARS-CoV-2_virus|VOC_B.1.1.529_Omicron | Gt(ROSA)26Sorem1(CAG-ACE2)MlknEndonuclease-mediated |
Tang AT, bioRxiv 2021 Dec;(): Tang AT, PLoS Biol 2023 Feb;21(2):e3001989 |
|||||||
Gt(ROSA)26Sorem1(DPP4)Yowa | MGI:6403442 | Endonuclease-mediated | Humanized sequence|Inserted expressed sequence|Reporter | MGI:6403447 | Middle East respiratory syndrome | DOID:0080642 | immune system nervous system | MP:0005387 MP:0003631 | Fan C, Viruses 2018 Aug 23;10(9): Zhou H, Nat Commun 2019 Jul 11;10(1):3068 Singh A, Virol Sin 2020 Jun;35(3):290-304 | J:279060 J:279324 J:295349 | Infection|MERS-CoV_virus|Pathology|Treatment MERS-CoV_virus MERS-CoV-MA_virus|MERS-CoV_virus|SARS-CoV-2-MA_virus|SARS-CoV-2_virus|SARS-CoV_virus | Gt(ROSA)26Sorem1(DPP4)YowaEndonuclease-mediated |
MGI:6403447 | immune system nervous system Middle East respiratory syndrome |
Fan C, Viruses 2018 Aug 23;10(9): Zhou H, Nat Commun 2019 Jul 11;10(1):3068 Singh A, Virol Sin 2020 Jun;35(3):290-304 |
Gt(ROSA)26Sortm1.1(Ace2)Spo | MGI:6406372 | Targeted | Inserted expressed sequence | Jia H, Nat Commun 2020 Oct 14;11(1):5165 | J:296535 | SARS-CoV-2_virus | Gt(ROSA)26Sortm1.1(Ace2)SpoTargeted |
Jia H, Nat Commun 2020 Oct 14;11(1):5165 |
|||||||
Gt(ROSA)26Sortm14(CAG-tdTomato)Hze | MGI:3809524 | Targeted | Conditional ready|Reporter | Pan R, Proc Natl Acad Sci U S A 2020 Jul 7;117(27):15902-15910 Tang AT, bioRxiv 2021 Dec;(): Nakandakari-Higa S, Front Immunol 2022;13():1007080 Tang AT, PLoS Biol 2023 Feb;21(2):e3001989 | J:291543 J:315719 J:335150 J:337814 | Infection|Mouse_Hepatitis_virus Pathology|SARS-CoV-2_virus Infection|SARS-CoV-2_virus|VOC_B.1.1.529_Omicron Pathology|SARS-CoV-2_virus|VOC_B.1.1.529_Omicron | Gt(ROSA)26Sortm14(CAG-tdTomato)HzeTargeted |
Pan R, Proc Natl Acad Sci U S A 2020 Jul 7;117(27):15902-15910 Tang AT, bioRxiv 2021 Dec;(): Nakandakari-Higa S, Front Immunol 2022;13():1007080 Tang AT, PLoS Biol 2023 Feb;21(2):e3001989 |
|||||||
Gt(ROSA)26Sortm1(cre/ERT)Nat | MGI:2669525 | Targeted | Inducible|Recombinase | Sepe S, EMBO Rep 2022 Feb 3;23(2):e53658 | J:326929 | Gene | Gt(ROSA)26Sortm1(cre/ERT)NatTargeted |
||||||||
Gt(ROSA)26Sortm1(EYFP)Cos | MGI:2449038 | Targeted | Conditional ready|Reporter | Gregoire C, bioRxiv 2021 Dec;(): | J:316768 | SARS-CoV-2_virus | Gt(ROSA)26Sortm1(EYFP)CosTargeted |
Gregoire C, bioRxiv 2021 Dec;(): |
|||||||
Gt(ROSA)26Sortm1(FLP1)Dym | MGI:2429412 | Targeted | Recombinase | Pfaender S, Nat Microbiol 2020 Jul 23;(): | J:291868 | Gene|HCoV-229E_virus|HCoV-OC43_virus|MERS-CoV_virus|Mouse_Hepatitis_virus|SARS-CoV-2_virus|SARS-CoV_virus | Gt(ROSA)26Sortm1(FLP1)DymTargeted |
Pfaender S, Nat Microbiol 2020 Jul 23;(): |
|||||||
Gt(ROSA)26Sortm1(gp80,EGFP)Eces | MGI:5004724 | Targeted | Conditional ready|Inserted expressed sequence|Reporter | Musiu C, bioRxiv 2021 May;(): Musiu C, Cell Death Differ 2021 Sep 13;(): | J:308717 J:313338 | SARS-CoV-2_virus Pathology|SARS-CoV-2_virus | Gt(ROSA)26Sortm1(gp80,EGFP)EcesTargeted |
Musiu C, bioRxiv 2021 May;(): Musiu C, Cell Death Differ 2021 Sep 13;(): |
|||||||
Gt(ROSA)26Sortm1(rtTA,EGFP)Nagy | MGI:3583817 | Targeted | Conditional ready|Reporter|Transactivator | Wu J, Immunity 2021 Nov 9;54(11):2632-2649.e6 | J:323769 | Gene|Pathology | Gt(ROSA)26Sortm1(rtTA,EGFP)NagyTargeted |
Wu J, Immunity 2021 Nov 9;54(11):2632-2649.e6 |
|||||||
Gt(ROSA)26Sortm9(CAG-tdTomato)Hze | MGI:3809523 | Targeted | Conditional ready|Reporter | Sariol A, J Immunol 2022 Apr 15;208(8):1989-1997 | J:324704 | Infection|Mouse_Hepatitis_virus | Gt(ROSA)26Sortm9(CAG-tdTomato)HzeTargeted |
Sariol A, J Immunol 2022 Apr 15;208(8):1989-1997 |
|||||||
H2-Ab1b-tm1Doi | MGI:1927483 | Targeted | Null/knockout | Brentville VA, bioRxiv 2021 Jun;(): Houtman JJ, J Neurovirol 1996 APR;2(2):101-110 | J:308658 J:33974 | SARS-CoV-2_virus|Vaccine Mouse_Hepatitis_virus | H2-Ab1b-tm1DoiTargeted |
Brentville VA, bioRxiv 2021 Jun;(): Houtman JJ, J Neurovirol 1996 APR;2(2):101-110 |
|||||||
H2b | MGI:3579319 | Not Applicable | Bergmann CC, J Immunol 2001 Aug 1;167(3):1575-83 | J:120484 | Mouse_Hepatitis_virus | H2bNot Applicable |
Bergmann CC, J Immunol 2001 Aug 1;167(3):1575-83 |
||||||||
H2-Kbm1 | MGI:3618114 | Spontaneous | Khanolkar A, J Immunol 2010 Jul 15;185(2):1132-41 | J:161935 | Mouse_Hepatitis_virus|Pathology | H2-Kbm1Spontaneous |
Khanolkar A, J Immunol 2010 Jul 15;185(2):1132-41 |
||||||||
Hopxtm2.1(cre/ERT2)Joe | MGI:5300731 | Targeted | Inducible|Recombinase | Tang AT, PLoS Biol 2023 Feb;21(2):e3001989 | J:337814 | Pathology|SARS-CoV-2_virus|VOC_B.1.1.529_Omicron | Hopxtm2.1(cre/ERT2)JoeTargeted |
Tang AT, PLoS Biol 2023 Feb;21(2):e3001989 |
|||||||
Hrsq10C57BL/6J | MGI:6404145 | QTL | Gralinski LE, G3 (Bethesda) 2017 Jun 7;7(6):1653-1663 | J:270045 | Pathology|SARS-CoV-MA_virus | Hrsq10C57BL/6JQTL |
Gralinski LE, G3 (Bethesda) 2017 Jun 7;7(6):1653-1663 |
||||||||
Hrsq10PWK/PhJ | MGI:6404144 | QTL | Gralinski LE, G3 (Bethesda) 2017 Jun 7;7(6):1653-1663 | J:270045 | Pathology|SARS-CoV-MA_virus | Hrsq10PWK/PhJQTL |
Gralinski LE, G3 (Bethesda) 2017 Jun 7;7(6):1653-1663 |
||||||||
Hrsq11C57BL/6J | MGI:6404147 | QTL | Gralinski LE, G3 (Bethesda) 2017 Jun 7;7(6):1653-1663 | J:270045 | Pathology|SARS-CoV-MA_virus | Hrsq11C57BL/6JQTL |
Gralinski LE, G3 (Bethesda) 2017 Jun 7;7(6):1653-1663 |
||||||||
Hrsq11PWK/PhJ | MGI:6404146 | QTL | Gralinski LE, G3 (Bethesda) 2017 Jun 7;7(6):1653-1663 | J:270045 | Pathology|SARS-CoV-MA_virus | Hrsq11PWK/PhJQTL |
Gralinski LE, G3 (Bethesda) 2017 Jun 7;7(6):1653-1663 |
||||||||
Hrsq12C57BL/6J | MGI:6404149 | QTL | Gralinski LE, G3 (Bethesda) 2017 Jun 7;7(6):1653-1663 | J:270045 | Pathology|SARS-CoV-MA_virus | Hrsq12C57BL/6JQTL |
Gralinski LE, G3 (Bethesda) 2017 Jun 7;7(6):1653-1663 |
||||||||
Hrsq12PWK/PhJ | MGI:6404148 | QTL | Gralinski LE, G3 (Bethesda) 2017 Jun 7;7(6):1653-1663 | J:270045 | Pathology|SARS-CoV-MA_virus | Hrsq12PWK/PhJQTL |
Gralinski LE, G3 (Bethesda) 2017 Jun 7;7(6):1653-1663 |
||||||||
Hrsq1C57BL/6J | MGI:6403775 | QTL | Gralinski LE, PLoS Genet 2015 Oct;11(10):e1005504 | J:268979 | Infection|SARS-CoV-MA_virus | Hrsq1C57BL/6JQTL |
Gralinski LE, PLoS Genet 2015 Oct;11(10):e1005504 |
||||||||
Hrsq1WSB/EiJ | MGI:6403776 | QTL | Gralinski LE, PLoS Genet 2015 Oct;11(10):e1005504 | J:268979 | Infection|SARS-CoV-MA_virus | Hrsq1WSB/EiJQTL |
Gralinski LE, PLoS Genet 2015 Oct;11(10):e1005504 |
||||||||
Hrsq2PWK/PhJ | MGI:6403777 | QTL | Gralinski LE, PLoS Genet 2015 Oct;11(10):e1005504 | J:268979 | Infection|SARS-CoV-MA_virus | Hrsq2PWK/PhJQTL |
Gralinski LE, PLoS Genet 2015 Oct;11(10):e1005504 |
||||||||
Hrsq3A/J | MGI:6403778 | QTL | Gralinski LE, PLoS Genet 2015 Oct;11(10):e1005504 | J:268979 | Infection|SARS-CoV-MA_virus | Hrsq3A/JQTL |
Gralinski LE, PLoS Genet 2015 Oct;11(10):e1005504 |
||||||||
Hrsq4CAST/EiJ | MGI:6403779 | QTL | Gralinski LE, PLoS Genet 2015 Oct;11(10):e1005504 | J:268979 | Infection|SARS-CoV-MA_virus | Hrsq4CAST/EiJQTL |
Gralinski LE, PLoS Genet 2015 Oct;11(10):e1005504 |
||||||||
Hrsq5C57BL/6J | MGI:6404143 | QTL | Gralinski LE, G3 (Bethesda) 2017 Jun 7;7(6):1653-1663 | J:270045 | Pathology|SARS-CoV-MA_virus | Hrsq5C57BL/6JQTL |
Gralinski LE, G3 (Bethesda) 2017 Jun 7;7(6):1653-1663 |
||||||||
Hrsq5PWK/PhJ | MGI:6404142 | QTL | Gralinski LE, G3 (Bethesda) 2017 Jun 7;7(6):1653-1663 | J:270045 | Pathology|SARS-CoV-MA_virus | Hrsq5PWK/PhJQTL |
Gralinski LE, G3 (Bethesda) 2017 Jun 7;7(6):1653-1663 |
||||||||
Hrsq6C57BL/6J | MGI:6404175 | QTL | Gralinski LE, G3 (Bethesda) 2017 Jun 7;7(6):1653-1663 | J:270045 | Pathology|SARS-CoV-MA_virus | Hrsq6C57BL/6JQTL |
Gralinski LE, G3 (Bethesda) 2017 Jun 7;7(6):1653-1663 |
||||||||
Hrsq6WSB/EiJ | MGI:6404176 | QTL | Gralinski LE, G3 (Bethesda) 2017 Jun 7;7(6):1653-1663 | J:270045 | Pathology|SARS-CoV-MA_virus | Hrsq6WSB/EiJQTL |
Gralinski LE, G3 (Bethesda) 2017 Jun 7;7(6):1653-1663 |
||||||||
Hrsq7129S1/SvImJ | MGI:6404180 | QTL | Gralinski LE, G3 (Bethesda) 2017 Jun 7;7(6):1653-1663 | J:270045 | Pathology|SARS-CoV-MA_virus | Hrsq7129S1/SvImJQTL |
Gralinski LE, G3 (Bethesda) 2017 Jun 7;7(6):1653-1663 |
||||||||
Hrsq7C57BL/6J | MGI:6404178 | QTL | Gralinski LE, G3 (Bethesda) 2017 Jun 7;7(6):1653-1663 | J:270045 | Pathology|SARS-CoV-MA_virus | Hrsq7C57BL/6JQTL |
Gralinski LE, G3 (Bethesda) 2017 Jun 7;7(6):1653-1663 |
||||||||
Hrsq7PWK/PhJ | MGI:6404177 | QTL | Gralinski LE, G3 (Bethesda) 2017 Jun 7;7(6):1653-1663 | J:270045 | Pathology|SARS-CoV-MA_virus | Hrsq7PWK/PhJQTL |
Gralinski LE, G3 (Bethesda) 2017 Jun 7;7(6):1653-1663 |
||||||||
Hrsq7WSB/EiJ | MGI:6404182 | QTL | Gralinski LE, G3 (Bethesda) 2017 Jun 7;7(6):1653-1663 | J:270045 | Pathology|SARS-CoV-MA_virus | Hrsq7WSB/EiJQTL |
Gralinski LE, G3 (Bethesda) 2017 Jun 7;7(6):1653-1663 |
||||||||
Hrsq8CAST/EiJ | MGI:6404186 | QTL | Gralinski LE, G3 (Bethesda) 2017 Jun 7;7(6):1653-1663 | J:270045 | Pathology|SARS-CoV-MA_virus | Hrsq8CAST/EiJQTL |
Gralinski LE, G3 (Bethesda) 2017 Jun 7;7(6):1653-1663 |
||||||||
Hrsq8NOD/ShiLtJ | MGI:6404183 | QTL | Gralinski LE, G3 (Bethesda) 2017 Jun 7;7(6):1653-1663 | J:270045 | Pathology|SARS-CoV-MA_virus | Hrsq8NOD/ShiLtJQTL |
Gralinski LE, G3 (Bethesda) 2017 Jun 7;7(6):1653-1663 |
||||||||
Hrsq8WSB/EiJ | MGI:6404185 | QTL | Gralinski LE, G3 (Bethesda) 2017 Jun 7;7(6):1653-1663 | J:270045 | Pathology|SARS-CoV-MA_virus | Hrsq8WSB/EiJQTL |
Gralinski LE, G3 (Bethesda) 2017 Jun 7;7(6):1653-1663 |
||||||||
Hrsq9129S1/SvImJ | MGI:6404194 | QTL | Gralinski LE, G3 (Bethesda) 2017 Jun 7;7(6):1653-1663 | J:270045 | Pathology|SARS-CoV-MA_virus | Hrsq9129S1/SvImJQTL |
Gralinski LE, G3 (Bethesda) 2017 Jun 7;7(6):1653-1663 |
||||||||
Hrsq9CAST/EiJ | MGI:6404195 | QTL | Gralinski LE, G3 (Bethesda) 2017 Jun 7;7(6):1653-1663 | J:270045 | Pathology|SARS-CoV-MA_virus | Hrsq9CAST/EiJQTL |
Gralinski LE, G3 (Bethesda) 2017 Jun 7;7(6):1653-1663 |
||||||||
Hrsq9NOD/ShiLtJ | MGI:6404192 | QTL | Gralinski LE, G3 (Bethesda) 2017 Jun 7;7(6):1653-1663 | J:270045 | Pathology|SARS-CoV-MA_virus | Hrsq9NOD/ShiLtJQTL |
Gralinski LE, G3 (Bethesda) 2017 Jun 7;7(6):1653-1663 |
||||||||
Hrsq9NZO/HlLtJ | MGI:6404190 | QTL | Gralinski LE, G3 (Bethesda) 2017 Jun 7;7(6):1653-1663 | J:270045 | Pathology|SARS-CoV-MA_virus | Hrsq9NZO/HlLtJQTL |
Gralinski LE, G3 (Bethesda) 2017 Jun 7;7(6):1653-1663 |
||||||||
Hrsq9PWK/PhJ | MGI:6404189 | QTL | Gralinski LE, G3 (Bethesda) 2017 Jun 7;7(6):1653-1663 | J:270045 | Pathology|SARS-CoV-MA_virus | Hrsq9PWK/PhJQTL |
Gralinski LE, G3 (Bethesda) 2017 Jun 7;7(6):1653-1663 |
||||||||
Ido1tm1.1Mkks | MGI:5775113 | Targeted | Null/knockout | Grunewald ME, J Virol 2020 Jan 17;94(3): | J:290586 | Infection|Mouse_Hepatitis_virus | Ido1tm1.1MkksTargeted |
Grunewald ME, J Virol 2020 Jan 17;94(3): |
|||||||
Ido1tm1Alm | MGI:3505776 | Targeted | Null/knockout | McDermott JE, BMC Syst Biol 2016 Sep 23;10(1):93 | J:288523 | Pathology|SARS-CoV-MA_virus | Ido1tm1AlmTargeted |
McDermott JE, BMC Syst Biol 2016 Sep 23;10(1):93 |
|||||||
Ifih1tm1.1Cln | MGI:3663677 | Targeted | Null/knockout | Menachery VD, J Virol 2014 Apr;88(8):4251-64 Zalinger ZB, J Virol 2015 Dec 15;89(24):12330-40 Deng X, Proc Natl Acad Sci U S A 2017 May 23;114(21):E4251-E4260 Zheng M, Nat Immunol 2021 Jul;22(7):829-838 | J:213001 J:227926 J:242293 J:308903 | SARS-CoV-MA_virus|SARS-CoV_virus|Treatment|Vaccine Infection|Mouse_Hepatitis_virus Pathology|SARS-CoV-2_virus | Ifih1tm1.1ClnTargeted |
Menachery VD, J Virol 2014 Apr;88(8):4251-64 Zalinger ZB, J Virol 2015 Dec 15;89(24):12330-40 Deng X, Proc Natl Acad Sci U S A 2017 May 23;114(21):E4251-E4260 Zheng M, Nat Immunol 2021 Jul;22(7):829-838 |
|||||||
Ifih1tm1Aki | MGI:3801032 | Targeted | Null/knockout | Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 | J:296686 | Pathology|SARS-CoV-2_virus|Treatment | Ifih1tm1AkiTargeted |
Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 |
|||||||
Ifit1tm1(KOMP)Vlcg | MGI:3808310 | Targeted | Null/knockout|Reporter | MGI:6436931 | growth/size/body hematopoietic system homeostasis/metabolism immune system nervous system mortality/aging | MP:0005378 MP:0005397 MP:0005376 MP:0005387 MP:0003631 MP:0010768 | Daffis S, Nature 2010 Nov 18;468(7322):452-6 Butchi NB, J Virol 2014 Jan;88(2):1051-64 Menachery VD, J Virol 2014 Apr;88(8):4251-64 | J:187561 J:205203 J:213001 | Mouse_Hepatitis_virus SARS-CoV-MA_virus|SARS-CoV_virus|Treatment|Vaccine | Ifit1tm1(KOMP)VlcgTargeted |
MGI:6436931 | growth/size/body hematopoietic system homeostasis/metabolism immune system nervous system mortality/aging |
Daffis S, Nature 2010 Nov 18;468(7322):452-6 Butchi NB, J Virol 2014 Jan;88(2):1051-64 Menachery VD, J Virol 2014 Apr;88(8):4251-64 |
||
Ifit2tm1(KOMP)Vlcg | MGI:3799963 | Targeted | Null/knockout|Reporter | Das Sarma J, PLoS Pathog 2020 Nov;16(11):e1009034 | J:313166 | Mouse_Hepatitis_virus | Ifit2tm1(KOMP)VlcgTargeted |
Das Sarma J, PLoS Pathog 2020 Nov;16(11):e1009034 |
|||||||
Ifitm3em1Jsy | MGI:6362958 | Endonuclease-mediated | Null/knockout | Zani A, bioRxiv 2021Dec;(): | J:316764 | Gene|SARS-CoV-2-MA_virus|SARS-CoV-2_virus | Ifitm3em1JsyEndonuclease-mediated |
Zani A, bioRxiv 2021Dec;(): |
|||||||
Ifnar1tm1.1Ees | MGI:5692160 | Targeted | Conditional ready|No functional change | Anand G, bioRxiv 2020 Dec;(): | J:298270 | Pathology|SARS-CoV-2_virus | Ifnar1tm1.1EesTargeted |
Anand G, bioRxiv 2020 Dec;(): |
|||||||
Ifnar1tm1.2Ees | MGI:5692167 | Targeted | Null/knockout | Israelow B, J Exp Med 2020 Dec 7;217(12): Sun J, Cell 2020 Jun 10;(): Mao T, bioRxiv 2021 Jun;(): | J:291862 J:291881 J:308656 | Infection|Pathology|SARS-CoV-2_virus Infection|Pathology|SARS-CoV-2_virus|Treatment Treatment|VOC_B.1.1.7_Alpha|VOC_B.1.351_Beta|VOC_P.1_Gamma | Ifnar1tm1.2EesTargeted |
Israelow B, J Exp Med 2020 Dec 7;217(12): Sun J, Cell 2020 Jun 10;(): Mao T, bioRxiv 2021 Jun;(): |
|||||||
Ifnar1tm1Agt | MGI:1930950 | Targeted | Null/knockout | MGI:2654514 MGI:3575517 MGI:6449667 | behavior/neurological cardiovascular system hematopoietic system homeostasis/metabolism immune system liver/biliary system vision/eye mortality/aging cellular | MP:0005386 MP:0005385 MP:0005397 MP:0005376 MP:0005387 MP:0005370 MP:0005391 MP:0010768 MP:0005384 | Cervantes-Barragan L, J Immunol 2009 Jan 15;182(2):1099-106 Cervantes-Barragan L, Blood 2007 Feb 1;109(3):1131-7 Ireland DD, J Virol 2008 Jan;82(1):300-10 Phares TW, J Immunol 2009 May 1;182(9):5430-8 Daffis S, Nature 2010 Nov 18;468(7322):452-6 Zhao J, Proc Natl Acad Sci U S A 2014 Apr 1;111(13):4970-5 Menachery VD, J Virol 2014 Apr;88(8):4251-64 Deng X, J Virol 2014 Oct 15;88(20):11886-98 Fehr AR, J Virol 2015 Feb;89(3):1523-36 Deng X, Proc Natl Acad Sci U S A 2017 May 23;114(21):E4251-E4260 Peng X, mBio 2010 Oct 26;1(5): Frieman MB, PLoS Pathog 2010 Apr 8;6(4):e1000849 Hassan AO, Cell 2020 Jun 10;(): Channappanavar R, Cell Host Microbe 2016 Feb 10;19(2):181-93 Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Miner JJ, Cell Rep 2020 Nov 3;33(5):108339 Horner C, Proc Natl Acad Sci U S A 2020 Dec 22;117(51):32657-32666 Malczyk AH, J Virol 2015 Nov;89(22):11654-67 Xiao Y, Cell 2021 Dec 9;184(25):6037-6051.e14 Hassert M, PLoS Pathog 2020 Dec;16(12):e1009163 | J:143484 J:144400 J:145215 J:147948 J:187561 J:207380 J:213001 J:214600 J:221981 J:242293 J:276986 J:286237 J:290258 J:291874 J:296686 J:300094 J:300105 J:312515 J:317125 J:319459 | Mouse_Hepatitis_virus Infection|Mouse_Hepatitis_virus|SARS-CoV_virus Infection|Mouse_Hepatitis_virus MERS-CoV_virus SARS-CoV-MA_virus|SARS-CoV_virus|Treatment|Vaccine Mouse_Hepatitis_virus|Pathology Infection|SARS-CoV-MA_virus Pathology|SARS-CoV-MA_virus Infection|SARS-CoV-2_virus|Treatment Gene|Infection|Pathology|SARS-CoV-MA_virus Pathology|SARS-CoV-2_virus|Treatment SARS-CoV-2_virus SARS-CoV-2_virus|Vaccine MERS-CoV_virus|Vaccine SARS-CoV-2_virus|Treatment|VOC_B.1.1.7_Alpha|VOC_B.1.427|VOC_B.1.617.2_Delta Infection|SARS-CoV-2_virus | Ifnar1tm1AgtTargeted |
MGI:2654514 MGI:3575517 MGI:6449667 | behavior/neurological cardiovascular system hematopoietic system homeostasis/metabolism immune system liver/biliary system vision/eye mortality/aging cellular |
Cervantes-Barragan L, J Immunol 2009 Jan 15;182(2):1099-106 Cervantes-Barragan L, Blood 2007 Feb 1;109(3):1131-7 Ireland DD, J Virol 2008 Jan;82(1):300-10 Phares TW, J Immunol 2009 May 1;182(9):5430-8 Daffis S, Nature 2010 Nov 18;468(7322):452-6 Zhao J, Proc Natl Acad Sci U S A 2014 Apr 1;111(13):4970-5 Menachery VD, J Virol 2014 Apr;88(8):4251-64 Deng X, J Virol 2014 Oct 15;88(20):11886-98 Fehr AR, J Virol 2015 Feb;89(3):1523-36 Deng X, Proc Natl Acad Sci U S A 2017 May 23;114(21):E4251-E4260 Peng X, mBio 2010 Oct 26;1(5): Frieman MB, PLoS Pathog 2010 Apr 8;6(4):e1000849 Hassan AO, Cell 2020 Jun 10;(): Channappanavar R, Cell Host Microbe 2016 Feb 10;19(2):181-93 Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Miner JJ, Cell Rep 2020 Nov 3;33(5):108339 Horner C, Proc Natl Acad Sci U S A 2020 Dec 22;117(51):32657-32666 Malczyk AH, J Virol 2015 Nov;89(22):11654-67 Xiao Y, Cell 2021 Dec 9;184(25):6037-6051.e14 Hassert M, PLoS Pathog 2020 Dec;16(12):e1009163 |
||
Ifnar1tm1Pjh | MGI:2667975 | Targeted | Null/knockout | Rawle DJ, bioRxiv 2021 Feb;(): Ogger PP, Eur J Immunol 2022 Nov;52(11):1768-1775 | J:302157 J:333792 | SARS-CoV-2_virus Infection|SARS-CoV-2_virus | Ifnar1tm1PjhTargeted |
Rawle DJ, bioRxiv 2021 Feb;(): Ogger PP, Eur J Immunol 2022 Nov;52(11):1768-1775 |
|||||||
Ifnar1tm1Uka | MGI:2655303 | Targeted | Conditional ready|No functional change | Cervantes-Barragan L, J Immunol 2009 Jan 15;182(2):1099-106 | J:143484 | Mouse_Hepatitis_virus | Ifnar1tm1UkaTargeted |
Cervantes-Barragan L, J Immunol 2009 Jan 15;182(2):1099-106 |
|||||||
Ifnar2tm1Pjh | MGI:2680693 | Targeted | Null/knockout | Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Rawle DJ, bioRxiv 2021 Feb;(): | J:296686 J:302157 | Pathology|SARS-CoV-2_virus|Treatment SARS-CoV-2_virus | Ifnar2tm1PjhTargeted |
Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Rawle DJ, bioRxiv 2021 Feb;(): |
|||||||
Ifngr1tm1Agt | MGI:1857286 | Targeted | Null/knockout | MGI:3575517 MGI:6403197 | hematopoietic system immune system mortality/aging | MP:0005397 MP:0005387 MP:0010768 | Templeton SP, J Neuroimmunol 2008 Feb;194(1-2):18-26 Frieman MB, PLoS Pathog 2010 Apr 8;6(4):e1000849 Hassan AO, Cell 2020 Jun 10;(): Miner JJ, Cell Rep 2020 Nov 3;33(5):108339 Schijns VE, J Immunol 1996 Jul 15;157(2):815-21 | J:131907 J:286237 J:290258 J:300094 J:34040 | Mouse_Hepatitis_virus Pathology|SARS-CoV-MA_virus Infection|SARS-CoV-2_virus|Treatment SARS-CoV-2_virus | Ifngr1tm1AgtTargeted |
MGI:3575517 MGI:6403197 | hematopoietic system immune system mortality/aging |
Templeton SP, J Neuroimmunol 2008 Feb;194(1-2):18-26 Frieman MB, PLoS Pathog 2010 Apr 8;6(4):e1000849 Hassan AO, Cell 2020 Jun 10;(): Miner JJ, Cell Rep 2020 Nov 3;33(5):108339 Schijns VE, J Immunol 1996 Jul 15;157(2):815-21 |
||
Ifngtm1Ts | MGI:1857184 | Targeted | Null/knockout | MGI:4365971 | endocrine/exocrine glands hematopoietic system immune system neoplasm mortality/aging | MP:0005379 MP:0005397 MP:0005387 MP:0002006 MP:0010768 | Parra B, J Immunol 1999 Feb 1;162(3):1641-7 Phares TW, J Immunol 2009 May 1;182(9):5430-8 Malone KE, Glia 2008 Mar;56(4):426-35 Sun J, Cell 2020 Jun 10;(): Savarin C, J Neuroinflammation 2012 May 29;9():104 France MP, Aust Vet J 1999 Sep;77(9):600-4 Dandekar AA, Am J Pathol 2004 Feb;164(2):363-9 | J:112048 J:147948 J:156284 J:291881 J:331807 J:59661 J:88552 | Infection|Mouse_Hepatitis_virus Mouse_Hepatitis_virus Infection|Pathology|SARS-CoV-2_virus|Treatment Mouse_Hepatitis_virus|Pathology | Ifngtm1TsTargeted |
MGI:4365971 | endocrine/exocrine glands hematopoietic system immune system neoplasm mortality/aging |
Parra B, J Immunol 1999 Feb 1;162(3):1641-7 Phares TW, J Immunol 2009 May 1;182(9):5430-8 Malone KE, Glia 2008 Mar;56(4):426-35 Sun J, Cell 2020 Jun 10;(): Savarin C, J Neuroinflammation 2012 May 29;9():104 France MP, Aust Vet J 1999 Sep;77(9):600-4 Dandekar AA, Am J Pathol 2004 Feb;164(2):363-9 |
||
Ifngtm1Yiw | MGI:3036127 | Targeted | Null/knockout | MGI:6430478 MGI:6430488 | behavior/neurological cellular digestive/alimentary system growth/size/body homeostasis/metabolism immune system liver/biliary system mortality/aging | MP:0005386 MP:0005384 MP:0005381 MP:0005378 MP:0005376 MP:0005387 MP:0005370 MP:0010768 | Kyuwa S, J Virol 1998 Nov;72(11):9286-90 Kyuwa S, Virus Res 2002 Feb 26;83(1-2):169-77 | J:50405 J:91691 | Mouse_Hepatitis_virus|Pathology Infection|Mouse_Hepatitis_virus|Pathology | Ifngtm1YiwTargeted |
MGI:6430478 MGI:6430488 | behavior/neurological cellular digestive/alimentary system growth/size/body homeostasis/metabolism immune system liver/biliary system mortality/aging |
Kyuwa S, J Virol 1998 Nov;72(11):9286-90 Kyuwa S, Virus Res 2002 Feb 26;83(1-2):169-77 |
||
Ifnl2tm1.1Arte | MGI:7493919 | Targeted | No functional change|Reporter | Chong Z, Cell Rep 2022 May 10;39(6):110799 | J:325089 | SARS-CoV-2_virus|Treatment|VOC_B.1.1.529_Omicron|VOC_B.1.351_Beta | Ifnl2tm1.1ArteTargeted |
Chong Z, Cell Rep 2022 May 10;39(6):110799 |
|||||||
Ifnlr1tm1Palu | MGI:3775762 | Targeted | Null/knockout | MGI:6403849 | immune system | MP:0005387 | Frieman MB, PLoS Pathog 2010 Apr 8;6(4):e1000849 Miner JJ, Cell Rep 2020 Nov 3;33(5):108339 Chong Z, bioRxiv 2022;(): Chong Z, Cell Rep 2022 May 10;39(6):110799 | J:286237 J:300094 J:321761 J:325089 | Pathology|SARS-CoV-MA_virus SARS-CoV-2_virus SARS-CoV-2_virus|Treatment|VOC_B.1.1.529_Omicron|VOC_B.1.351_Beta | Ifnlr1tm1PaluTargeted |
MGI:6403849 | immune system |
Frieman MB, PLoS Pathog 2010 Apr 8;6(4):e1000849 Miner JJ, Cell Rep 2020 Nov 3;33(5):108339 Chong Z, bioRxiv 2022;(): Chong Z, Cell Rep 2022 May 10;39(6):110799 |
||
Ighem1Rcas | MGI:6725128 | Endonuclease-mediated | Inserted expressed sequence | Xu J, Nature 2021 Jun 7;(): | J:307753 | SARS-CoV-2_virus|Treatment|VOC_B.1.1.7_Alpha|VOC_B.1.351_Beta|VOC_P.1_Gamma | Ighem1RcasEndonuclease-mediated |
Xu J, Nature 2021 Jun 7;(): |
|||||||
Igh-Jtm1Dhu | MGI:2158307 | Targeted | Null/knockout | Afkhami S, bioRxiv 2021 Jul;(): | J:308640 | SARS-CoV-2_virus|Vaccine|VOC_B.1.1.7_Alpha|VOC_B.1.351_Beta | Igh-Jtm1DhuTargeted |
Afkhami S, bioRxiv 2021 Jul;(): |
|||||||
Ighmtm1Cgn | MGI:1857187 | Targeted | Null/knockout | Bergmann CC, J Immunol 2001 Aug 1;167(3):1575-83 Zhao J, Proc Natl Acad Sci U S A 2014 Apr 1;111(13):4970-5 Israelow B, bioRxiv 2021 May;(): Sarden N, Sci Transl Med 2022 Dec 7;14(674):eabq6682 | J:120484 J:207380 J:308733 J:336666 | Mouse_Hepatitis_virus MERS-CoV_virus Infection|SARS-CoV-2_virus Comorbidity|SARS-CoV-2_virus | Ighmtm1CgnTargeted |
Bergmann CC, J Immunol 2001 Aug 1;167(3):1575-83 Zhao J, Proc Natl Acad Sci U S A 2014 Apr 1;111(13):4970-5 Israelow B, bioRxiv 2021 May;(): Sarden N, Sci Transl Med 2022 Dec 7;14(674):eabq6682 |
|||||||
Ightm3.1(VRC01)Nemz | MGI:5779356 | Targeted | Inserted expressed sequence | Luo Y, Signal Transduct Target Ther 2022 Jan 4;7(1):7 | J:333746 | SARS-CoV-2_virus|Vaccine | Ightm3.1(VRC01)NemzTargeted |
Luo Y, Signal Transduct Target Ther 2022 Jan 4;7(1):7 |
|||||||
Igs2em1(KRT18-ACE2)Gpt | MGI:6452440 | Endonuclease-mediated | Inserted expressed sequence | Yu S, Proc Natl Acad Sci U S A 2022 Jan 4;119(1):e2111199119 Yuan Y, bioRxiv 2022 Feb;(): | J:318831 J:321891 | Infection|SARS-CoV-2_virus Vaccine|VOC_B.1.617.2_Delta | Igs2em1(KRT18-ACE2)GptEndonuclease-mediated |
Yu S, Proc Natl Acad Sci U S A 2022 Jan 4;119(1):e2111199119 Yuan Y, bioRxiv 2022 Feb;(): |
|||||||
Ikbkbtm2Mka | MGI:2445462 | Targeted | Conditional ready|No functional change | Satta S, Theranostics 2022;12(6):2639-2657 | J:331825 | SARS-CoV-2_virus|Variant | Ikbkbtm2MkaTargeted |
Satta S, Theranostics 2022;12(6):2639-2657 |
|||||||
Ikbkgtm1.1Mpa | MGI:2679024 | Targeted | Conditional ready|No functional change | Wenzel J, Nat Neurosci 2021 Nov;24(11):1522-1533 | J:323957 | Pathology|SARS-CoV-2_virus|VOC_B.1.351_Beta | Ikbkgtm1.1MpaTargeted |
Wenzel J, Nat Neurosci 2021 Nov;24(11):1522-1533 |
|||||||
Il10tm1.1Karp | MGI:4355198 | Targeted | Reporter | Trandem K, J Immunol 2011 Mar 15;186(6):3642-52 | J:169759 | Mouse_Hepatitis_virus|Pathology | Il10tm1.1KarpTargeted |
Trandem K, J Immunol 2011 Mar 15;186(6):3642-52 |
|||||||
Il10tm1Cgn | MGI:1857199 | Targeted | Null/knockout | Trandem K, J Immunol 2011 Mar 15;186(6):3642-52 Puntambekar SS, Glia 2015 Jun 30;(): | J:169759 J:225834 | Mouse_Hepatitis_virus|Pathology Mouse_Hepatitis_virus | Il10tm1CgnTargeted |
Trandem K, J Immunol 2011 Mar 15;186(6):3642-52 Puntambekar SS, Glia 2015 Jun 30;(): |
|||||||
Il17aem1Cya | MGI:6695195 | Endonuclease-mediated | Null/knockout | Lin X, iScience 2021 Apr 23;24(4):102293 | J:304178 | Pathology|SARS-CoV-2_virus|Treatment | Il17aem1CyaEndonuclease-mediated |
Lin X, iScience 2021 Apr 23;24(4):102293 |
|||||||
Il18r1tm1Aki | MGI:2136765 | Targeted | Null/knockout | Sheahan T, PLoS Pathog 2008 Dec;4(12):e1000240 Zalinger ZB, J Neurovirol 2017 Dec;23(6):845-854 | J:162707 J:331829 | Pathology|SARS-CoV-MA_virus Mouse_Hepatitis_virus | Il18r1tm1AkiTargeted |
Sheahan T, PLoS Pathog 2008 Dec;4(12):e1000240 Zalinger ZB, J Neurovirol 2017 Dec;23(6):845-854 |
|||||||
Il1r1tm1Imx | MGI:1861112 | Targeted | Null/knockout | Sheahan T, PLoS Pathog 2008 Dec;4(12):e1000240 Zalinger ZB, J Neurovirol 2017 Dec;23(6):845-854 | J:162707 J:331829 | Pathology|SARS-CoV-MA_virus Mouse_Hepatitis_virus | Il1r1tm1ImxTargeted |
Sheahan T, PLoS Pathog 2008 Dec;4(12):e1000240 Zalinger ZB, J Neurovirol 2017 Dec;23(6):845-854 |
|||||||
Il2rgem26Gpt | MGI:5827573 | Endonuclease-mediated | Not Specified | Hu Z, bioRxiv 2021 Nov;(): | J:313461 | Infection|SARS-CoV-2_virus | Il2rgem26GptEndonuclease-mediated |
Hu Z, bioRxiv 2021 Nov;(): |
|||||||
Il2rgtm1.1Flv | MGI:4887837 | Targeted | Null/knockout | Sefik E, bioRxiv 2021;(): | J:311907 | SARS-CoV-2_virus | Il2rgtm1.1FlvTargeted |
Sefik E, bioRxiv 2021;(): |
|||||||
Il2rgtm1Wjl | MGI:1857455 | Targeted | Null/knockout | Halwe S, bioRxiv 2021 Jun;(): | J:308648 | SARS-CoV-2_virus|Treatment|VOC_B.1.1.7_Alpha|VOC_B.1.351_Beta | Il2rgtm1WjlTargeted |
Halwe S, bioRxiv 2021 Jun;(): |
|||||||
Il6tm1Kopf | MGI:1857197 | Targeted | Null/knockout | MGI:3837132 | hematopoietic system homeostasis/metabolism immune system liver/biliary system nervous system mortality/aging | MP:0005397 MP:0005376 MP:0005387 MP:0005370 MP:0003631 MP:0010768 | Imai Y, Cell 2008 Apr 18;133(2):235-49 Kumaki Y, Antiviral Res 2017 Mar;139():1-12 Ndeupen S, bioRxiv 2021 Aug;(): Alameh MG, Immunity 2021 Dec 14;54(12):2877-2892.e7 | J:145306 J:286953 J:308580 J:337329 | SARS-CoV_virus SARS-CoV-MA_virus|SARS-CoV_virus|Treatment SARS-CoV-2_virus|Vaccine | Il6tm1KopfTargeted |
MGI:3837132 | hematopoietic system homeostasis/metabolism immune system liver/biliary system nervous system mortality/aging |
Imai Y, Cell 2008 Apr 18;133(2):235-49 Kumaki Y, Antiviral Res 2017 Mar;139():1-12 Ndeupen S, bioRxiv 2021 Aug;(): Alameh MG, Immunity 2021 Dec 14;54(12):2877-2892.e7 |
||
Il6tm2(IL6)Flv | MGI:6405713 | Targeted | Humanized sequence|Inserted expressed sequence|Null/knockout | Sefik E, bioRxiv 2021;(): | J:311907 | SARS-CoV-2_virus | Il6tm2(IL6)FlvTargeted |
Sefik E, bioRxiv 2021;(): |
|||||||
Irf1tm1Mak | MGI:1857205 | Targeted | Null/knockout | Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 | J:296686 | Pathology|SARS-CoV-2_virus|Treatment | Irf1tm1MakTargeted |
Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 |
|||||||
Irf3tm1Ttg | MGI:3577601 | Targeted | Null/knockout | Imai Y, Cell 2008 Apr 18;133(2):235-49 Daffis S, Nature 2010 Nov 18;468(7322):452-6 Israelow B, J Exp Med 2020 Dec 7;217(12): Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 | J:145306 J:187561 J:291862 J:296686 | SARS-CoV_virus Mouse_Hepatitis_virus Infection|Pathology|SARS-CoV-2_virus Pathology|SARS-CoV-2_virus|Treatment | Irf3tm1TtgTargeted |
Imai Y, Cell 2008 Apr 18;133(2):235-49 Daffis S, Nature 2010 Nov 18;468(7322):452-6 Israelow B, J Exp Med 2020 Dec 7;217(12): Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 |
|||||||
Irf5tm1Ppr | MGI:5291913 | Targeted | Conditional ready|No functional change | Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 | J:296686 | Pathology|SARS-CoV-2_virus|Treatment | Irf5tm1PprTargeted |
Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 |
|||||||
Irf7tm1Ttg | MGI:3577089 | Targeted | Null/knockout | Daffis S, Nature 2010 Nov 18;468(7322):452-6 Israelow B, J Exp Med 2020 Dec 7;217(12): Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 | J:187561 J:291862 J:296686 | Mouse_Hepatitis_virus Infection|Pathology|SARS-CoV-2_virus Pathology|SARS-CoV-2_virus|Treatment | Irf7tm1TtgTargeted |
Daffis S, Nature 2010 Nov 18;468(7322):452-6 Israelow B, J Exp Med 2020 Dec 7;217(12): Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 |
|||||||
Irf9tm1Ttg | MGI:2446102 | Targeted | Null/knockout | Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 | J:296686 | Pathology|SARS-CoV-2_virus|Treatment | Irf9tm1TtgTargeted |
Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 |
|||||||
Kctd9em1Beij | MGI:6382731 | Endonuclease-mediated | Null/knockout | MGI:6382782 | hematopoietic system homeostasis/metabolism immune system mortality/aging | MP:0005397 MP:0005376 MP:0005387 MP:0010768 | Zhang X, Front Immunol 2019;10():744 | J:281803 | Mouse_Hepatitis_virus | Kctd9em1BeijEndonuclease-mediated |
MGI:6382782 | hematopoietic system homeostasis/metabolism immune system mortality/aging |
Zhang X, Front Immunol 2019;10():744 |
||
Ldlrtm1Her | MGI:1857212 | Targeted | Null/knockout | Ensor CM, bioRxiv 2021-09;(): | J:310122 | SARS-CoV-2_virus | Ldlrtm1HerTargeted |
Ensor CM, bioRxiv 2021-09;(): |
|||||||
Leprdb | MGI:1856009 | Spontaneous | Choi JY, Biochem Biophys Res Commun 2020 Jul 30;528(3):413-419 Vergara A, Mol Cell Endocrinol 2021 Jun 1;529():111263 | J:292007 J:308897 | Gene Comorbidity | LeprdbSpontaneous |
Choi JY, Biochem Biophys Res Commun 2020 Jul 30;528(3):413-419 Vergara A, Mol Cell Endocrinol 2021 Jun 1;529():111263 |
||||||||
Ltb4r1tm1Adl | MGI:2385786 | Targeted | Null/knockout | Sarden N, Sci Transl Med 2022 Dec 7;14(674):eabq6682 | J:336666 | Comorbidity|SARS-CoV-2_virus | Ltb4r1tm1AdlTargeted |
Sarden N, Sci Transl Med 2022 Dec 7;14(674):eabq6682 |
|||||||
Ly6etm1a(EUCOMM)Hmgu | MGI:5428615 | Targeted | Conditional ready|Null/knockout|Reporter | Pfaender S, Nat Microbiol 2020 Jul 23;(): | J:291868 | Gene|HCoV-229E_virus|HCoV-OC43_virus|MERS-CoV_virus|Mouse_Hepatitis_virus|SARS-CoV-2_virus|SARS-CoV_virus | Ly6etm1a(EUCOMM)HmguTargeted |
Pfaender S, Nat Microbiol 2020 Jul 23;(): |
|||||||
Ly6etm1c(EUCOMM)Hmgu | MGI:6448980 | Targeted | Conditional ready | Pfaender S, Nat Microbiol 2020 Jul 23;(): | J:291868 | Gene|HCoV-229E_virus|HCoV-OC43_virus|MERS-CoV_virus|Mouse_Hepatitis_virus|SARS-CoV-2_virus|SARS-CoV_virus | Ly6etm1c(EUCOMM)HmguTargeted |
Pfaender S, Nat Microbiol 2020 Jul 23;(): |
|||||||
Lystbg-J | MGI:1855969 | Spontaneous | Glass WG, J Immunol 2004 Sep 15;173(6):4030-9 | J:92752 | Infection|SARS-CoV_virus | Lystbg-JSpontaneous |
Glass WG, J Immunol 2004 Sep 15;173(6):4030-9 |
||||||||
Lyz2tm1(cre)Ifo | MGI:1934631 | Targeted | Recombinase | Cervantes-Barragan L, J Immunol 2009 Jan 15;182(2):1099-106 Imai Y, Cell 2008 Apr 18;133(2):235-49 Zhao Z, Autophagy 2007 Nov-Dec;3(6):581-5 Page C, J Virol 2012 Dec;86(24):13334-49 Musiu C, bioRxiv 2021 May;(): Melvin WJ, Proc Natl Acad Sci U S A 2021 Sep 21;118(38):e2101071118 Musiu C, Cell Death Differ 2021 Sep 13;(): Verma AK, mBio 2021 Oct 26;12(5):e0196921 Wang Y, Sci Adv 2021 Jan;7(1): de Almeida L, Sci Adv 2022 Sep 16;8(37):eabo5400 Satta S, Theranostics 2022;12(6):2639-2657 | J:143484 J:145306 J:282479 J:286337 J:308717 J:311033 J:313338 J:313438 J:314537 J:331763 J:331825 | Mouse_Hepatitis_virus SARS-CoV_virus Pathology|SARS-CoV_virus SARS-CoV-2_virus Comorbidity|Gene|Mouse_Hepatitis_virus Pathology|SARS-CoV-2_virus SARS-CoV-2_virus|Variant | Lyz2tm1(cre)IfoTargeted |
Cervantes-Barragan L, J Immunol 2009 Jan 15;182(2):1099-106 Imai Y, Cell 2008 Apr 18;133(2):235-49 Zhao Z, Autophagy 2007 Nov-Dec;3(6):581-5 Page C, J Virol 2012 Dec;86(24):13334-49 Musiu C, bioRxiv 2021 May;(): Melvin WJ, Proc Natl Acad Sci U S A 2021 Sep 21;118(38):e2101071118 Musiu C, Cell Death Differ 2021 Sep 13;(): Verma AK, mBio 2021 Oct 26;12(5):e0196921 Wang Y, Sci Adv 2021 Jan;7(1): de Almeida L, Sci Adv 2022 Sep 16;8(37):eabo5400 Satta S, Theranostics 2022;12(6):2639-2657 |
|||||||
Mavstm1Aki | MGI:3773161 | Targeted | Null/knockout | Zhao J, Proc Natl Acad Sci U S A 2014 Apr 1;111(13):4970-5 Channappanavar R, J Clin Invest 2019 Jul 29;130():3625-3639 Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Zheng M, Nat Immunol 2021 Jul;22(7):829-838 | J:207380 J:288107 J:296686 J:308903 | MERS-CoV_virus Infection|MERS-CoV-MA_virus|Treatment Pathology|SARS-CoV-2_virus|Treatment Pathology|SARS-CoV-2_virus | Mavstm1AkiTargeted |
Zhao J, Proc Natl Acad Sci U S A 2014 Apr 1;111(13):4970-5 Channappanavar R, J Clin Invest 2019 Jul 29;130():3625-3639 Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Zheng M, Nat Immunol 2021 Jul;22(7):829-838 |
|||||||
Mavstm1Zjc | MGI:3654145 | Targeted | Null/knockout | Alameh MG, Immunity 2021 Dec 14;54(12):2877-2892.e7 | J:337329 | SARS-CoV-2_virus|Vaccine | Mavstm1ZjcTargeted |
Alameh MG, Immunity 2021 Dec 14;54(12):2877-2892.e7 |
|||||||
Mbd2em1Wgcy | MGI:6825813 | Endonuclease-mediated | Conditional ready|No functional change | Wang Y, Sci Adv 2021 Jan;7(1): | J:314537 | SARS-CoV-2_virus | Mbd2em1WgcyEndonuclease-mediated |
Wang Y, Sci Adv 2021 Jan;7(1): |
|||||||
Mcph1Tg(HLA-A2.1)1Enge | MGI:3056375 | Transgenic | Humanized sequence|Inserted expressed sequence|Null/knockout | Carter B, bioRxiv 2021 May;(): | J:308712 | SARS-CoV-2_virus|Vaccine | Mcph1Tg(HLA-A2.1)1EngeTransgenic |
Carter B, bioRxiv 2021 May;(): |
|||||||
Mlkltm1.2Wsa | MGI:5614464 | Targeted | Null/knockout | Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Zheng M, J Biol Chem 2020 Oct 9;295(41):14040-14052 | J:296686 J:298138 | Pathology|SARS-CoV-2_virus|Treatment Mouse_Hepatitis_virus | Mlkltm1.2WsaTargeted |
Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Zheng M, J Biol Chem 2020 Oct 9;295(41):14040-14052 |
|||||||
Mmp14tm1Ktry | MGI:2386246 | Targeted | Null/knockout | Guo X, Nat Commun 2022 Dec 23;13(1):7907 | J:333743 | SARS-CoV-2_virus | Mmp14tm1KtryTargeted |
Guo X, Nat Commun 2022 Dec 23;13(1):7907 |
|||||||
Muc16tm1Bhr | MGI:3840843 | Targeted | Null/knockout | Biering SB, Nat Genet 2022 Aug;54(8):1078-1089 | J:331758 | SARS-CoV-2-MA_virus|SARS-CoV-2_virus | Muc16tm1BhrTargeted |
Biering SB, Nat Genet 2022 Aug;54(8):1078-1089 |
|||||||
Muc1tm1Gend | MGI:2447730 | Targeted | Null/knockout | Biering SB, Nat Genet 2022 Aug;54(8):1078-1089 | J:331758 | SARS-CoV-2-MA_virus|SARS-CoV-2_virus | Muc1tm1GendTargeted |
Biering SB, Nat Genet 2022 Aug;54(8):1078-1089 |
|||||||
Muc4PWK/PhJ | MGI:6423091 | Not Applicable | Hypomorph | MGI:6423103 | immune system | MP:0005387 | Plante JA, bioRxiv 2020;(): | J:287566 | Infection|SARS-CoV-MA_virus|Sex_bias | Muc4PWK/PhJNot Applicable |
MGI:6423103 | immune system |
Plante JA, bioRxiv 2020;(): |
||
Muc4tm1Unc | MGI:6416171 | Targeted | Null/knockout | MGI:6423102 | Coronavirus infectious disease | DOID:0080599 | growth/size/body immune system respiratory system mortality/aging | MP:0005378 MP:0005387 MP:0005388 MP:0010768 | Plante JA, bioRxiv 2020;(): Biering SB, Nat Genet 2022 Aug;54(8):1078-1089 | J:287566 J:331758 | Infection|SARS-CoV-MA_virus|Sex_bias SARS-CoV-2-MA_virus|SARS-CoV-2_virus | Muc4tm1UncTargeted |
MGI:6423102 | growth/size/body immune system respiratory system mortality/aging Coronavirus infectious disease |
Plante JA, bioRxiv 2020;(): Biering SB, Nat Genet 2022 Aug;54(8):1078-1089 |
Mx1tm1.1Agsa | MGI:6275981 | Targeted | Inducible|Inserted expressed sequence|Null/knockout|Reporter | Anand G, bioRxiv 2020 Dec;(): | J:298270 | Pathology|SARS-CoV-2_virus | Mx1tm1.1AgsaTargeted |
Anand G, bioRxiv 2020 Dec;(): |
|||||||
Myd88tm1.1Defr | MGI:4421295 | Targeted | Null/knockout | MGI:6272304 | behavior/neurological hematopoietic system immune system nervous system mortality/aging | MP:0005386 MP:0005397 MP:0005387 MP:0003631 MP:0010768 | Butchi N, J Virol 2015 Sep 15;89(18):9299-312 Khan S, bioRxiv 2021 Mar;(): Alameh MG, Immunity 2021 Dec 14;54(12):2877-2892.e7 | J:224849 J:303202 J:337329 | Infection|Mouse_Hepatitis_virus|Pathology Infection|SARS-CoV-2_virus SARS-CoV-2_virus|Vaccine | Myd88tm1.1DefrTargeted |
MGI:6272304 | behavior/neurological hematopoietic system immune system nervous system mortality/aging |
Butchi N, J Virol 2015 Sep 15;89(18):9299-312 Khan S, bioRxiv 2021 Mar;(): Alameh MG, Immunity 2021 Dec 14;54(12):2877-2892.e7 |
||
Myd88tm1Aki | MGI:2385681 | Targeted | Null/knockout | MGI:3694811 MGI:3577712 | Coronavirus infectious disease | DOID:0080599 | digestive/alimentary system endocrine/exocrine glands hematopoietic system homeostasis/metabolism immune system liver/biliary system respiratory system vision/eye neoplasm cardiovascular system cellular hearing/vestibular/ear nervous system renal/urinary system mortality/aging | MP:0005381 MP:0005379 MP:0005397 MP:0005376 MP:0005387 MP:0005370 MP:0005388 MP:0005391 MP:0002006 MP:0005385 MP:0005384 MP:0005377 MP:0003631 MP:0005367 MP:0010768 | Cervantes-Barragan L, Blood 2007 Feb 1;109(3):1131-7 Imai Y, Cell 2008 Apr 18;133(2):235-49 Sheahan T, PLoS Pathog 2008 Dec;4(12):e1000240 Zhao J, Proc Natl Acad Sci U S A 2014 Apr 1;111(13):4970-5 Zheng M, J Biol Chem 2020 Oct 9;295(41):14040-14052 Salvi V, bioRxiv 2021 Apr;(): Zheng M, Nat Immunol 2021 Jul;22(7):829-838 Salvi V, JCI Insight 2021 Sep 22;6(18):e150542 | J:144400 J:145306 J:162707 J:207380 J:298138 J:304651 J:308903 J:313336 | Infection|Mouse_Hepatitis_virus|SARS-CoV_virus SARS-CoV_virus Pathology|SARS-CoV-MA_virus MERS-CoV_virus Mouse_Hepatitis_virus Infection|SARS-CoV-2_virus Pathology|SARS-CoV-2_virus SARS-CoV-2_virus | Myd88tm1AkiTargeted |
MGI:3694811 MGI:3577712 | digestive/alimentary system endocrine/exocrine glands hematopoietic system homeostasis/metabolism immune system liver/biliary system respiratory system vision/eye neoplasm cardiovascular system cellular hearing/vestibular/ear nervous system renal/urinary system mortality/aging Coronavirus infectious disease |
Cervantes-Barragan L, Blood 2007 Feb 1;109(3):1131-7 Imai Y, Cell 2008 Apr 18;133(2):235-49 Sheahan T, PLoS Pathog 2008 Dec;4(12):e1000240 Zhao J, Proc Natl Acad Sci U S A 2014 Apr 1;111(13):4970-5 Zheng M, J Biol Chem 2020 Oct 9;295(41):14040-14052 Salvi V, bioRxiv 2021 Apr;(): Zheng M, Nat Immunol 2021 Jul;22(7):829-838 Salvi V, JCI Insight 2021 Sep 22;6(18):e150542 |
Ncf1m1J | MGI:2661962 | Spontaneous | MGI:2661972 | chronic granulomatous disease | DOID:3265 | hematopoietic system immune system | MP:0005397 MP:0005387 | Imai Y, Cell 2008 Apr 18;133(2):235-49 | J:145306 | SARS-CoV_virus | Ncf1m1JSpontaneous |
MGI:2661972 | hematopoietic system immune system chronic granulomatous disease |
Imai Y, Cell 2008 Apr 18;133(2):235-49 |
|
Nlrc4tm1Vmd | MGI:3046934 | Targeted | Null/knockout | Zheng M, J Biol Chem 2020 Oct 9;295(41):14040-14052 | J:298138 | Mouse_Hepatitis_virus | Nlrc4tm1VmdTargeted |
Zheng M, J Biol Chem 2020 Oct 9;295(41):14040-14052 |
|||||||
Nlrp3tm1Bhk | MGI:5465108 | Targeted | Null/knockout | Wu J, Immunity 2021 Nov 9;54(11):2632-2649.e6 Yalcinkaya M, Sci Rep 2021 Dec 24;11(1):24432 Duhalde Vega M, Sci Adv 2022 Sep 23;8(38):eabn6545 | J:323769 J:329139 J:331762 | Gene|Pathology Pathology|SARS-CoV-2_virus Mouse_Hepatitis_virus | Nlrp3tm1BhkTargeted |
Wu J, Immunity 2021 Nov 9;54(11):2632-2649.e6 Yalcinkaya M, Sci Rep 2021 Dec 24;11(1):24432 Duhalde Vega M, Sci Adv 2022 Sep 23;8(38):eabn6545 |
|||||||
Nlrp3tm1Flv | MGI:3686871 | Targeted | Null/knockout | Zheng M, J Biol Chem 2020 Oct 9;295(41):14040-14052 Zheng M, Nat Immunol 2021 Jul;22(7):829-838 | J:298138 J:308903 | Mouse_Hepatitis_virus Pathology|SARS-CoV-2_virus | Nlrp3tm1FlvTargeted |
Zheng M, J Biol Chem 2020 Oct 9;295(41):14040-14052 Zheng M, Nat Immunol 2021 Jul;22(7):829-838 |
|||||||
Nlrp3tm1Tsc | MGI:3721141 | Targeted | Null/knockout|Reporter | Zeng J, EBioMedicine 2021 Dec 31;75():103803 | J:319443 | Pathology|SARS-CoV-2_virus | Nlrp3tm1TscTargeted |
Zeng J, EBioMedicine 2021 Dec 31;75():103803 |
|||||||
Nos2tm1Lau | MGI:1857228 | Targeted | Null/knockout | Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 | J:296686 | Pathology|SARS-CoV-2_virus|Treatment | Nos2tm1LauTargeted |
Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 |
|||||||
Omptm3Mom | MGI:3692201 | Targeted | Null/knockout|Reporter | Brechbuhl J, Commun Biol 2021 Jul 15;4(1):880 | J:319436 | Gene | Omptm3MomTargeted |
||||||||
Pdgfbtm3.1Cbet | MGI:2670574 | Targeted | Null/knockout | He L, bioRxiv 2020;(): | J:295372 | Infection|SARS-CoV-2_virus | Pdgfbtm3.1CbetTargeted |
He L, bioRxiv 2020;(): |
|||||||
Pj1BALB/cHeA | MGI:3613181 | QTL | Kyuwa S, Microb Pathog 1992 Feb;12(2):95-104 | J:1357 | Mouse_Hepatitis_virus | Pj1BALB/cHeAQTL |
Kyuwa S, Microb Pathog 1992 Feb;12(2):95-104 |
||||||||
Pj1STS/A | MGI:3613177 | QTL | Kyuwa S, Microb Pathog 1992 Feb;12(2):95-104 | J:1357 | Mouse_Hepatitis_virus | Pj1STS/AQTL |
Kyuwa S, Microb Pathog 1992 Feb;12(2):95-104 |
||||||||
Pla2g2dtm1.1Mhg | MGI:5517549 | Targeted | Null/knockout | MGI:5520923 | cellular hematopoietic system homeostasis/metabolism immune system mortality/aging | MP:0005384 MP:0005397 MP:0005376 MP:0005387 MP:0010768 | Vijay R, J Exp Med 2015 Oct 19;212(11):1851-68 Zheng J, J Clin Invest 2021 Jun 1;131(11): | J:229035 J:311966 | Infection|SARS-CoV-MA_virus Comorbidity|MERS-CoV_virus | Pla2g2dtm1.1MhgTargeted |
MGI:5520923 | cellular hematopoietic system homeostasis/metabolism immune system mortality/aging |
Vijay R, J Exp Med 2015 Oct 19;212(11):1851-68 Zheng J, J Clin Invest 2021 Jun 1;131(11): |
||
Plattm1Mlg | MGI:1857288 | Targeted | Null/knockout | MGI:6433845 | immune system mortality/aging | MP:0005387 MP:0010768 | Gralinski LE, mBio 2013 Aug 6;4(4): | J:288556 | Infection|Pathology|SARS-CoV-MA_virus | Plattm1MlgTargeted |
MGI:6433845 | immune system mortality/aging |
Gralinski LE, mBio 2013 Aug 6;4(4): |
||
Ppp1r14ctm1Uhl | MGI:4450989 | Targeted | Null/knockout | MGI:6433773 | Coronavirus infectious disease | DOID:0080599 | immune system | MP:0005387 | McDermott JE, BMC Syst Biol 2016 Sep 23;10(1):93 | J:288523 | Pathology|SARS-CoV-MA_virus | Ppp1r14ctm1UhlTargeted |
MGI:6433773 | immune system Coronavirus infectious disease |
McDermott JE, BMC Syst Biol 2016 Sep 23;10(1):93 |
Prkdcem26Gpt | MGI:5827572 | Endonuclease-mediated | Not Specified | Hu Z, bioRxiv 2021 Nov;(): | J:313461 | Infection|SARS-CoV-2_virus | Prkdcem26GptEndonuclease-mediated |
Hu Z, bioRxiv 2021 Nov;(): |
|||||||
Prkdcscid | MGI:1857113 | Spontaneous | Graham RL, Nat Med 2012 Dec;18(12):1820-6 Halwe S, bioRxiv 2021 Jun;(): Abdelnabi R, J Virol 2022 Aug 24;96(16):e0075822 Pewe L, J Virol 1997 Oct;71(10):7640-7 | J:286309 J:308648 J:331764 J:42952 | SARS-CoV_virus|Vaccine SARS-CoV-2_virus|Treatment|VOC_B.1.1.7_Alpha|VOC_B.1.351_Beta Treatment|VOC_B.1.351_Beta Mouse_Hepatitis_virus | PrkdcscidSpontaneous |
Graham RL, Nat Med 2012 Dec;18(12):1820-6 Halwe S, bioRxiv 2021 Jun;(): Abdelnabi R, J Virol 2022 Aug 24;96(16):e0075822 Pewe L, J Virol 1997 Oct;71(10):7640-7 |
||||||||
Ptgdrtm1.1Brey | MGI:6802150 | Targeted | Conditional ready|No functional change | Verma AK, mBio 2021 Oct 26;12(5):e0196921 | J:313438 | Mouse_Hepatitis_virus | Ptgdrtm1.1BreyTargeted |
Verma AK, mBio 2021 Oct 26;12(5):e0196921 |
|||||||
Ptgdrtm1Sna | MGI:2386956 | Targeted | Null/knockout | MGI:3057193 | hematopoietic system immune system nervous system respiratory system mortality/aging | MP:0005397 MP:0005387 MP:0003631 MP:0005388 MP:0010768 | Vijay R, Proc Natl Acad Sci U S A 2017 Jul 03;114(27):E5444-E5453 Verma AK, mBio 2021 Oct 26;12(5):e0196921 | J:243958 J:313438 | Mouse_Hepatitis_virus | Ptgdrtm1SnaTargeted |
MGI:3057193 | hematopoietic system immune system nervous system respiratory system mortality/aging |
Vijay R, Proc Natl Acad Sci U S A 2017 Jul 03;114(27):E5444-E5453 Verma AK, mBio 2021 Oct 26;12(5):e0196921 |
||
Ptges2tm1Bhk | MGI:3620552 | Targeted | Null/knockout | McDermott JE, BMC Syst Biol 2016 Sep 23;10(1):93 | J:288523 | Pathology|SARS-CoV-MA_virus | Ptges2tm1BhkTargeted |
McDermott JE, BMC Syst Biol 2016 Sep 23;10(1):93 |
|||||||
Ptpn2tm1c(EUCOMM)Wtsi | MGI:5902694 | Targeted | Conditional ready | Spalinger MR, bioRxiv 2020 Dec 9;(): | J:300213 | SARS-CoV-2_virus|Treatment | Ptpn2tm1c(EUCOMM)WtsiTargeted |
Spalinger MR, bioRxiv 2020 Dec 9;(): |
|||||||
Ptpn2tm1Mtr | MGI:3044910 | Targeted | Null/knockout | Spalinger MR, bioRxiv 2020 Dec 9;(): | J:300213 | SARS-CoV-2_virus|Treatment | Ptpn2tm1MtrTargeted |
Spalinger MR, bioRxiv 2020 Dec 9;(): |
|||||||
Ptx3tm1Zuk | MGI:2670952 | Targeted | Null/knockout | MGI:2670955 | cellular endocrine/exocrine glands immune system reproductive system | MP:0005384 MP:0005379 MP:0005387 MP:0005389 | Han B, Lab Invest 2012 Sep;92(9):1285-96 | J:188421 | Mouse_Hepatitis_virus | Ptx3tm1ZukTargeted |
MGI:2670955 | cellular endocrine/exocrine glands immune system reproductive system |
Han B, Lab Invest 2012 Sep;92(9):1285-96 |
||
Pycardtm1Nnz | MGI:3771030 | Targeted | Null/knockout | Zheng M, J Biol Chem 2020 Oct 9;295(41):14040-14052 | J:298138 | Mouse_Hepatitis_virus | Pycardtm1NnzTargeted |
Zheng M, J Biol Chem 2020 Oct 9;295(41):14040-14052 |
|||||||
Rag1tm1Mom | MGI:1857241 | Targeted | Null/knockout | Chen BP, J Immunol 2001 Oct 15;167(8):4585-92 Templeton SP, J Neuroimmunol 2008 Feb;194(1-2):18-26 Graham RL, Nat Med 2012 Dec;18(12):1820-6 Channappanavar R, J Infect Dis 2015 Dec 15;212(12):1894-903 Hassan AO, Cell 2020 Jun 10;(): Johansen MD, Mucosal Immunol 2020 Aug 20;(): Halwe S, bioRxiv 2021 Jun;(): Mao T, bioRxiv 2021 Jun;(): Israelow B, bioRxiv 2021 May;(): Israelow B, Sci Immunol 2021 Oct 15;6(64):eabl4509 Glass WG, J Immunol 2004 Sep 15;173(6):4030-9 | J:106738 J:131907 J:286309 J:287959 J:290258 J:295350 J:308648 J:308656 J:308733 J:331753 J:92752 | Mouse_Hepatitis_virus|Pathology Mouse_Hepatitis_virus SARS-CoV_virus|Vaccine MERS-CoV_virus|Treatment Infection|SARS-CoV-2_virus|Treatment MERS-CoV-MA_virus|MERS-CoV_virus|SARS-CoV-2-MA_virus|SARS-CoV-2_virus|SARS-CoV-MA_virus|SARS-CoV_virus SARS-CoV-2_virus|Treatment|VOC_B.1.1.7_Alpha|VOC_B.1.351_Beta Treatment|VOC_B.1.1.7_Alpha|VOC_B.1.351_Beta|VOC_P.1_Gamma Infection|SARS-CoV-2_virus Infection|SARS-CoV_virus | Rag1tm1MomTargeted |
Chen BP, J Immunol 2001 Oct 15;167(8):4585-92 Templeton SP, J Neuroimmunol 2008 Feb;194(1-2):18-26 Graham RL, Nat Med 2012 Dec;18(12):1820-6 Channappanavar R, J Infect Dis 2015 Dec 15;212(12):1894-903 Hassan AO, Cell 2020 Jun 10;(): Johansen MD, Mucosal Immunol 2020 Aug 20;(): Halwe S, bioRxiv 2021 Jun;(): Mao T, bioRxiv 2021 Jun;(): Israelow B, bioRxiv 2021 May;(): Israelow B, Sci Immunol 2021 Oct 15;6(64):eabl4509 Glass WG, J Immunol 2004 Sep 15;173(6):4030-9 |
|||||||
Rag2tm1.1Flv | MGI:4887836 | Targeted | Null/knockout | Mao T, bioRxiv 2021 Jun;(): Sefik E, bioRxiv 2021;(): | J:308656 J:311907 | Treatment|VOC_B.1.1.7_Alpha|VOC_B.1.351_Beta|VOC_P.1_Gamma SARS-CoV-2_virus | Rag2tm1.1FlvTargeted |
Mao T, bioRxiv 2021 Jun;(): Sefik E, bioRxiv 2021;(): |
|||||||
Rapgef3tm1.1Chen | MGI:5559594 | Targeted | Null/knockout | Xiao J, J Biol Chem 2021 Oct 19;():101315 | J:313334 | Pathology | Rapgef3tm1.1ChenTargeted |
||||||||
Ripk3tm1.1Vmd | MGI:7256694 | Targeted | Null/knockout | Wenzel J, Nat Neurosci 2021 Nov;24(11):1522-1533 | J:323957 | Pathology|SARS-CoV-2_virus|VOC_B.1.351_Beta | Ripk3tm1.1VmdTargeted |
Wenzel J, Nat Neurosci 2021 Nov;24(11):1522-1533 |
|||||||
Ripk3tm1Vmd | MGI:3028853 | Targeted | Null/knockout | Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Zheng M, J Biol Chem 2020 Oct 9;295(41):14040-14052 | J:296686 J:298138 | Pathology|SARS-CoV-2_virus|Treatment Mouse_Hepatitis_virus | Ripk3tm1VmdTargeted |
Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Zheng M, J Biol Chem 2020 Oct 9;295(41):14040-14052 |
|||||||
Rnaseltm1Slvm | MGI:2182763 | Targeted | Null/knockout | Zhang R, Proc Natl Acad Sci U S A 2013 Aug 6;110(32):13114-9 Goldstein SA, J Virol 2017 Mar 01;91(5): Kindler E, PLoS Pathog 2017 Feb;13(2):e1006195 Thornbrough JM, mBio 2016 Mar 29;7(2):e00258 | J:200706 J:239306 J:291588 J:292006 | Mouse_Hepatitis_virus Infection|Mouse_Hepatitis_virus HCoV-229E_virus|Mouse_Hepatitis_virus MERS-CoV_virus|Mouse_Hepatitis_virus | Rnaseltm1SlvmTargeted |
Zhang R, Proc Natl Acad Sci U S A 2013 Aug 6;110(32):13114-9 Goldstein SA, J Virol 2017 Mar 01;91(5): Kindler E, PLoS Pathog 2017 Feb;13(2):e1006195 Thornbrough JM, mBio 2016 Mar 29;7(2):e00258 |
|||||||
Rnh1tm2.1Rall | MGI:7407148 | Targeted | Conditional ready | Bombaci G, Life Sci Alliance 2022 Jun;5(6):e202101226 | J:331827 | SARS-CoV-2_virus | Rnh1tm2.1RallTargeted |
Bombaci G, Life Sci Alliance 2022 Jun;5(6):e202101226 |
|||||||
Serpine1tm1Mlg | MGI:1857287 | Targeted | Null/knockout | MGI:3690223 | Coronavirus infectious disease | DOID:0080599 | cardiovascular system homeostasis/metabolism immune system liver/biliary system respiratory system mortality/aging | MP:0005385 MP:0005376 MP:0005387 MP:0005370 MP:0005388 MP:0010768 | Gralinski LE, mBio 2013 Aug 6;4(4): | J:288556 | Infection|Pathology|SARS-CoV-MA_virus | Serpine1tm1MlgTargeted |
MGI:3690223 | cardiovascular system homeostasis/metabolism immune system liver/biliary system respiratory system mortality/aging Coronavirus infectious disease |
Gralinski LE, mBio 2013 Aug 6;4(4): |
Setdb2tm1c(KOMP)Wtsi | MGI:5816257 | Targeted | Conditional ready | Melvin WJ, Proc Natl Acad Sci U S A 2021 Sep 21;118(38):e2101071118 | J:311033 | Comorbidity|Gene|Mouse_Hepatitis_virus | Setdb2tm1c(KOMP)WtsiTargeted |
Melvin WJ, Proc Natl Acad Sci U S A 2021 Sep 21;118(38):e2101071118 |
|||||||
Sftpctm1(cre/ERT2)Blh | MGI:5305340 | Targeted | Inducible|Recombinase | Tang AT, bioRxiv 2021 Dec;(): Tang AT, PLoS Biol 2023 Feb;21(2):e3001989 | J:315719 J:337814 | Pathology|SARS-CoV-2_virus Pathology|SARS-CoV-2_virus|VOC_B.1.1.529_Omicron | Sftpctm1(cre/ERT2)BlhTargeted |
Tang AT, bioRxiv 2021 Dec;(): Tang AT, PLoS Biol 2023 Feb;21(2):e3001989 |
|||||||
Shhtm1(EGFP/cre)Cjt | MGI:3053959 | Targeted | Null/knockout|Recombinase | Tang AT, bioRxiv 2021 Dec;(): Tang AT, PLoS Biol 2023 Feb;21(2):e3001989 | J:315719 J:337814 | Pathology|SARS-CoV-2_virus Pathology|SARS-CoV-2_virus|VOC_B.1.1.529_Omicron | Shhtm1(EGFP/cre)CjtTargeted |
Tang AT, bioRxiv 2021 Dec;(): Tang AT, PLoS Biol 2023 Feb;21(2):e3001989 |
|||||||
Shhtm2(cre/ERT2)Cjt | MGI:3053960 | Targeted | Inducible|Recombinase | Anand G, bioRxiv 2020 Dec;(): | J:298270 | Pathology|SARS-CoV-2_virus | Shhtm2(cre/ERT2)CjtTargeted |
Anand G, bioRxiv 2020 Dec;(): |
|||||||
Smad3tm1Cxd | MGI:1857695 | Targeted | Null/knockout | Wang W, Adv Sci (Weinh) 2022 Jan;9(3):e2103248 | J:333753 | Pathology|SARS-CoV-2_virus | Smad3tm1CxdTargeted |
Wang W, Adv Sci (Weinh) 2022 Jan;9(3):e2103248 |
|||||||
Srydl1Rlb | MGI:1857786 | Spontaneous | Ensor CM, bioRxiv 2021-09;(): | J:310122 | SARS-CoV-2_virus | Srydl1RlbSpontaneous |
Ensor CM, bioRxiv 2021-09;(): |
||||||||
Stat1tm1Dlv | MGI:1930947 | Targeted | Null/knockout | MGI:3806318 MGI:6403902 MGI:6403905 | Coronavirus infectious disease | DOID:0080599 | hematopoietic system homeostasis/metabolism immune system vision/eye cardiovascular system digestive/alimentary system respiratory system | MP:0005397 MP:0005376 MP:0005387 MP:0005391 MP:0005385 MP:0005381 MP:0005388 | Lassnig C, Transgenic Res 2005 Dec;14(6):803-6 Venkataraman T, J Virol 2017 Jun 15;91(12): Page C, J Virol 2012 Dec;86(24):13334-49 Hassan AO, Cell 2020 Jun 10;(): Sun J, Cell 2020 Jun 10;(): Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Lassnig C, Proc Natl Acad Sci U S A 2005 Jun 7;102(23):8275-80 | J:103578 J:243599 J:286337 J:290258 J:291881 J:296686 J:99728 | HCoV-229E_virus Pathology|SARS-CoV-MA_virus Pathology|SARS-CoV_virus Infection|SARS-CoV-2_virus|Treatment Infection|Pathology|SARS-CoV-2_virus|Treatment Pathology|SARS-CoV-2_virus|Treatment | Stat1tm1DlvTargeted |
MGI:3806318 MGI:6403902 MGI:6403905 | hematopoietic system homeostasis/metabolism immune system vision/eye cardiovascular system digestive/alimentary system respiratory system Coronavirus infectious disease |
Lassnig C, Transgenic Res 2005 Dec;14(6):803-6 Venkataraman T, J Virol 2017 Jun 15;91(12): Page C, J Virol 2012 Dec;86(24):13334-49 Hassan AO, Cell 2020 Jun 10;(): Sun J, Cell 2020 Jun 10;(): Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Lassnig C, Proc Natl Acad Sci U S A 2005 Jun 7;102(23):8275-80 |
Stat1tm1Mam | MGI:4821871 | Targeted | Conditional ready|No functional change | Page C, J Virol 2012 Dec;86(24):13334-49 | J:286337 | Pathology|SARS-CoV_virus | Stat1tm1MamTargeted |
Page C, J Virol 2012 Dec;86(24):13334-49 |
|||||||
Stat1tm1Rds | MGI:1861949 | Targeted | Null/knockout | MGI:3771372 | breast cancer severe acute respiratory syndrome | DOID:1612 DOID:2945 | cardiovascular system cellular digestive/alimentary system endocrine/exocrine glands hematopoietic system homeostasis/metabolism immune system integument liver/biliary system muscle nervous system respiratory system skeleton neoplasm mortality/aging | MP:0005385 MP:0005384 MP:0005381 MP:0005379 MP:0005397 MP:0005376 MP:0005387 MP:0010771 MP:0005370 MP:0005369 MP:0003631 MP:0005388 MP:0005390 MP:0002006 MP:0010768 | Zornetzer GA, J Virol 2010 Nov;84(21):11297-309 Peng X, mBio 2010 Oct 26;1(5): Frieman MB, PLoS Pathog 2010 Apr 8;6(4):e1000849 Graham RL, Nat Med 2012 Dec;18(12):1820-6 Singh A, Virol Sin 2020 Jun;35(3):290-304 Johansen MD, Mucosal Immunol 2020 Aug 20;(): | J:164586 J:276986 J:286237 J:286309 J:295349 J:295350 | Pathology|SARS-CoV-MA_virus Infection|SARS-CoV-MA_virus SARS-CoV_virus|Vaccine MERS-CoV-MA_virus|MERS-CoV_virus|SARS-CoV-2-MA_virus|SARS-CoV-2_virus|SARS-CoV_virus MERS-CoV-MA_virus|MERS-CoV_virus|SARS-CoV-2-MA_virus|SARS-CoV-2_virus|SARS-CoV-MA_virus|SARS-CoV_virus | Stat1tm1RdsTargeted |
MGI:3771372 | cardiovascular system cellular digestive/alimentary system endocrine/exocrine glands hematopoietic system homeostasis/metabolism immune system integument liver/biliary system muscle nervous system respiratory system skeleton neoplasm mortality/aging breast cancer severe acute respiratory syndrome |
Zornetzer GA, J Virol 2010 Nov;84(21):11297-309 Peng X, mBio 2010 Oct 26;1(5): Frieman MB, PLoS Pathog 2010 Apr 8;6(4):e1000849 Graham RL, Nat Med 2012 Dec;18(12):1820-6 Singh A, Virol Sin 2020 Jun;35(3):290-304 Johansen MD, Mucosal Immunol 2020 Aug 20;(): |
Stat6tm1Gru | MGI:1888385 | Targeted | Null/knockout | Page C, J Virol 2012 Dec;86(24):13334-49 | J:286337 | Pathology|SARS-CoV_virus | Stat6tm1GruTargeted |
Page C, J Virol 2012 Dec;86(24):13334-49 |
|||||||
Sting1gt | MGI:4939597 | Chemically induced (ENU) | Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 | J:296686 | Pathology|SARS-CoV-2_virus|Treatment | Sting1gtChemically induced (ENU) |
Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 |
||||||||
Sting1tm1.2Camb | MGI:5639232 | Targeted | Null/knockout | Yang J, Nature 2020 Jul 29;(): Wu J, Immunity 2021 Nov 9;54(11):2632-2649.e6 | J:292665 J:323769 | SARS-CoV-2_virus|Vaccine Gene|Pathology | Sting1tm1.2CambTargeted |
Yang J, Nature 2020 Jul 29;(): Wu J, Immunity 2021 Nov 9;54(11):2632-2649.e6 |
|||||||
Sting1tm1Gnb | MGI:3817418 | Targeted | Null/knockout | Humphries F, Sci Immunol 2021 May 18;6(59): | J:333769 | SARS-CoV-2_virus|Treatment | Sting1tm1GnbTargeted |
Humphries F, Sci Immunol 2021 May 18;6(59): |
|||||||
Tcrbtm1Mom | MGI:1857256 | Targeted | Null/knockout | Dandekar AA, J Virol 2005 Aug;79(15):9388-96 | J:153339 | Mouse_Hepatitis_virus | Tcrbtm1MomTargeted |
Dandekar AA, J Virol 2005 Aug;79(15):9388-96 |
|||||||
Terctm1Rdp | MGI:1857930 | Targeted | Null/knockout | Sepe S, bioRxiv 2021 Jun;(): Sepe S, EMBO Rep 2022 Feb 3;23(2):e53658 | J:309195 J:326929 | Comorbidity|Gene Gene | Terctm1RdpTargeted |
Sepe S, bioRxiv 2021 Jun;(): |
|||||||
Terf2tm1Tdl | MGI:3619524 | Targeted | Conditional ready|No functional change | Sepe S, bioRxiv 2021 Jun;(): Sepe S, EMBO Rep 2022 Feb 3;23(2):e53658 | J:309195 J:326929 | Comorbidity|Gene Gene | Terf2tm1TdlTargeted |
Sepe S, bioRxiv 2021 Jun;(): |
|||||||
Tg(Ace2-ACE2)1Cqin | MGI:6401292 | Transgenic | Humanized sequence|Inserted expressed sequence | MGI:6402641 | COVID-19 severe acute respiratory syndrome | DOID:0080600 DOID:2945 | cardiovascular system cellular digestive/alimentary system endocrine/exocrine glands growth/size/body homeostasis/metabolism immune system liver/biliary system nervous system renal/urinary system respiratory system | MP:0005385 MP:0005384 MP:0005381 MP:0005379 MP:0005378 MP:0005376 MP:0005387 MP:0005370 MP:0003631 MP:0005367 MP:0005388 | Yang XH, Comp Med 2007 Oct;57(5):450-9 Bao L, Nature 2020 May 7;(): Natoli S, Eur J Neurol 2020 Apr 25;(): Bao L, J Infect Dis 2020 May 23;(): Lutz C, Hum Genomics 2020 Jun 4;14(1):20 Mullick JB, Cell Mol Bioeng 2020 Jul 27;():1-11 Leist SR, Dis Model Mech 2020 Sep 1;13(9):dmm046581 Singh A, Virol Sin 2020 Jun;35(3):290-304 Johansen MD, Mucosal Immunol 2020 Aug 20;(): Munoz-Fontela C, Nature 2020 Sep 23;(): Jia H, Nat Commun 2020 Oct 14;11(1):5165 Guo Q, Cell Host Microbe 2021 Feb 10;29(2):222-235.e4 Shang C, J Virol 2021 Nov 23;95(24):e0153721 | J:141460 J:287631 J:287925 J:288244 J:288402 J:294026 J:295328 J:295349 J:295350 J:295351 J:296535 J:308901 J:331770 | Infection|SARS-CoV_virus Infection|Pathology|SARS-CoV-2_virus Infection|SARS-CoV-2_virus SARS-CoV-2_virus SARS-CoV-2_virus|SARS-CoV_virus MERS-CoV-MA_virus|MERS-CoV_virus|SARS-CoV-2-MA_virus|SARS-CoV-2_virus|SARS-CoV_virus MERS-CoV-MA_virus|MERS-CoV_virus|SARS-CoV-2-MA_virus|SARS-CoV-2_virus|SARS-CoV-MA_virus|SARS-CoV_virus SARS-CoV-2-MA_virus|SARS-CoV-2_virus|SARS-CoV_virus Pathology|SARS-CoV-2_virus SARS-CoV-2_virus|Treatment | Tg(Ace2-ACE2)1CqinTransgenic |
MGI:6402641 | cardiovascular system cellular digestive/alimentary system endocrine/exocrine glands growth/size/body homeostasis/metabolism immune system liver/biliary system nervous system renal/urinary system respiratory system COVID-19 severe acute respiratory syndrome |
Yang XH, Comp Med 2007 Oct;57(5):450-9 Bao L, Nature 2020 May 7;(): Natoli S, Eur J Neurol 2020 Apr 25;(): Bao L, J Infect Dis 2020 May 23;(): Lutz C, Hum Genomics 2020 Jun 4;14(1):20 Mullick JB, Cell Mol Bioeng 2020 Jul 27;():1-11 Leist SR, Dis Model Mech 2020 Sep 1;13(9):dmm046581 Singh A, Virol Sin 2020 Jun;35(3):290-304 Johansen MD, Mucosal Immunol 2020 Aug 20;(): Munoz-Fontela C, Nature 2020 Sep 23;(): Jia H, Nat Commun 2020 Oct 14;11(1):5165 Guo Q, Cell Host Microbe 2021 Feb 10;29(2):222-235.e4 Shang C, J Virol 2021 Nov 23;95(24):e0153721 |
Tg(Acta2-GFP)1Pfk | MGI:5805225 | Transgenic | Inserted expressed sequence|Reporter | He L, bioRxiv 2020;(): | J:295372 | Infection|SARS-CoV-2_virus | Tg(Acta2-GFP)1PfkTransgenic |
He L, bioRxiv 2020;(): |
|||||||
Tg(ANPEP)270Mmul | MGI:5645778 | Transgenic | Inserted expressed sequence | MGI:6403902 MGI:6403906 | Coronavirus infectious disease | DOID:0080599 | cardiovascular system immune system | MP:0005385 MP:0005387 | Lassnig C, Proc Natl Acad Sci U S A 2005 Jun 7;102(23):8275-80 | J:99728 | HCoV-229E_virus | Tg(ANPEP)270MmulTransgenic |
MGI:6403902 MGI:6403906 | cardiovascular system immune system Coronavirus infectious disease |
Lassnig C, Proc Natl Acad Sci U S A 2005 Jun 7;102(23):8275-80 |
Tg(ANPEP)861Mmul | MGI:5645779 | Transgenic | Inserted expressed sequence | MGI:6403905 MGI:6403907 | Coronavirus infectious disease | DOID:0080599 | cardiovascular system digestive/alimentary system immune system respiratory system | MP:0005385 MP:0005381 MP:0005387 MP:0005388 | Lassnig C, Proc Natl Acad Sci U S A 2005 Jun 7;102(23):8275-80 | J:99728 | HCoV-229E_virus | Tg(ANPEP)861MmulTransgenic |
MGI:6403905 MGI:6403907 | cardiovascular system digestive/alimentary system immune system respiratory system Coronavirus infectious disease |
Lassnig C, Proc Natl Acad Sci U S A 2005 Jun 7;102(23):8275-80 |
Tg(ANPEP)#Mmul | MGI:5582782 | Transgenic | Inserted expressed sequence | Lassnig C, Proc Natl Acad Sci U S A 2005 Jun 7;102(23):8275-80 | J:99728 | HCoV-229E_virus | Tg(ANPEP)#MmulTransgenic |
Lassnig C, Proc Natl Acad Sci U S A 2005 Jun 7;102(23):8275-80 |
|||||||
Tg(APPSwFlLon,PSEN1*M146L*L286V)6799Vas | MGI:3693208 | Transgenic | Humanized sequence|Inserted expressed sequence | Lim KH, Front Genet 2021;12():741175 Hohsfield LA, Glia 2022 May;70(5):875-891 | J:319460 J:324342 | Gene|SARS-CoV-2_virus Mouse_Hepatitis_virus | Tg(APPSwFlLon,PSEN1*M146L*L286V)6799VasTransgenic |
Lim KH, Front Genet 2021;12():741175 Hohsfield LA, Glia 2022 May;70(5):875-891 |
|||||||
Tg(CAG-ACE2)AC22Ctkt | MGI:6402929 | Transgenic | Humanized sequence|Inserted expressed sequence | Tseng CT, J Virol 2007 Feb;81(3):1162-73 Yoshikawa N, J Virol 2009 Jun;83(11):5451-65 Lutz C, Hum Genomics 2020 Jun 4;14(1):20 | J:117824 J:148946 J:288402 | Infection|SARS-CoV_virus Pathology|SARS-CoV_virus SARS-CoV-2_virus | Tg(CAG-ACE2)AC22CtktTransgenic |
Tseng CT, J Virol 2007 Feb;81(3):1162-73 Yoshikawa N, J Virol 2009 Jun;83(11):5451-65 Lutz C, Hum Genomics 2020 Jun 4;14(1):20 |
|||||||
Tg(CAG-ACE2)AC63Ctkt | MGI:6402829 | Transgenic | Humanized sequence|Inserted expressed sequence | MGI:6402831 | immune system | MP:0005387 | Tseng CT, J Virol 2007 Feb;81(3):1162-73 Gretebeck LM, Curr Opin Virol 2015 Aug;13():123-9 Lutz C, Hum Genomics 2020 Jun 4;14(1):20 Mullick JB, Cell Mol Bioeng 2020 Jul 27;():1-11 | J:117824 J:284000 J:288402 J:294026 | Infection|SARS-CoV_virus MERS-CoV_virus|SARS-CoV_virus SARS-CoV-2_virus SARS-CoV-2_virus|SARS-CoV_virus | Tg(CAG-ACE2)AC63CtktTransgenic |
MGI:6402831 | immune system |
Tseng CT, J Virol 2007 Feb;81(3):1162-73 Gretebeck LM, Curr Opin Virol 2015 Aug;13():123-9 Lutz C, Hum Genomics 2020 Jun 4;14(1):20 Mullick JB, Cell Mol Bioeng 2020 Jul 27;():1-11 |
||
Tg(CAG-ACE2)AC70Ctkt | MGI:6402828 | Transgenic | Humanized sequence|Inserted expressed sequence | MGI:6402832 | severe acute respiratory syndrome | DOID:2945 | cardiovascular system homeostasis/metabolism immune system respiratory system mortality/aging | MP:0005385 MP:0005376 MP:0005387 MP:0005388 MP:0010768 | Tseng CT, J Virol 2007 Feb;81(3):1162-73 Yoshikawa N, J Virol 2009 Jun;83(11):5451-65 Zumla A, Nat Rev Drug Discov 2016 May;15(5):327-47 Gretebeck LM, Curr Opin Virol 2015 Aug;13():123-9 Lutz C, Hum Genomics 2020 Jun 4;14(1):20 Mullick JB, Cell Mol Bioeng 2020 Jul 27;():1-11 Jia H, Nat Commun 2020 Oct 14;11(1):5165 Yuan L, Emerg Microbes Infect 2020 Dec;9(1):949-961 Ma H, bioRxiv 2021;(): | J:117824 J:148946 J:283999 J:284000 J:288402 J:294026 J:296535 J:300104 J:311906 | Infection|SARS-CoV_virus Pathology|SARS-CoV_virus MERS-CoV_virus|SARS-CoV_virus SARS-CoV-2_virus SARS-CoV-2_virus|SARS-CoV_virus MERS-CoV_virus|SARS-CoV-2_virus|SARS-CoV_virus SARS-CoV-2_virus|Treatment|VOC_B.1.1.7_Alpha|VOC_B.1.351_Beta|VOC_B.1.617.2_Delta|VOC_P.1_Gamma | Tg(CAG-ACE2)AC70CtktTransgenic |
MGI:6402832 | cardiovascular system homeostasis/metabolism immune system respiratory system mortality/aging severe acute respiratory syndrome |
Tseng CT, J Virol 2007 Feb;81(3):1162-73 Yoshikawa N, J Virol 2009 Jun;83(11):5451-65 Zumla A, Nat Rev Drug Discov 2016 May;15(5):327-47 Gretebeck LM, Curr Opin Virol 2015 Aug;13():123-9 Lutz C, Hum Genomics 2020 Jun 4;14(1):20 Mullick JB, Cell Mol Bioeng 2020 Jul 27;():1-11 Jia H, Nat Commun 2020 Oct 14;11(1):5165 Yuan L, Emerg Microbes Infect 2020 Dec;9(1):949-961 Ma H, bioRxiv 2021;(): |
Tg(CAG-ACE2)GT5-027Cyt | MGI:6711183 | Transgenic | Epitope tag|Humanized sequence|Inserted expressed sequence | Tsai C-Y, bioRxiv 2021;(): Liao HY, bioRxiv 2021 May;(): | J:305559 J:308661 | SARS-CoV-2_virus SARS-CoV-2_virus|Vaccine | Tg(CAG-ACE2)GT5-027CytTransgenic |
Tsai C-Y, bioRxiv 2021;(): Liao HY, bioRxiv 2021 May;(): |
|||||||
Tg(CAG-ACE2,-luc)1Smoc | MGI:7279190 | Transgenic | Humanized sequence|Inserted expressed sequence|Reporter | Li C, Cell 2022 Apr 14;185(8):1389-1401.e18 | J:324335 | SARS-CoV-2_virus|Treatment|VOC_B.1.1.529_Omicron | Tg(CAG-ACE2,-luc)1SmocTransgenic |
Li C, Cell 2022 Apr 14;185(8):1389-1401.e18 |
|||||||
Tg(CAG-DPP4)4Yuzh | MGI:6402443 | Transgenic | Humanized sequence|Inserted expressed sequence | MGI:6402445 | Middle East respiratory syndrome | DOID:0080642 | behavior/neurological cardiovascular system hematopoietic system homeostasis/metabolism immune system liver/biliary system nervous system renal/urinary system respiratory system mortality/aging | MP:0005386 MP:0005385 MP:0005397 MP:0005376 MP:0005387 MP:0005370 MP:0003631 MP:0005367 MP:0005388 MP:0010768 | Zhao G, PLoS One 2015;10(12):e0145561 Jiang Y, Viruses 2019 Jan 9;11(1): Singh A, Virol Sin 2020 Jun;35(3):290-304 Tai W, Virology 2016 Dec;499():375-382 | J:286175 J:295108 J:295349 J:331809 | Infection|MERS-CoV_virus MERS-CoV_virus MERS-CoV-MA_virus|MERS-CoV_virus|SARS-CoV-2-MA_virus|SARS-CoV-2_virus|SARS-CoV_virus MERS-CoV_virus|Treatment | Tg(CAG-DPP4)4YuzhTransgenic |
MGI:6402445 | behavior/neurological cardiovascular system hematopoietic system homeostasis/metabolism immune system liver/biliary system nervous system renal/urinary system respiratory system mortality/aging Middle East respiratory syndrome |
Zhao G, PLoS One 2015;10(12):e0145561 Jiang Y, Viruses 2019 Jan 9;11(1): Singh A, Virol Sin 2020 Jun;35(3):290-304 Tai W, Virology 2016 Dec;499():375-382 |
Tg(CAG-DPP4)52Ctkt | MGI:6402051 | Transgenic | Humanized sequence|Inserted expressed sequence | MGI:6402055 | Middle East respiratory syndrome | DOID:0080642 | growth/size/body hematopoietic system immune system nervous system respiratory system mortality/aging | MP:0005378 MP:0005397 MP:0005387 MP:0003631 MP:0005388 MP:0010768 | Tao X, J Virol 2015;90(1):57-67 Agrawal AS, J Virol 2015 Apr;89(7):3659-70 Agrawal AS, Sci Rep 2016 Aug 19;6():31629 Gretebeck LM, Curr Opin Virol 2015 Aug;13():123-9 Leist SR, Methods Mol Biol 2020;2099():137-159 Algaissi A, J Infect Dis 2019 Feb 15;219(5):829-835 Hao XY, Animal Model Exp Med 2019 Dec;2(4):269-281 Natoli S, Eur J Neurol 2020 Apr 25;(): Choi JH, PLoS One 2020;15(5):e0232757 Agrawal AS, Hum Vaccin Immunother 2016 Sep;12(9):2351-6 Singh A, Virol Sin 2020 Jun;35(3):290-304 Johansen MD, Mucosal Immunol 2020 Aug 20;(): Yuan L, Emerg Microbes Infect 2020 Dec;9(1):949-961 | J:227925 J:258199 J:266753 J:284000 J:285962 J:286197 J:286454 J:287925 J:288262 J:291895 J:295349 J:295350 J:300104 | Infection|MERS-CoV_virus|Vaccine Infection|MERS-CoV_virus MERS-CoV_virus|Treatment MERS-CoV_virus|SARS-CoV_virus MERS-CoV_virus Infection|MERS-CoV_virus|Pathology MERS-CoV_virus|Pathology Infection|SARS-CoV-2_virus MERS-CoV_virus|Vaccine MERS-CoV-MA_virus|MERS-CoV_virus|SARS-CoV-2-MA_virus|SARS-CoV-2_virus|SARS-CoV_virus MERS-CoV-MA_virus|MERS-CoV_virus|SARS-CoV-2-MA_virus|SARS-CoV-2_virus|SARS-CoV-MA_virus|SARS-CoV_virus MERS-CoV_virus|SARS-CoV-2_virus|SARS-CoV_virus | Tg(CAG-DPP4)52CtktTransgenic |
MGI:6402055 | growth/size/body hematopoietic system immune system nervous system respiratory system mortality/aging Middle East respiratory syndrome |
Tao X, J Virol 2015;90(1):57-67 Agrawal AS, J Virol 2015 Apr;89(7):3659-70 Agrawal AS, Sci Rep 2016 Aug 19;6():31629 Gretebeck LM, Curr Opin Virol 2015 Aug;13():123-9 Leist SR, Methods Mol Biol 2020;2099():137-159 Algaissi A, J Infect Dis 2019 Feb 15;219(5):829-835 Hao XY, Animal Model Exp Med 2019 Dec;2(4):269-281 Natoli S, Eur J Neurol 2020 Apr 25;(): Choi JH, PLoS One 2020;15(5):e0232757 Agrawal AS, Hum Vaccin Immunother 2016 Sep;12(9):2351-6 Singh A, Virol Sin 2020 Jun;35(3):290-304 Johansen MD, Mucosal Immunol 2020 Aug 20;(): Yuan L, Emerg Microbes Infect 2020 Dec;9(1):949-961 |
Tg(CAG-OVAL)916Jen | MGI:3050829 | Transgenic | Inserted expressed sequence | Khanolkar A, J Immunol 2010 Jul 15;185(2):1132-41 | J:161935 | Mouse_Hepatitis_virus|Pathology | Tg(CAG-OVAL)916JenTransgenic |
Khanolkar A, J Immunol 2010 Jul 15;185(2):1132-41 |
|||||||
Tg(CAG-Serpine1)1Dgi | MGI:3763900 | Transgenic | Inserted expressed sequence | Jain KG, Am J Physiol Lung Cell Mol Physiol 2022 Nov 1;323(5):L515-L524 | J:329972 | Gene | Tg(CAG-Serpine1)1DgiTransgenic |
Jain KG, Am J Physiol Lung Cell Mol Physiol 2022 Nov 1;323(5):L515-L524 |
|||||||
Tg(CD207-Dta)312Dhka | MGI:3762048 | Transgenic | Inserted expressed sequence | Ndeupen S, bioRxiv 2021 Aug;(): | J:308580 | SARS-CoV-2_virus|Vaccine | Tg(CD207-Dta)312DhkaTransgenic |
Ndeupen S, bioRxiv 2021 Aug;(): |
|||||||
Tg(CD46)373Zbz | MGI:6501992 | Transgenic | Humanized sequence|Inserted expressed sequence | Horner C, Proc Natl Acad Sci U S A 2020 Dec 22;117(51):32657-32666 Malczyk AH, J Virol 2015 Nov;89(22):11654-67 | J:300105 J:312515 | SARS-CoV-2_virus|Vaccine MERS-CoV_virus|Vaccine | Tg(CD46)373ZbzTransgenic |
Horner C, Proc Natl Acad Sci U S A 2020 Dec 22;117(51):32657-32666 Malczyk AH, J Virol 2015 Nov;89(22):11654-67 |
|||||||
Tg(Cd4-CD4)2362Litt | MGI:3702083 | Transgenic | Humanized sequence|Inserted expressed sequence | Brentville VA, bioRxiv 2021 Jun;(): | J:308658 | SARS-CoV-2_virus|Vaccine | Tg(Cd4-CD4)2362LittTransgenic |
Brentville VA, bioRxiv 2021 Jun;(): |
|||||||
Tg(DPP4)2Nnag | MGI:6403115 | Transgenic | Humanized sequence|Inserted expressed sequence | MGI:6403636 MGI:6403118 | Middle East respiratory syndrome | DOID:0080642 | immune system homeostasis/metabolism respiratory system | MP:0005387 MP:0005376 MP:0005388 | Iwata-Yoshikawa N, J Virol 2019 Mar 15;93(6): Hao XY, Animal Model Exp Med 2019 Dec;2(4):269-281 Singh A, Virol Sin 2020 Jun;35(3):290-304 Yuan L, Emerg Microbes Infect 2020 Dec;9(1):949-961 | J:283077 J:286321 J:286454 J:295349 J:300104 | MERS-CoV-MA_virus|MERS-CoV_virus|Pathology Infection|MERS-CoV_virus MERS-CoV_virus|Pathology MERS-CoV-MA_virus|MERS-CoV_virus|SARS-CoV-2-MA_virus|SARS-CoV-2_virus|SARS-CoV_virus MERS-CoV_virus|SARS-CoV-2_virus|SARS-CoV_virus | Tg(DPP4)2NnagTransgenic |
MGI:6403636 MGI:6403118 | immune system homeostasis/metabolism respiratory system Middle East respiratory syndrome |
Iwata-Yoshikawa N, J Virol 2019 Mar 15;93(6): Iwata-Yoshikawa N, J Virol 2019 Mar 15;93(6): Hao XY, Animal Model Exp Med 2019 Dec;2(4):269-281 Singh A, Virol Sin 2020 Jun;35(3):290-304 Yuan L, Emerg Microbes Infect 2020 Dec;9(1):949-961 |
Tg(FCGRT)32Dcr | MGI:4944199 | Transgenic | Humanized sequence|Inserted expressed sequence | Halwe S, bioRxiv 2021 Jun;(): | J:308648 | SARS-CoV-2_virus|Treatment|VOC_B.1.1.7_Alpha|VOC_B.1.351_Beta | Tg(FCGRT)32DcrTransgenic |
Halwe S, bioRxiv 2021 Jun;(): |
|||||||
Tg(FOXJ1-ACE2)1Rba | MGI:6415223 | Transgenic | Inserted expressed sequence | MGI:6415340 | Coronavirus infectious disease COVID-19 severe acute respiratory syndrome | DOID:0080599 DOID:0080600 DOID:2945 | cardiovascular system cellular hematopoietic system homeostasis/metabolism immune system muscle respiratory system mortality/aging | MP:0005385 MP:0005384 MP:0005397 MP:0005376 MP:0005387 MP:0005369 MP:0005388 MP:0010768 | Menachery VD, Proc Natl Acad Sci U S A 2016 Mar 15;113(11):3048-53 Jiang RD, Cell 2020 May 21;(): Lutz C, Hum Genomics 2020 Jun 4;14(1):20 Dinnon KH 3rd, Nature 2020 Aug 27;(): Leist SR, Dis Model Mech 2020 Sep 1;13(9):dmm046581 Singh A, Virol Sin 2020 Jun;35(3):290-304 Johansen MD, Mucosal Immunol 2020 Aug 20;(): Hou Y, bioRxiv 2020;(): Jia H, Nat Commun 2020 Oct 14;11(1):5165 Li W, Proc Natl Acad Sci U S A 2020 Nov 24;117(47):29832-29838 Huang Q, Nat Commun 2021 Feb 3;12(1):776 Li D, Cell 2021 Aug 5;184(16):4203-4219.e32 | J:287092 J:288386 J:288402 J:294063 J:295328 J:295349 J:295350 J:295381 J:296535 J:299936 J:302315 J:313328 | Infection Pathology|SARS-CoV-2_virus SARS-CoV-2_virus Infection|SARS-CoV-2-MA_virus|Treatment Infection|SARS-CoV-2_virus MERS-CoV-MA_virus|MERS-CoV_virus|SARS-CoV-2-MA_virus|SARS-CoV-2_virus|SARS-CoV_virus MERS-CoV-MA_virus|MERS-CoV_virus|SARS-CoV-2-MA_virus|SARS-CoV-2_virus|SARS-CoV-MA_virus|SARS-CoV_virus SARS-CoV-2-MA_virus|SARS-CoV-2_virus|Treatment SARS-CoV-2_virus|Vaccine SARS-CoV-2-MA_virus|SARS-CoV-2_virus|SARS-CoV_virus|Treatment | Tg(FOXJ1-ACE2)1RbaTransgenic |
MGI:6415340 | cardiovascular system cellular hematopoietic system homeostasis/metabolism immune system muscle respiratory system mortality/aging Coronavirus infectious disease COVID-19 severe acute respiratory syndrome |
Menachery VD, Proc Natl Acad Sci U S A 2016 Mar 15;113(11):3048-53 Jiang RD, Cell 2020 May 21;(): Lutz C, Hum Genomics 2020 Jun 4;14(1):20 Dinnon KH 3rd, Nature 2020 Aug 27;(): Leist SR, Dis Model Mech 2020 Sep 1;13(9):dmm046581 Singh A, Virol Sin 2020 Jun;35(3):290-304 Johansen MD, Mucosal Immunol 2020 Aug 20;(): Hou Y, bioRxiv 2020;(): Jia H, Nat Commun 2020 Oct 14;11(1):5165 Li W, Proc Natl Acad Sci U S A 2020 Nov 24;117(47):29832-29838 Huang Q, Nat Commun 2021 Feb 3;12(1):776 Li D, Cell 2021 Aug 5;184(16):4203-4219.e32 |
Tg(H2-Aa-HLA-DPA1)1Lone | MGI:5494673 | Transgenic | Inserted expressed sequence | Brentville VA, bioRxiv 2021 Jun;(): | J:308658 | SARS-CoV-2_virus|Vaccine | Tg(H2-Aa-HLA-DPA1)1LoneTransgenic |
Brentville VA, bioRxiv 2021 Jun;(): |
|||||||
Tg(H2-Ab1-HLA-DPB1)1Lone | MGI:5494677 | Transgenic | Inserted expressed sequence | Brentville VA, bioRxiv 2021 Jun;(): | J:308658 | SARS-CoV-2_virus|Vaccine | Tg(H2-Ab1-HLA-DPB1)1LoneTransgenic |
Brentville VA, bioRxiv 2021 Jun;(): |
|||||||
Tg(HLA-A2*/H2-Kb)273Rtct | MGI:3851006 | Transgenic | Inserted expressed sequence | Prakash S, bioRxiv 2020;(): | J:295374 | SARS-CoV-2_virus|Vaccine | Tg(HLA-A2*/H2-Kb)273RtctTransgenic |
Prakash S, bioRxiv 2020;(): |
|||||||
Tg(HLA-A/H2-D/B2M)1Bpe | MGI:3711164 | Transgenic | Inserted expressed sequence | Brentville VA, bioRxiv 2021 Jun;(): | J:308658 | SARS-CoV-2_virus|Vaccine | Tg(HLA-A/H2-D/B2M)1BpeTransgenic |
Brentville VA, bioRxiv 2021 Jun;(): |
|||||||
Tg(HLA-DRA*0101,HLA-DRB1*0101)1Dma | MGI:5312109 | Transgenic | Inserted expressed sequence | Brentville VA, bioRxiv 2021 Jun;(): | J:308658 | SARS-CoV-2_virus|Vaccine | Tg(HLA-DRA*0101,HLA-DRB1*0101)1DmaTransgenic |
Brentville VA, bioRxiv 2021 Jun;(): |
|||||||
Tg(HLA-DRA*0101,HLA-DRB1*0101)1Dmz | MGI:3809457 | Transgenic | Humanized sequence|Inserted expressed sequence | Prakash S, bioRxiv 2020;(): | J:295374 | SARS-CoV-2_virus|Vaccine | Tg(HLA-DRA*0101,HLA-DRB1*0101)1DmzTransgenic |
Prakash S, bioRxiv 2020;(): |
|||||||
Tg(K18-ACE2)2Prlmn | MGI:6389235 | Transgenic | Humanized sequence|Inserted expressed sequence | MGI:6399965 MGI:6455041 | severe acute respiratory syndrome COVID-19 | DOID:2945 DOID:0080600 | cardiovascular system immune system respiratory system mortality/aging behavior/neurological cellular growth/size/body hematopoietic system homeostasis/metabolism liver/biliary system nervous system vision/eye | MP:0005385 MP:0005387 MP:0005388 MP:0010768 MP:0005386 MP:0005384 MP:0005378 MP:0005397 MP:0005376 MP:0005370 MP:0003631 MP:0005391 | Netland J, J Virol 2008 Aug;82(15):7264-75 McCray PB Jr, J Virol 2007 Jan;81(2):813-21 Zhao J, J Virol 2009 Mar;83(5):2368-73 Dediego ML, Virology 2008 Jul 5;376(2):379-89 Zumla A, Nat Rev Drug Discov 2016 May;15(5):327-47 Gretebeck LM, Curr Opin Virol 2015 Aug;13():123-9 Netland J, Virology 2010 Mar 30;399(1):120-128 Natoli S, Eur J Neurol 2020 Apr 25;(): Lutz C, Hum Genomics 2020 Jun 4;14(1):20 Moreau GB, Am J Trop Med Hyg 2020 Jul 28;(): Cleary SJ, Br J Pharmacol 2020 May 27;(): Mullick JB, Cell Mol Bioeng 2020 Jul 27;():1-11 Case JB, Cell Host Microbe 2020 Sep 9;28(3):465-474.e4 Winkler ES, Nat Immunol 2020 Aug 24;(): Golden JW, JCI Insight 2020 Aug 25;(): Johansen MD, Mucosal Immunol 2020 Aug 20;(): Munoz-Fontela C, Nature 2020 Sep 23;(): Clark JJ, bioRxiv 2020;(): Bai L, bioRxiv 2020;(): Rathnasinghe R, Emerg Microbes Infect 2020 Oct 17;():1-19 Jia H, Nat Commun 2020 Oct 14;11(1):5165 Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Ho JSY , bioRxiv 2020 Dec;(): Zhang H, bioRxiv 2020 Dec;(): Kumari P, bioRxiv 2020 Dec;(): Chen JS, bioRxiv 2020 Sep 25;(): Winkler ES, bioRxiv 2020 Dec;(): Soni DK, bioRxiv 2020 Dec;(): Liu R, bioRxiv 2021 Jan;(): Garcia-Arriaza J, J Virol 2021 Jan 7;(): Yuan L, Emerg Microbes Infect 2020 Dec;9(1):949-961 Chen JS, J Virol 2021 Jan 13;(): Carossino M, bioRxiv 2021 Jan;(): Oladunni FS, Nat Commun 2020 Nov 30;11(1):6122 Ku MW, bioRxiv 2021 Feb;(): Dampalla CS, bioRxiv 2021 Feb;(): Noy-Porat T, bioRxiv 2021 Feb;(): Biswas R, bioRxiv 2021 Feb;(): Brunaugh AD, PLoS One 2021;16(2):e0246803 Yinda CK, PLoS Pathog 2021 Jan;17(1):e1009195 Song E, J Exp Med 2021 Mar 1;218(3): Arce VM, Cell Mol Immunol 2021 Jan 14;(): Case JB, bioRxiv 2021 Mar;(): Silvas J, bioRxiv 2021 Mar;(): Zhai C, bioRxiv 2021 Mar;(): Hassler L, bioRxiv 2021 Mar;(): Napolitano V, bioRxiv 2021 Mar;(): Hanke L, bioRxiv 2021 Mar;(): Hoffmann D, bioRxiv 2021 Mar;(): Ullah i, bioRxiv 2021 Mar;(): Zheng J, Nature 2021 Jan;589(7843):603-607 White KM, Science 2021 Feb 26;371(6532):926-931 Elia U, bioRxiv 2021 Mar;(): Liu R, Proc Natl Acad Sci U S A 2021 Mar 23;118(12):e2026785118 Rosenfeld R, Nat Commun 2021 Feb 11;12(1):944 Joag V, J Immunol 2021 Mar 1;206(5):931-935 Sims JJ, bioRxiv 2021 Apr;(): Cao H, bioRxiv 2021 Apr;(): Seehusen F, bioRxiv 2021 Apr;(): Idris A, bioRxiv 2021 Apr;(): Matchett WE, bioRxiv 2021 Apr;(): Seibert B, bioRxiv 2021 Apr;(): Zhang X, Cell 2021 Apr 15;184(8):2229-2238.e13 Johnson BA, Nature 2021 Mar;591(7849):293-299 Xian H, Immunity 2021 Jul 13;54(7):1463-1477.e11 Marx S, bioRxiv 2021 Aug;(): Ryu DK, bioRxiv 2021 Jul;(): Alvaradov DM, bioRxiv 2021 Aug;(): Li W, bioRxiv 2021 Aug;(): Tarres-Frexas F, bioRxiv 2021 Aug;(): Ndeupen S, bioRxiv 2021 Aug;(): Fumagalli V, bioRxiv 2021 Aug;(): Wagner TR, bioRxiv 2021 Aug;(): Ulrich L, bioRxiv 2021 Jun;(): Belouzard S, bioRxiv 2021 Jun;(): Madar-Balakirski N, bioRxiv 2021 Jul;(): Hunt AC, bioRxiv 2021 Jul;(): Grandi A, bioRxiv 2021 Jul;(): Afkhami S, bioRxiv 2021 Jul;(): Venzon M, bioRxiv 2021 Jul;(): Radvak P, bioRxiv 2021 Jun;(): Dong W, bioRxiv 2021 Jun;(): Melamed S, bioRxiv 2021 Jun;(): Conforti A, bioRxiv 2021 Jun;(): Chen JS, bioRxiv 2021 Jun;(): Mao T, bioRxiv 2021 Jun;(): Scaglione A, bioRxiv 2021 Jun;(): Visualization of SARS-CoV-2 infection dynamic., bioRxiv 2021 Jun;(): Chaparian RR, bioRxiv 2021 Apr;(): Shapira T, bioRxiv 2021 May;(): Horspool AM, bioRxiv 2021 May;(): Van Dyke MC, bioRxiv 2021 May;(): Stefan MA, bioRxiv 2021 May;(): Amruta N, bioRxiv 2021 May;(): Dong W, bioRxiv 2021 May;(): Joyce MGl Chen WH, bioRxiv 2021 May;(): Israelow B, bioRxiv 2021 May;(): Greer CD, bioRxiv 2021 Aug;(): Salzer R, bioRxiv 2021 May;(): McMillan CL, bioRxiv 2021 May;(): Zhu C, bioRxiv 2021 May;(): Ho JSY, Cell 2021 May 13;184(10):2618-2632.e17 Caceres CJ, Sci Rep 2021 May 5;11(1):9609 Noy-Porat T, iScience 2021 May 21;24(5):102479 Zheng M, Nat Immunol 2021 Jul;22(7):829-838 Subramaniam S, bioRxiv 2021 Aug;(): Ying B, bioRxiv 2021 Aug;(): Hilligan KL, bioRxiv 2021 Aug;(): Colunga Biancatelli R, Am J Physiol Lung Cell Mol Physiol 2021 Jun;(): Hassan AO, Cell Rep 2021 Jul 27;36(4):109452 Turan RD, Sci Rep 2021 Aug 4;11(1):15799 Chan CEZ, PLoS One 2021;16(6):e0253487 Beaudoin-Bussieres G, bioRxiv 2021 Sep;(): Dhanyalayam D, bioRxiv 2021 Sep;(): Castro JT, bioRxiv 2021 Sep;(): Robertson SJ, bioRxiv 2021 Sep;(): Eltobgy M, bioRxiv 2021;(): Puhl AC, bioRxiv 2021;(): Sohn SY, mBio 2021 Nov 2;():e0275621 Li K, mBio 2021 Aug 31;12(4):e0097021 Kaiser R, JCI Insight 2021 Sep 22;6(18):e150862 Zhou R, bioRxiv 2021 Oct;(): Tada T, Cell Rep 2020 Dec 22;33(12):108528 Hong J, bioRxiv 2021 Oct;(): Mejia OR, bioRxiv 2021 Nov;(): Olivarria GM, bioRxiv 2021 Nov;(): Barreiro A, bioRxiv 2021 Dec;(): Chen Y, bioRxiv 2021 Nov;(): Chaves OA, bioRxiv 2021 Nov;(): Ng KW, bioRxiv 2021 Dec;(): Lin X, bioRxiv 2021 Dec;(): Zhao Y, bioRxiv 2021 Dec;(): Zani A, bioRxiv 2021Dec;(): Zhang L, bioRxiv 2021 Dec;(): Gregoire C, bioRxiv 2021 Dec;(): Puhl AC, bioRxiv 2021 Dec;(): Xiao Y, Cell 2021 Dec 9;184(25):6037-6051.e14 Liu X, mBio 2021 Apr 20;12(2): Gawish R, Elife 2022 Jan 13;11():e74623 Ku MW, EMBO Mol Med 2021 Dec 7;13(12):e14459 Khaddaj-Mallat R, Neurobiol Dis 2021 Dec;161():105561 Awosanya OD, Bone 2022 Jan;154():116227 Kim GN, PLoS Pathog 2021 Dec;17(12):e1010092 Qin Z, Theranostics 2021;11(16):8076-8091 Hassert M, PLoS Pathog 2020 Dec;16(12):e1009163 Ceon E, bioRxiv 2022 Jan;(): Jeong GU, bioRxiv 2022;(): Chong Z, bioRxiv 2022;(): Lee KS, bioRxiv 2022;(): Duty A, bioRxiv 2022;(): Tatham L, bioRxiv 2022;(): Mao T, bioRxiv 2022;(): Ying B, bioRxiv 2022 Feb;(): Liu Y, bioRxiv 2022 Feb;(): Bishop CR, bioRxiv 2022 Feb;(): Mann BJ, bioRxiv 2022 Feb;(): Ye C, bioRxiv 2022 Mar;(): Sun CP, PLoS Pathog 2021 Aug;17(8):e1009758 Smeyne RJ, bioRxiv 2022 Feb;(): Wenzel J, Nat Neurosci 2021 Nov;24(11):1522-1533 Cohen AA, bioRxiv 2022 Mar;(): Zhang L, bioRxiv 2022 Mar;(): Natekar JP, bioRxiv 2022 Apr;(): Jeong GU, bioRxiv 2022 Apr;(): Rizvi ZA, bioRxiv 2022 Apr;(): Chong Z, Cell Rep 2022 May 10;39(6):110799 Walls AC, Cell Rep 2022 Aug 30;40(9):111299 Bishop CR, PLoS Pathog 2022 Sep;18(9):e1010867 Zhang L, EMBO Mol Med 2022 Sep 12;():e16109 Israelow B, Sci Immunol 2021 Oct 15;6(64):eabl4509 Kim SH, Front Immunol 2022;13():1055811 de Almeida L, Sci Adv 2022 Sep 16;8(37):eabo5400 Manangeeswaran M, Front Immunol 2022;13():919815 Su P, Mol Brain 2022 Aug 9;15(1):71 Chen IP, Cell Rep 2022 Jul 19;40(3):111088 Winkler ES, J Virol 2022 Jan 12;96(1):e0151121 Pan R, mBio 2022 Jan 25;():e0366221 Qin C, Proc Natl Acad Sci U S A 2022 Jun 28;119(26):e2122897119 Solopov PA, Am J Pathol 2022 Jul;192(7):990-1000 Eltobgy MM, Proc Natl Acad Sci U S A 2022 May 24;119(21):e2202012119 Dhanyalayam D, Front Cardiovasc Med 2022;9():783974 Parray HA, PLoS Pathog 2022 Dec;18(12):e1010994 Humphries F, Sci Immunol 2021 May 18;6(59): Lee S, Nature 2021 Nov;599(7884):283-289 Hassan AO, Cell 2020 Oct 1;183(1):169-184.e13 Amarilla AA, Nat Commun 2021 Jun 8;12(1):3431 Dugan HL, Immunity 2021 Jun 8;54(6):1290-1303.e7 Jennewein MF, Cell Rep 2021 Jul 13;36(2):109353 Garcia-Ayllon MS, FASEB J 2021 Aug;35(8):e21745 Li M, Sci Immunol 2021 May 18;6(59): Callahan V, Viruses 2021 Jun 3;13(6): Achdout H, Nat Commun 2021 Oct 5;12(1):5819 Scaglione A, Front Immunol 2021;12():719077 Vitner EB, Life Sci Alliance 2022 Jan;5(1): Roberts LM, J Immunol 2021 Nov 15;207(10):2399-2404 Chaouat AE, PLoS Pathog 2021 Dec;17(12):e1010175 El-Shennawy L, Nat Commun 2022 Jan 20;13(1):405 Chen EC, Cell Rep 2021 Aug 24;36(8):109604 Bertoglio F, Cell Rep 2021 Jul 27;36(4):109433 Makdasi E, Cell Rep 2021 Sep 7;36(10):109679 Li W, Cell Rep 2022 Jan 11;38(2):110210 Konrath KM, Cell Rep 2022 Feb 1;38(5):110318 Joyce MG, Cell Rep 2021 Dec 21;37(12):110143 Ordonez AA, Commun Biol 2022 Mar 18;5(1):242 Schepens B, Sci Transl Med 2021 Nov 24;13(621):eabi7826 Hauser BM, Cell Rep 2022 Mar 22;38(12):110561 Syenina A, PLoS Biol 2022 May;20(5):e3001643 Suryadevara N, J Clin Invest 2022 Jun 1;132(11):e159062 Hong J, Proc Natl Acad Sci U S A 2022 May 3;119(18):e2201433119 Americo JL, Proc Natl Acad Sci U S A 2022 Jun 14;119(24):e2202069119 Dubuc I, Front Immunol 2022;13():893792 Zhu C, Nat Commun 2022 Aug 3;13(1):4503 Perez P, Front Immunol 2022;13():995235 Mao T, Science 2022 Nov 25;378(6622):eabo2523 Yang JH, Sci Rep 2023 Feb 27;13(1):3303 Oktay E, Commun Biol 2023 Mar 23;6(1):308 Weiss S, Int J Mol Sci 2023 May 5;24(9): Ying B, Sci Transl Med 2022 Feb 2;14(630):eabm3302 Dampalla CS, Proc Natl Acad Sci U S A 2021 Jul 20;118(29): Zhao S, Nat Commun 2021 Aug 9;12(1):4887 Drayman N, Science 2021 Aug 20;373(6557):931-936 VanBlargan LA, Immunity 2021 Aug 19;(): van Oosten L, mBio 2021 Oct 26;12(5):e0181321 Dong W, J Virol 2022 Jan 12;96(1):e0096421 Kim EH, J Virol 2022 Mar 23;96(6):e0187321 Villadiego J, Nat Neurosci 2023 Feb;26(2):226-238 | J:138136 J:283648 J:283997 J:283998 J:283999 J:284000 J:286214 J:287925 J:288402 J:291888 J:292835 J:294026 J:294058 J:294083 J:294084 J:295350 J:295351 J:296067 J:296212 J:296397 J:296535 J:296686 J:298250 J:298262 J:298267 J:298866 J:299082 J:299096 J:299104 J:300041 J:300104 J:300110 J:300428 J:300960 J:302144 J:302145 J:302148 J:302158 J:302248 J:302313 J:302314 J:302316 J:302703 J:302912 J:302918 J:302921 J:303204 J:303206 J:303207 J:303209 J:303220 J:303457 J:303462 J:303465 J:303472 J:303898 J:304613 J:304616 J:304647 J:304677 J:304678 J:304698 J:305460 J:307033 J:308159 J:308571 J:308573 J:308575 J:308578 J:308579 J:308580 J:308584 J:308585 J:308620 J:308621 J:308635 J:308636 J:308637 J:308639 J:308640 J:308642 J:308643 J:308647 J:308651 J:308652 J:308655 J:308656 J:308666 J:308672 J:308713 J:308716 J:308719 J:308721 J:308723 J:308724 J:308725 J:308726 J:308733 J:308745 J:308749 J:308889 J:308890 J:308894 J:308895 J:308896 J:308903 J:309192 J:309196 J:309197 J:309512 J:309629 J:309630 J:309634 J:310110 J:310121 J:310123 J:310124 J:311911 J:311915 J:312952 J:313329 J:313337 J:313436 J:313439 J:313447 J:315717 J:315722 J:315723 J:315729 J:315731 J:315739 J:315744 J:316763 J:316764 J:316765 J:316768 J:316769 J:317125 J:317455 J:318828 J:319366 J:319440 J:319441 J:319447 J:319458 J:319459 J:321756 J:321757 J:321761 J:321763 J:321764 J:321766 J:321770 J:321873 J:321879 J:321906 J:321910 J:321927 J:322631 J:322638 J:323957 J:324935 J:324936 J:324941 J:324951 J:325034 J:325089 J:328107 J:330016 J:330045 J:331753 J:331754 J:331763 J:331765 J:331766 J:331767 J:331773 J:331808 J:331821 J:331822 J:331823 J:331826 J:333745 J:333769 J:334872 J:335892 J:335897 J:335898 J:335899 J:335902 J:335904 J:335906 J:335907 J:335910 J:335914 J:335918 J:335919 J:335924 J:335928 J:335929 J:335930 J:335931 J:335933 J:335935 J:335939 J:335943 J:335945 J:335947 J:335949 J:335952 J:335960 J:335961 J:335969 J:335976 J:335986 J:335996 J:335997 J:336005 J:336008 J:336014 J:336016 J:336017 J:336018 J:336021 J:336025 J:336026 J:336189 | Infection|SARS-CoV_virus Infection|Mouse_Hepatitis_virus|SARS-CoV_virus MERS-CoV_virus|SARS-CoV_virus SARS-CoV-MA_virus|SARS-CoV_virus|Vaccine Infection|SARS-CoV-2_virus SARS-CoV-2_virus Infection|Pathology|SARS-CoV-2_virus SARS-CoV-2_virus|SARS-CoV_virus SARS-CoV-2_virus|Vaccine Infection|Pathology|SARS-CoV-2_virus|Sex_bias MERS-CoV-MA_virus|MERS-CoV_virus|SARS-CoV-2-MA_virus|SARS-CoV-2_virus|SARS-CoV-MA_virus|SARS-CoV_virus SARS-CoV-2-MA_virus|SARS-CoV-2_virus|SARS-CoV_virus Comorbidity|Pathology|SARS-CoV-2_virus Comorbidity|SARS-CoV-2_virus Pathology|SARS-CoV-2_virus|Treatment SARS-CoV-2_virus|Treatment Vaccine MERS-CoV_virus|SARS-CoV-2_virus|SARS-CoV_virus Pathology|SARS-CoV-2_virus Gene|SARS-CoV-2_virus MERS-CoV_virus|SARS-CoV-2_virus|Treatment SARS-CoV-2_virus|Treatment|VOC_B.1.1.7_Alpha|VOC_B.1.351_Beta SARS-CoV-2_virus|Treatment|VOC_B.1.351_Beta SARS-CoV-2_virus|Vaccine|VOC_B.1.351_Beta SARS-CoV-2_virus|Treatment|VOC_B.1.617.2_Delta Treatment|VOC_B.1.1.7_Alpha|VOC_B.1.351_Beta|VOC_B.1.429|VOC_B.1.617.2_Delta|VOC_P.1_Gamma Infection|SARS-CoV-2_virus|VOC_B.1.351_Beta Infection|SARS-CoV-2_virus|VOC_B.1.1.7_Alpha|VOC_B.1.351_Beta SARS-CoV-2_virus|Treatment|VOC_P.1_Gamma SARS-CoV-2_virus|Treatment|VOC_B.1.1.7_Alpha|VOC_B.1.351_Beta|VOC_P.1_Gamma SARS-CoV-2_virus|Vaccine|VOC_B.1.1.7_Alpha|VOC_B.1.351_Beta Pathology|SARS-CoV-2_virus|VOC_B.1.1.7_Alpha|VOC_B.1.351_Beta SARS-CoV-2_virus|Treatment|VOC_B.1.1.7_Alpha SARS-CoV-2_virus|VOC_B.1.351_Beta Treatment|VOC_B.1.1.7_Alpha|VOC_B.1.351_Beta|VOC_P.1_Gamma SARS-CoV-2_virus|VOC_B.1.1.7_Alpha|VOC_B.1.351_Beta SARS-CoV-2-MA_virus|SARS-CoV-2_virus|Vaccine|VOC_B.1.1.7_Alpha|VOC_B.1.351_Beta|VOC_B.1.617.2_Delta Gene|SARS-CoV-2-MA_virus SARS-CoV-2_virus|Treatment|VOC_B.1.1.7_Alpha|VOC_B.1.351_Beta|VOC_B.1.617.2_Delta|VOC_P.1_Gamma Comorbidity|SARS-CoV-2-MA_virus|SARS-CoV-2_virus Gene|Pathology|SARS-CoV-2_virus Vaccine|VOC_B.1.1.7_Alpha|VOC_B.1.351_Beta|VOC_B.1.617.2_Delta Gene|SARS-CoV-2-MA_virus|SARS-CoV-2_virus Mouse_Hepatitis_virus|SARS-CoV-2_virus|Treatment SARS-CoV-2_virus|Treatment|VOC_B.1.1.7_Alpha|VOC_B.1.427|VOC_B.1.617.2_Delta Pathology|SARS-CoV-2-MA_virus SARS-CoV-2_virus|Vaccine|VOC_P.1_Gamma SARS-CoV-2_virus|Treatment|VOC_B.1.1.529_Omicron|VOC_B.1.351_Beta Pathology|VOC_B.1.617.2_Delta Treatment|VOC_B.1.1.529_Omicron|VOC_B.1.1.7_Alpha|VOC_B.1.351_Beta|VOC_B.1.617.2_Delta|VOC_P.1_Gamma Treatment|VOC_B.1.1.529_Omicron|VOC_B.1.617.2_Delta Vaccine|VOC_B.1.1.529_Omicron Pathology PASC|SARS-CoV-2_virus Pathology|SARS-CoV-2_virus|VOC_B.1.351_Beta SARS-CoV-2_virus|Treatment|Variant|VOC_B.1.1.529_Omicron|VOC_P.1_Gamma Infection|SARS-CoV-2-MA_virus|SARS-CoV-2_virus|VOC_B.1.1.529_Omicron|VOC_B.1.1.7_Alpha|VOC_B.1.351_Beta|VOC_B.1.617.2_Delta Infection|Pathology|SARS-CoV-2_virus|VOC_B.1.1.529_Omicron|VOC_B.1.617.2_Delta SARS-CoV-2_virus|Vaccine|Variant|VOC_B.1.351_Beta SARS-CoV-2-MA_virus|SARS-CoV-2_virus SARS-CoV-2_virus|Treatment|VOC_B.1.1.529_Omicron Infection|Mouse_Hepatitis_virus|SARS-CoV-2_virus Infection|SARS-CoV-2_virus|Treatment Comorbidity|SARS-CoV-2_virus|Sex_bias SARS-CoV-2_virus|Treatment|Variant SARS-CoV-2_virus|Treatment|Vaccine SARS-CoV-2_virus|Treatment|VOC_B.1.1.529_Omicron|VOC_B.1.617.2_Delta SARS-CoV-2_virus|Treatment|VOC_B.1.351_Beta|VOC_B.1.617.2_Delta SARS-CoV-2_virus|Vaccine|Variant SARS-CoV-2_virus|Vaccine|VOC_B.1.1.7_Alpha|VOC_B.1.351_Beta|VOC_B.1.617.2_Delta Comorbidity|Infection|SARS-CoV-2_virus Pathology|SARS-CoV-2_virus|Vaccine | Tg(K18-ACE2)2PrlmnTransgenic |
MGI:6399965 MGI:6455041 | cardiovascular system immune system respiratory system mortality/aging severe acute respiratory syndrome behavior/neurological cellular growth/size/body hematopoietic system homeostasis/metabolism liver/biliary system nervous system vision/eye COVID-19 |
Netland J, J Virol 2008 Aug;82(15):7264-75 McCray PB Jr, J Virol 2007 Jan;81(2):813-21 Zhao J, J Virol 2009 Mar;83(5):2368-73 Dediego ML, Virology 2008 Jul 5;376(2):379-89 Zumla A, Nat Rev Drug Discov 2016 May;15(5):327-47 Gretebeck LM, Curr Opin Virol 2015 Aug;13():123-9 Netland J, Virology 2010 Mar 30;399(1):120-128 Natoli S, Eur J Neurol 2020 Apr 25;(): Lutz C, Hum Genomics 2020 Jun 4;14(1):20 Moreau GB, Am J Trop Med Hyg 2020 Jul 28;(): Cleary SJ, Br J Pharmacol 2020 May 27;(): Mullick JB, Cell Mol Bioeng 2020 Jul 27;():1-11 Case JB, Cell Host Microbe 2020 Sep 9;28(3):465-474.e4 Winkler ES, Nat Immunol 2020 Aug 24;(): Golden JW, JCI Insight 2020 Aug 25;(): Johansen MD, Mucosal Immunol 2020 Aug 20;(): Munoz-Fontela C, Nature 2020 Sep 23;(): Clark JJ, bioRxiv 2020;(): Bai L, bioRxiv 2020;(): Rathnasinghe R, Emerg Microbes Infect 2020 Oct 17;():1-19 Jia H, Nat Commun 2020 Oct 14;11(1):5165 Karki R, bioRxiv 2021 Jan 7;184(1):149-168.e17 Ho JSY , bioRxiv 2020 Dec;(): Zhang H, bioRxiv 2020 Dec;(): Kumari P, bioRxiv 2020 Dec;(): Chen JS, bioRxiv 2020 Sep 25;(): Winkler ES, bioRxiv 2020 Dec;(): Soni DK, bioRxiv 2020 Dec;(): Liu R, bioRxiv 2021 Jan;(): Garcia-Arriaza J, J Virol 2021 Jan 7;(): Yuan L, Emerg Microbes Infect 2020 Dec;9(1):949-961 Chen JS, J Virol 2021 Jan 13;(): Carossino M, bioRxiv 2021 Jan;(): Oladunni FS, Nat Commun 2020 Nov 30;11(1):6122 Ku MW, bioRxiv 2021 Feb;(): Dampalla CS, bioRxiv 2021 Feb;(): Noy-Porat T, bioRxiv 2021 Feb;(): Biswas R, bioRxiv 2021 Feb;(): Brunaugh AD, PLoS One 2021;16(2):e0246803 Yinda CK, PLoS Pathog 2021 Jan;17(1):e1009195 Song E, J Exp Med 2021 Mar 1;218(3): Arce VM, Cell Mol Immunol 2021 Jan 14;(): Case JB, bioRxiv 2021 Mar;(): Silvas J, bioRxiv 2021 Mar;(): Zhai C, bioRxiv 2021 Mar;(): Hassler L, bioRxiv 2021 Mar;(): Napolitano V, bioRxiv 2021 Mar;(): Hanke L, bioRxiv 2021 Mar;(): Hoffmann D, bioRxiv 2021 Mar;(): Ullah i, bioRxiv 2021 Mar;(): Zheng J, Nature 2021 Jan;589(7843):603-607 White KM, Science 2021 Feb 26;371(6532):926-931 Elia U, bioRxiv 2021 Mar;(): Liu R, Proc Natl Acad Sci U S A 2021 Mar 23;118(12):e2026785118 Rosenfeld R, Nat Commun 2021 Feb 11;12(1):944 Joag V, J Immunol 2021 Mar 1;206(5):931-935 Sims JJ, bioRxiv 2021 Apr;(): Cao H, bioRxiv 2021 Apr;(): Seehusen F, bioRxiv 2021 Apr;(): Idris A, bioRxiv 2021 Apr;(): Matchett WE, bioRxiv 2021 Apr;(): Seibert B, bioRxiv 2021 Apr;(): Zhang X, Cell 2021 Apr 15;184(8):2229-2238.e13 Johnson BA, Nature 2021 Mar;591(7849):293-299 Xian H, Immunity 2021 Jul 13;54(7):1463-1477.e11 Marx S, bioRxiv 2021 Aug;(): Ryu DK, bioRxiv 2021 Jul;(): Alvaradov DM, bioRxiv 2021 Aug;(): Li W, bioRxiv 2021 Aug;(): Tarres-Frexas F, bioRxiv 2021 Aug;(): Ndeupen S, bioRxiv 2021 Aug;(): Fumagalli V, bioRxiv 2021 Aug;(): Wagner TR, bioRxiv 2021 Aug;(): Ulrich L, bioRxiv 2021 Jun;(): Belouzard S, bioRxiv 2021 Jun;(): Madar-Balakirski N, bioRxiv 2021 Jul;(): Ryu DK, bioRxiv 2021 Jul;(): Hunt AC, bioRxiv 2021 Jul;(): Grandi A, bioRxiv 2021 Jul;(): Afkhami S, bioRxiv 2021 Jul;(): Venzon M, bioRxiv 2021 Jul;(): Radvak P, bioRxiv 2021 Jun;(): Dong W, bioRxiv 2021 Jun;(): Melamed S, bioRxiv 2021 Jun;(): Conforti A, bioRxiv 2021 Jun;(): Chen JS, bioRxiv 2021 Jun;(): Mao T, bioRxiv 2021 Jun;(): Scaglione A, bioRxiv 2021 Jun;(): Visualization of SARS-CoV-2 infection dynamic., bioRxiv 2021 Jun;(): Chaparian RR, bioRxiv 2021 Apr;(): Shapira T, bioRxiv 2021 May;(): Horspool AM, bioRxiv 2021 May;(): Van Dyke MC, bioRxiv 2021 May;(): Stefan MA, bioRxiv 2021 May;(): Amruta N, bioRxiv 2021 May;(): Dong W, bioRxiv 2021 May;(): Joyce MGl Chen WH, bioRxiv 2021 May;(): Israelow B, bioRxiv 2021 May;(): Greer CD, bioRxiv 2021 Aug;(): Salzer R, bioRxiv 2021 May;(): McMillan CL, bioRxiv 2021 May;(): Zhu C, bioRxiv 2021 May;(): Ho JSY, Cell 2021 May 13;184(10):2618-2632.e17 Caceres CJ, Sci Rep 2021 May 5;11(1):9609 Noy-Porat T, iScience 2021 May 21;24(5):102479 Zheng M, Nat Immunol 2021 Jul;22(7):829-838 Subramaniam S, bioRxiv 2021 Aug;(): Ying B, bioRxiv 2021 Aug;(): Hilligan KL, bioRxiv 2021 Aug;(): Colunga Biancatelli R, Am J Physiol Lung Cell Mol Physiol 2021 Jun;(): Hassan AO, Cell Rep 2021 Jul 27;36(4):109452 Turan RD, Sci Rep 2021 Aug 4;11(1):15799 Chan CEZ, PLoS One 2021;16(6):e0253487 Beaudoin-Bussieres G, bioRxiv 2021 Sep;(): Dhanyalayam D, bioRxiv 2021 Sep;(): Castro JT, bioRxiv 2021 Sep;(): Robertson SJ, bioRxiv 2021 Sep;(): Eltobgy M, bioRxiv 2021;(): Puhl AC, bioRxiv 2021;(): Sohn SY, mBio 2021 Nov 2;():e0275621 Li K, mBio 2021 Aug 31;12(4):e0097021 Kaiser R, JCI Insight 2021 Sep 22;6(18):e150862 Zhou R, bioRxiv 2021 Oct;(): Tada T, Cell Rep 2020 Dec 22;33(12):108528 Hong J, bioRxiv 2021 Oct;(): Mejia OR, bioRxiv 2021 Nov;(): Olivarria GM, bioRxiv 2021 Nov;(): Barreiro A, bioRxiv 2021 Dec;(): Chen Y, bioRxiv 2021 Nov;(): Chaves OA, bioRxiv 2021 Nov;(): Ng KW, bioRxiv 2021 Dec;(): Lin X, bioRxiv 2021 Dec;(): Zhao Y, bioRxiv 2021 Dec;(): Zani A, bioRxiv 2021Dec;(): Zhang L, bioRxiv 2021 Dec;(): Gregoire C, bioRxiv 2021 Dec;(): Puhl AC, bioRxiv 2021 Dec;(): Xiao Y, Cell 2021 Dec 9;184(25):6037-6051.e14 Liu X, mBio 2021 Apr 20;12(2): Gawish R, Elife 2022 Jan 13;11():e74623 Ku MW, EMBO Mol Med 2021 Dec 7;13(12):e14459 Khaddaj-Mallat R, Neurobiol Dis 2021 Dec;161():105561 Awosanya OD, Bone 2022 Jan;154():116227 Kim GN, PLoS Pathog 2021 Dec;17(12):e1010092 Qin Z, Theranostics 2021;11(16):8076-8091 Hassert M, PLoS Pathog 2020 Dec;16(12):e1009163 Ceon E, bioRxiv 2022 Jan;(): Jeong GU, bioRxiv 2022;(): Chong Z, bioRxiv 2022;(): Lee KS, bioRxiv 2022;(): Duty A, bioRxiv 2022;(): Tatham L, bioRxiv 2022;(): Mao T, bioRxiv 2022;(): Ying B, bioRxiv 2022 Feb;(): Liu Y, bioRxiv 2022 Feb;(): Bishop CR, bioRxiv 2022 Feb;(): Mann BJ, bioRxiv 2022 Feb;(): Ye C, bioRxiv 2022 Mar;(): Sun CP, PLoS Pathog 2021 Aug;17(8):e1009758 Smeyne RJ, bioRxiv 2022 Feb;(): Wenzel J, Nat Neurosci 2021 Nov;24(11):1522-1533 Cohen AA, bioRxiv 2022 Mar;(): Zhang L, bioRxiv 2022 Mar;(): Natekar JP, bioRxiv 2022 Apr;(): Jeong GU, bioRxiv 2022 Apr;(): Rizvi ZA, bioRxiv 2022 Apr;(): Chong Z, Cell Rep 2022 May 10;39(6):110799 Walls AC, Cell Rep 2022 Aug 30;40(9):111299 Bishop CR, PLoS Pathog 2022 Sep;18(9):e1010867 Zhang L, EMBO Mol Med 2022 Sep 12;():e16109 Israelow B, Sci Immunol 2021 Oct 15;6(64):eabl4509 Kim SH, Front Immunol 2022;13():1055811 de Almeida L, Sci Adv 2022 Sep 16;8(37):eabo5400 Manangeeswaran M, Front Immunol 2022;13():919815 Su P, Mol Brain 2022 Aug 9;15(1):71 Chen IP, Cell Rep 2022 Jul 19;40(3):111088 Winkler ES, J Virol 2022 Jan 12;96(1):e0151121 Pan R, mBio 2022 Jan 25;():e0366221 Qin C, Proc Natl Acad Sci U S A 2022 Jun 28;119(26):e2122897119 Solopov PA, Am J Pathol 2022 Jul;192(7):990-1000 Eltobgy MM, Proc Natl Acad Sci U S A 2022 May 24;119(21):e2202012119 Dhanyalayam D, Front Cardiovasc Med 2022;9():783974 Parray HA, PLoS Pathog 2022 Dec;18(12):e1010994 Humphries F, Sci Immunol 2021 May 18;6(59): Lee S, Nature 2021 Nov;599(7884):283-289 Hassan AO, Cell 2020 Oct 1;183(1):169-184.e13 Amarilla AA, Nat Commun 2021 Jun 8;12(1):3431 Dugan HL, Immunity 2021 Jun 8;54(6):1290-1303.e7 Jennewein MF, Cell Rep 2021 Jul 13;36(2):109353 Garcia-Ayllon MS, FASEB J 2021 Aug;35(8):e21745 Li M, Sci Immunol 2021 May 18;6(59): Callahan V, Viruses 2021 Jun 3;13(6): Achdout H, Nat Commun 2021 Oct 5;12(1):5819 Scaglione A, Front Immunol 2021;12():719077 Vitner EB, Life Sci Alliance 2022 Jan;5(1): Roberts LM, J Immunol 2021 Nov 15;207(10):2399-2404 Chaouat AE, PLoS Pathog 2021 Dec;17(12):e1010175 El-Shennawy L, Nat Commun 2022 Jan 20;13(1):405 Chen EC, Cell Rep 2021 Aug 24;36(8):109604 Bertoglio F, Cell Rep 2021 Jul 27;36(4):109433 Makdasi E, Cell Rep 2021 Sep 7;36(10):109679 Li W, Cell Rep 2022 Jan 11;38(2):110210 Konrath KM, Cell Rep 2022 Feb 1;38(5):110318 Joyce MG, Cell Rep 2021 Dec 21;37(12):110143 Ordonez AA, Commun Biol 2022 Mar 18;5(1):242 Schepens B, Sci Transl Med 2021 Nov 24;13(621):eabi7826 Hauser BM, Cell Rep 2022 Mar 22;38(12):110561 Syenina A, PLoS Biol 2022 May;20(5):e3001643 Suryadevara N, J Clin Invest 2022 Jun 1;132(11):e159062 Hong J, Proc Natl Acad Sci U S A 2022 May 3;119(18):e2201433119 Americo JL, Proc Natl Acad Sci U S A 2022 Jun 14;119(24):e2202069119 Dubuc I, Front Immunol 2022;13():893792 Zhu C, Nat Commun 2022 Aug 3;13(1):4503 Perez P, Front Immunol 2022;13():995235 Mao T, Science 2022 Nov 25;378(6622):eabo2523 Yang JH, Sci Rep 2023 Feb 27;13(1):3303 Oktay E, Commun Biol 2023 Mar 23;6(1):308 Weiss S, Int J Mol Sci 2023 May 5;24(9): Ying B, Sci Transl Med 2022 Feb 2;14(630):eabm3302 Dampalla CS, Proc Natl Acad Sci U S A 2021 Jul 20;118(29): Zhao S, Nat Commun 2021 Aug 9;12(1):4887 Drayman N, Science 2021 Aug 20;373(6557):931-936 VanBlargan LA, Immunity 2021 Aug 19;(): van Oosten L, mBio 2021 Oct 26;12(5):e0181321 Dong W, J Virol 2022 Jan 12;96(1):e0096421 Kim EH, J Virol 2022 Mar 23;96(6):e0187321 Villadiego J, Nat Neurosci 2023 Feb;26(2):226-238 |
Tg(KRT18-DPP4)3Pbmj | MGI:6402178 | Transgenic | Epitope tag|Humanized sequence|Inserted expressed sequence | MGI:6402203 | Middle East respiratory syndrome | DOID:0080642 | cardiovascular system digestive/alimentary system hematopoietic system homeostasis/metabolism immune system nervous system renal/urinary system respiratory system mortality/aging | MP:0005385 MP:0005381 MP:0005397 MP:0005376 MP:0005387 MP:0003631 MP:0005367 MP:0005388 MP:0010768 | Li K, J Infect Dis 2016 Mar 1;213(5):712-22 Leist SR, Methods Mol Biol 2020;2099():137-159 Zhou J, Sci Adv 2017 Nov;3(11):eaao4966 Yuan S, Nat Commun 2019 Jan 10;10(1):120 Rathnayake AD, Sci Transl Med 2020 Aug 3;(): Knaap RC, bioRxiv 2019;(): Gutierrez-Alvarez J, Proc Natl Acad Sci U S A 2021 Oct 26;118(43):e2111075118 | J:285467 J:285962 J |